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The most effective way to treat clinical pain is to target the subpopulation of primary 
afferent neurons responsible. However, clinical pain is heterogeneous, reflecting, in part, 
differences in the relative contribution of different subpopulations of afferents. The functional 
heterogeneity of primary afferents is reflected in the heterogeneous regulation of intracellular 
Ca
2+
 ([Ca
2+
]i). Because the regulation of [Ca
2+
]i contributes to neuronal function, injury-induced 
changes in neuronal function may be due to dysregulation in the regulation of [Ca
2+
]i. Thus, the 
persistent inflammation-induced increase in the magnitude and duration of depolarization-
evoked Ca
2+
 transient in a subset of putative nociceptive cutaneous DRG neurons served as the 
focus of this thesis. I first ruled out the contribution of Ca
2+
-induced Ca
2+
 release to the 
inflammation-induced increase in the evoked Ca
2+
 transient. Results of these experiments also 
indicated the presence of tightly segregated Ca
2+
 regulatory domains where Ca
2+
 transients 
evoked via Ca
2+
 influx and release from intracellular stores are functionally isolated. Parametric 
analysis demonstrated that inflammation-induced changes in evoked Ca
2+
 had a high threshold 
for activation, thus I focused on low affinity Ca
2+
 extrusion mechanism, Na
+
/Ca
2+
 exchanger 
(NCX). I demonstrated that NCX regulates the decay of the evoked transient in the same subset 
of putative nociceptive afferents modified by inflammation, and can influence axonal [Ca
2+
]i 
levels, resting membrane potential, and nociceptive threshold. Finally, I confirmed a role for 
NCX in response to persistent inflammation, such that the increase in the duration of the evoked 
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 v 
transient is due to a loss of NCX in the cell body due to an increase in unidirectional NCX3 
trafficking to the peripheral terminals. These observations serve as the basis for my current 
working hypothesis that the inflammation-induced changes in trafficking of NCX3, underlie 
three major aspects of the inflammatory response: an increase in transmitter release from the 
central terminal to contribute to inflammatory hyperalgesia, a change in gene expression 
secondary to altered Ca
2+
 transients in the cell body, and a decrease in the neurogenic 
inflammatory response in the periphery secondary to a decrease in transmitter release. Increasing 
NCX function may be a potentially novel therapeutic strategy for treatment of inflammatory 
pain. 
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1.0  INTRODUCTION 
One of the most vital functions of the nervous system is to integrate information about 
the occurrence and threat of injury. Pain, as a submodality of somatic sensations, has been 
defined by the International Association for the Study of Pain as an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage. Pain is modulated by 
past experiences, setting, affect, cognitive influences, gender and even cultural expectations, and 
thus is always subjective (Merskey, 1994). Accordingly, the central nervous system (CNS) must 
be intact for pain to be perceived. However, while pain can originate from within the central 
nervous system (e.g stroke), the vast majority of pain experienced, including chronic pain 
associated with nerve injury and inflammatory disorders, arises from activity in primary afferent 
neurons. Under normal conditions, only stimulus modalities (mechanical, thermal, and chemical) 
extreme enough to potentially injure tissues are capable of initiating the neural process of 
encoding noxious stimuli, referred to as nociception, and ultimately the perception of pain. 
Noxious stimuli are detected by specialized sensory neurons referred to as nociceptors, which 
then relay this information to the CNS. This process is referred to as transduction, and major 
progress has been made in understanding the molecular mechanisms underlying this process 
within nociceptive primary afferents. There has also been significant progress in our 
understanding of the subsequent steps in the process including transmission, perception and 
modulation. We chose to focus on the role of the primary afferent in pain because of 
overwhelming evidence indicating that in the presence of ongoing pain, a reduction in the 
relevant primary afferent activity or block of their input to the CNS can attenuate or completely 
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relieve the complex sensory and emotional consequences of the noxious input. This has been 
found to be true not only for acute pain associated with tissue injury, but for many types of 
chronic pain as well (Gracely et al., 1992, Verne et al., 2003, Price et al., 2009, Staud et al., 
2009).  
While pain is often discussed as a singular entity, it is clearly more complex. Even in 
experimental settings, intense heat to the foot can be easily dissected into an initial component, 
referred to as first pain that is described as lancinating, stabbing, or pricking, and a second 
component referred to as second pain described as burning, throbbing, cramping, or aching 
(Price and Dubner, 1977). More relevantly, in clinical settings, patients can complain of a variety 
of different “types” of pain. For example, ongoing pain is the most common feature of 
neuropathic pain, and is manifest in the absence of any other stimuli. Movement-evoked pain is 
most bothersome to patients suffering from osteoarthritis, who feel pain in their knees when 
attempting to walk. Patients may also complain of increased sensitivity to shifts in temperature, 
where cool or warm stimuli can be perceived as painful; the latter is most commonly manifest in 
burn patients. Additionally, the source of the pain is also associated with unique perceptual 
components such that, for example, sore muscles feel nothing like the cramping associated with 
distention of the colon.  
The available evidence indicates that specific nociceptive primary afferents mediate these 
different conditions. For example, the more rapidly conducting A-δ fibers have been shown to 
mediate first pain, while more slowly conducting C-fibers mediating second pain (Price and 
Dubner, 1977, Fang et al., 2005). Similarly, ongoing pain must reflect the emergence of ongoing 
activity in afferents. There is a distinct population of mechanically sensitive C-fibers that are 
relatively insensitive to mechanical stimuli in the absence of tissue injury, referred to as “silent” 
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nociceptors. However, in the presence of injury these silent afferents become spontaneously 
active and show robust mechanical sensitivity suggesting that these afferents mediate ongoing 
pain in neuropathic pain patients. Nociceptive afferents, by definition, can be sensitized. 
Sensitization, which typically develops as a consequence of tissue insult and inflammation, is 
defined as a reduction in the threshold and an increase in the magnitude of a response to noxious 
stimulation (Bessou and Perl, 1969). Since not all nociceptive afferents are mechanically 
sensitive, a subpopulation of mechanically sensitive afferents must mediate the pain of 
osteoarthritis. A subset of C-fibers that transduces noxious levels of heat has been shown to be 
essential for thermal sensitivity associated with most types of tissue injury, whereas two other 
distinct populations appears to underlie cold sensitivity following sensitization versus after injury 
(Bautista et al., 2007, Karashima et al., 2008). Furthermore, there is additional evidence that 
subpopulations of visceral nociceptors might underlie different types of visceral pain such as 
hypersensitivity to organ filling, acidic or burning pain, bloating and gas sensations (Robinson 
and Gebhart, 2008). Even more interesting, and potentially important from a clinical perspective, 
there is evidence to suggest that there are two parallel but distinct nociceptive pathways that code 
for the affective emotional component of pain versus sensory discriminative components (Braz et 
al., 2005). All of these data suggest that to most effectively treat clinical pain, it may not only be 
possible, but necessary, to target the subpopulation of afferents responsible for the type of pain 
and thus, identification of the nociceptive afferent subpopulation responsible for a particular type 
of pain is an active area of investigation. 
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1.1 HETEROGENEITY OF CUTANEOUS PRIMARY AFFERENTS 
The first major theme of this dissertation is the molecular mechanism underlying pain in 
the presence of inflammation. Cutaneous (skin) afferents were chosen for three major reasons. 
First, while deep tissue pain is more common, sensory receptors in the skin have been more 
thoroughly studied, most likely due to the relative ease of accessibility, than receptors in any 
other tissue, thereby providing a broader context within which to interpret the experimental 
results. Second, the opportunity to perform correlative studies in animals and humans allows for 
powerful inferences to be made regarding function and the more rapid translation of preclinical 
observations to the clinic. Significant insights into the cellular and molecular basis of cutaneous 
nociception have been realized from studies on conscious humans and animal models (Le Bars et 
al., 2001, Namer et al., 2009) and furthermore, the morphology of sensory nociceptive nerve 
endings is highly conserved in animals from rodents to humans (Raja et al., 1988, Lewin and 
Moshourab, 2004). Third, cutaneous pain still has clinical significance as diseases associated 
with small-fiber neuropathies (e.g. postherpetic neuralgia) have profound effects on cutaneous 
sensory function often leading to severe pain.  
While, there is considerable heterogeneity among nociceptive afferents, all sensory 
afferents are pseudo-unipolar neurons with an axon arising from the soma and then bifurcating. 
One branch gives rise to peripheral axons that ultimately terminate in somatic tissue in what is 
referred to as a free nerve ending, due to the absence of specialized cells around the terminal. 
The second branch gives rise to the central projection, terminating in the superficial dorsal horn 
of the spinal cord. The cell bodies reside in a cluster referred to as the dorsal root ganglia (DRG) 
positioned on either side of the spinal cord providing the innervation pattern, referred to as 
dermatomes, mapped onto the spinal cord (Raja et al., 1988).  
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Despite the clinical need, there is currently no single criterion that can reliable identify 
specific subpopulations of nociceptive afferents. Nevertheless, attempts have been made to 
classify these neurons based on their anatomy, physiology, and biochemical content (Koerber et 
al., 1988, Lawson, 2002). One criterion, as alluded to above, is conduction velocity. The sensory 
neurons thought to transmit nociceptive input can be divided into two classes: 1) small diameter 
cell bodies and slowly conducting unmyelinated axons (C fibers) and 2) medium diameter cell 
bodies and faster conducting lightly myelinated axons (Aδ fibers) (Harper and Lawson, 1985, 
Lawson, 2002). There also is evidence that cell body diameter can be used to distinguish these 
two classes as neurons with a small cell body diameter tend to give rise to C-fibers, while those 
with a large diameter cell body tend to give rise to A-beta fibers (Harper and Lawson, 1985). A 
second criterion is the noxious sensory modalities to which nociceptors respond, such that 
afferents that respond to mechanical, thermal, and chemical stimuli are referred to as polymodal, 
whereas others are only activated by a subset (e.g. mechano-heat). However, these classes are 
neither functionally nor anatomically homogeneous (Caterina and Julius, 1999). Alternatively, as 
a third criterion, neurochemical studies have revealed a variety of different markers based on the 
histological/neurochemical properties. The most common of these is the presence of the 
neuropeptides, substance P and calcitonin gene related peptide (CGRP). The subpopulation of 
nociceptors that express these peptides are referred to as peptidergic, while those without are 
referred to as non-peptidergic. Neurotrophic receptors are also widely used to distinguish 
subpopulations of nociceptive afferents, where one group is defined by the presence of the 
receptor for nerve growth factor (NGF), trkA, and others are defined by the presence of receptors 
for different members of the glial cell line-derived family of neurotrophic factors (GDNF). 
Alternatively, neurons were screened with a panel of plant lectins that demonstrated distinct 
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patterns of staining within the DRG (Acosta et al., 2014). Of these, the most commonly used is 
the lectin, alpha-D-galactose-specific isolectin B4 (IB4), from the plant Griffonia Simplicifolia. 
At least in cutaneous neurons, IB4 appears to primarily bind to non-peptidergic neurons that give 
rise to C-fibers. However, there are still limitations using these criteria. For example, there is a 
subpopulation of IB4+ C-fibers that coexpress Ret and TrkA and are therefore responsive to both 
GDNF and NGF (Orozco et al., 2001). Substance P has also been observed in myelinated Aα/β 
fibers (Koerber and Mendell, 1988, Lawson et al., 1997) thought to be involved in non-
nociceptive transduction.  
A fifth criterion is based on the chemosensitivity of the neuron. For example, different 
subpopulations of nociceptive afferents are responsive to ATP, decreases in pH, or nicotine. In 
this context, capsaicin, the chemical ingredient in hot peppers responsible for the burning 
sensation (Caterina and Julius, 1999), has been used most widely to identify nociceptors, as the 
most prominent perception in response to capsaicin application to the skin is pain (Acosta et al., 
2014). Importantly, the advantage of this last criterion is that it is easily used on dissociated 
neurons in vitro, where in the absence of a peripheral axon to enable functional characterization 
of the afferent in question, capsaicin sensitivity can be used to identify a nociceptor. The receptor 
for capsaicin is transient receptor potential vanilloid 1 (TRPV1), shown to underlie inflammatory 
thermal sensitivity. However, the downside of TRPV1-mediated chemosensitivity is that it 
encompasses a large variety of nociceptive subtypes. Localization studies with TRPV1 show 
expression in 75% of IB4+ and 59-65% of CGRP expressing neurons from rat (Michael and 
Priestley, 1999, Popovich et al., 1999). Furthermore, genetic deletion of TRPV1 in mice only 
partially reduced noxious heat sensitivity in behavioral assays, and had no effect on heat 
responsiveness of C-fibers tested (Caterina et al., 2000, Davis et al., 2000, Woodbury et al., 
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2004) suggesting that, at least in mice, there exists a subset of fibers other than those expressing 
TRPV1 that contribute to thermal pain.  
1.2 CUTANEOUS NONPEPTIDERGIC C-FIBERS 
Of interest for the work described in the subsequent chapters is the C fiber nonpeptidergic 
subpopulation of nociceptors that innervate the skin. In order to establish a “neurochemical 
profile” for this subpopulation at the level of the isolated cell body and due to the limitations 
surrounding individual criteria, multi-criterion approach was utilized. A retrograde tracer was 
used to identify the neurons in the lumbar DRG that innverate the glabrous skin. The cell body 
diameter was used to identify the C-fiber subpopulation based on data indicating that there is a 
rough correlation between cell body (soma) size and axon conduction velocity (Harper and 
Lawson, 1985). IB4 binding was used to distinguish peptidergic from non-peptidergic fibers. 
Lastly, capsaicin was applied to identify capsaicin-sensitive putative nociceptive neurons.  
The IB4+ population of cells has recently been the focus of many studies in rodents 
(Stucky and Lewin, 1999, Braz et al., 2005, Lu et al., 2010) and ultimately proved to be the most 
important subpopulation studied in the subsequent chapters. There are unique properties of this 
subpopulation, found to be very distinct from the IB4-, presumably peptidergic, subpopulation. 
While both classes are believed to respond to all noxious stimulus modalities, they appear to 
have distinct innervation patterns in the spinal cord as well as specialized multisynaptic 
connectivity in the CNS. IB4+ fibers terminate mainly in inner lamina II of the dorsal horn of the 
spinal cord and the neurons in the inner portion are rich in protein kinase C (PKC). Transgenic 
animals that lack the gamma isoform of PKC showed normal acute pain responses but attenuated 
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response to neuropathic pain (Malmberg et al., 1997). Alternatively, peptidergic fibers are found 
to terminate in the most superficial layers, lamina I, as well as deeper lamina III/IV. The resident 
neurons in these lamina express the receptor for substance P, neurokinin 1 (NK1). However, 
ablation of these neurons with a substance P-conjugated neurotoxin had no effect on baseline 
responses to noxious mechanical and heat stimuli and instead, the hypersensitivity induced by 
capsaicin was significantly attenuated (Mantyh et al., 1997). These fundamental differences in 
the patterns of termination suggest that they engage different CNS pain transmission circuitry. 
Braz and colleagues found that in distinct contrast to the peptidergic nociceptors, which 
communicate with projection neurons of lamina I (Gauriau and Bernard, 2002), the IB4+ 
population predominately engages the limbic regions of the brain, via projection neurons in the 
deep dorsal horn, suggesting a parallel pain pathway to brain regions that process affect and 
emotional aspects of pain (Braz et al., 2005). 
Studies have also demonstrated functional differences in efferent activity of primary 
afferents, that is involved in regulation of vasculature and immune cells within the skin 
necessary to maintain general tissue health and bone integrity (Pierce et al., 1995, Offley et al., 
2005). Peptidergic afferents in particular appear to be the major effectors of this efferent 
mechanism, referred to as neurogenic inflammation (Cao et al., 1998). The hallmarks of 
inflammation are redness (rubor), swelling or edema (tumor), pain (dolor), and warmth (calor). 
CGRP and substance P are released from primary afferents into the skin and cause vasodilation 
(redness) and plasma extravasation (swelling), respectively, in addition to immune cell activation 
and recruitment, release of pro-inflammatory cytokines, and production of new immune cells. 
Neurogenic inflammation is thought to accelerate healing (Lynn et al., 1996). However, in some 
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situations, it can exacerbate tissue damage/pain by indirectly facilitating interplay between 
components of pro-inflammatory mechanisms and nociception (Chiu et al., 2012).  
The extent to which there is an efferent function for IB4+ afferents is not currently clear. 
However, recent evidence suggests that IB4+ neuron may be the major source of glutamate 
release in the periphery as proteins considered essential for vesicular uptake and exocytotic 
release of glutamate are not expressed at detectable levels in most peptidergic neurons (Morris et 
al., 2005). Glutamate has been shown to have a major role in signaling in the skin, regulating the 
release of adenosine, CGRP, and nitric oxide in the periphery from primary afferent nerve 
terminals (Jackson and Hargreaves, 1999, Beirith et al., 2002). While there is little evidence that 
glutamate directly contributes to signs of inflammation, when released from nociceptors or 
exogenously applied it produces nociceptive effects in animals and painful responses in humans 
(Miller et al., 2011). Results from animal studies show analgesic benefit from regulation of the 
peripheral glutamatergic system (Aley and Levine, 2002, Jang et al., 2004) and clinical studies 
show potential for relieving some aspects of chronic pain (Quan et al., 2003, Takahashi et al., 
2008, Miller et al., 2011). However, more evidence is needed to better understand the role of 
efferent glutamate signaling and pain.  
Although much remains to be learned regarding the functional importance of the 
specializations among nociceptors, the existing data provides a framework for study. A more 
complete understanding of how nociceptor heterogeneity contributes to the discriminative 
properties of the pain pathway will aid the continued search of more specialized therapeutic 
approaches to prevent chronic pain. 
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1.3 REGULATION OF INTRACELLULAR CALCIUM SIGNALING 
The second major theme of this dissertation is the regulation of intracellular Ca
2+
 
([Ca
2+
]i). Ca
2+
 is a highly versatile second messenger within the cell that is involved in the 
regulation of a multitude of physiological processes, where kinetics, amplitude, and spatio-
temporal patterning (Berridge et al., 2000). Ca
2+
 signaling begins when a neuron is stimulated, 
resulting in an increase in the concentration of free cytosolic Ca
2+
. The increase can occur via 
influx (e.g. voltage-gated cation channels) or release from internal Ca
2+
 stores. Ca
2+
 then 
functions as a second messenger, interacting with different Ca
2+
 binding proteins to stimulate 
numerous Ca
2+
-sensitive processes ranging from neurotransmitter release, neuronal excitability, 
gene transcription, and even apoptosis (Berridge et al., 2000). The brief increase in [Ca
2+
]i, 
referred to as the Ca
2+
 transient, is terminated by a series of buffers, re-uptake, and efflux 
mechanisms that remove Ca
2+
 from the cytoplasm to restore the resting state. These regulatory 
mechanisms, referred to as the “Ca2+ toolkit” (Berridge et al., 2003), serve to tightly regulate 
[Ca
2+
]i..  
Ca
2+
 signaling has been described in virtually all cell types, but each cell type expresses a 
unique version of the toolkit, based on their function within the organism, in order to sculpt 
spatial and temporal properties of the transient to fit the precise needs of the cell. The influx and 
intracellular release pathways initiate the magnitude of the [Ca
2+
]i transient. These pathways are 
comprised of plasma membrane Ca
2+
 channels, such as voltage gated Ca
2+
 channels (VGCC), 
whereas release is mediated by intracellular Ca
2+
 channels, such as Ins(1,4,5)P3 receptor 
(InsP3R) and ryanodine receptor (RYR) expressed on the endoplasmic reticulum (ER), an 
organelle responsible for protein synthesis and metabolic processes. Regulation of Ca
2+
 after the 
initial rise in [Ca
2+
]i is mediated by a complex interplay between cytosolic Ca
2+
 buffer proteins, 
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mitochondria, an organelle responsible for a bulk of the cell’s ATP production, and Ca2+ pumps 
and exchangers expressed on the internal stores and plasma membrane. The cytosolic Ca
2+
 
buffers and mitochondria serve to rapidly sequester Ca
2+
, thereby regulating the magnitude of the 
transient, and then slowly release it back into the cytosol to be further regulated. The Na
+
/Ca
2+
 
exchanger (NCX), a low affinity/high capacity extrusion mechanism located in the plasma 
membrane, the plasma membrane Ca
2+
 ATPase (PMCA), and the sarco-endoplasmic reticulum 
Ca
2+
 ATPase (SERCA), thought to be lower capacity pumps with a much higher affinity for 
Ca
2+
, work in unison to pump Ca
2+
 out of the cell or into the ER, respectively. Together these 
mechanisms complete the recovery process and the maintenance of resting Ca
2+
 levels (Berridge 
et al., 2003). Under normal conditions, the buffering and extrusion mechanisms can reduce the 
Ca
2+
 transient introduced by different influx pathways, thus maintaining tight regulation of the 
magnitude and duration of the Ca
2+
 transient.  
Another layer to the regulation of intracellular Ca
2+
 involves a concept, referred to as 
Ca
2+
 microdomains, in which a transient Ca
2+
 signal is focalized to a specific area of a cell and 
regulated by a unique combination of machinery. For example, Ca
2+
 microdomains have been 
implicated in the presynaptic regulation of transmitter release. Based on the classical mechanism 
of release, VGCC influx is associated with the exocytotic machinery to provide the localized 
pulse of Ca
2+
 that triggers exocytosis (Weiss and Zamponi, 2012). Grosche and colleagues 
(1999) found that exocytosis could also be triggered by a Ca
2+
 microdomain involving release 
from the ER found in the synaptic endings in neurons. The size of these microdomains depends 
on a number of aspects, such as the rate of signal generation, signal diffusion, and removal, and 
presumably the density and distribution of Ca
2+
 regulatory mechanisms. The presence of Ca
2+
 
buffers helps to restrict brief pulses to small microdomains within the cytoplasm (Berridge, 
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2006). The global Ca
2+
 signal is thus a reflection of the integrated output of temporally and 
spatially restricted microdomains, which, if appropriately organized, may be able to sustain Ca
2+
 
oscillations within the cytosol.  
1.4 INFLAMMATION AND INTRACELLULAR CALCIUM SIGNALING  
There is a large body of evidence establishing that the regulation of [Ca
2+
]i contributes to 
neuronal function. Thus, a change in neuronal function, such as an increase in excitability or 
neurotransmitter release caused by injury or inflammation, may be reflected in the regulation of 
[Ca
2+
]i. This is supported by observations that traumatic nerve injury is associated with decreases 
in VGCC density (Baccei and Kocsis, 2000, Hogan et al., 2000, McCallum et al., 2003), a 
decrease in resting [Ca
2+
]i and a decrease in both the magnitude and decay of evoked Ca
2+
 
transients in DRG neurons after nerve injury (Fuchs et al., 2007).  In contrast, Lu and colleagues 
(2008) assessed the impact of persistent inflammation on resting and evoked [Ca
2+
]i and found 
that while there was no change in resting [Ca
2+
]i, there was a marked increase in the magnitude 
and duration of depolarization-evoked Ca
2+
 transients in putative nociceptive cutaneous DRG 
neurons. Despite subsequent work by these investigators (Lu and Gold, 2008, Lu et al., 2010), 
the underlying mechanisms and functional implications for this inflammation-induced change are 
currently unknown and thus served as the focus of this thesis.  
Based on the earlier discussion regarding primary afferent signaling, it should not be 
surprising that there is extensive heterogeneity in the relative contribution of the various 
components of the Ca
2+
 toolkit among sensory DRG neurons. Lu and colleagues (2006) have 
done extensive work analyzing the contribution of individual Ca
2+
 regulatory mechanisms with 
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respect to the depolarization-evoked Ca
2+
 transient in the dissociated sensory neuron cell body. 
They demonstrated marked differences among subpopulations with respect to both the 
magnitude and duration of evoked Ca
2+
 transients. The magnitude of the evoked increase in 
[Ca
2+
]i was the largest and the decayed the slowest in small diameter, IB4+ and capsaicin-
responsive (CAP+) neurons. However, this population had the smallest high voltage activated 
(HVA) VGCC current density, suggesting differential contribution of other toolkit components 
are reflected in the kinetics of the evoked transient compared to the large diameter IB4- negative 
population (Lu et al., 2006).  
The impact of inflammation was the most substantial in small diameter, IB4+, CAP+ 
neurons innervating the site of inflammation. Lu and colleagues used depolarization through 
application 30mM KCl (high K
+
) to evoke a Ca
2+
 transient in the dissociated cell body. This 
technique results in a shift in resting membrane potential to -20 mV for the duration of high K
+
 
application, and demonstrated that there was no inflammation-induced change in either the 
magnitude of the depolarization or the number of action potentials evoked in response to 
depolarization, thereby ruling out an inflammation-induced shift in excitability as an underlying 
mechanism for this change. Furthermore, depolarization leads to Ca
2+
 influx through VGCC 
only, so while there may be inflammation-induced changes in other cation channels, such as 
NMDAR (Tan et al., 2008) and TRP channels (Koerber et al., 2010), these are not engaged by 
the stimulus used by Lu and colleagues.  An increase in HVA current density has been identified 
in a number of chronic pain conditions and is associated with a decrease in nociceptive threshold 
(Bourinet et al., 2014). However, inflammation was associated with a paradoxical decrease in the 
density of HVA current in small and medium but not large diameter cutaneous DRG neurons 
innervating the site of inflammation (Lu and Gold, 2008). While this decrease is attributed, at 
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least in part, to an inflammation-induced trafficking of the α2δ1 subunit and CaV2.2 protein to 
the central nerves of L4 and L5 ganglia ipsilateral to the site of inflammation (Lu and Gold, 
2008), it does not aid in understanding the underlying mechanism of the inflammation-induced 
increase in the evoked Ca
2+
 transient.  
Release from intracellular stores via a mechanism referred to as Ca
2+
 induced Ca
2+
 
release (CICR), is a potential player in the increase in the magnitude and/or duration of the Ca
2+
 
transient in the presence of inflammation. The major intracellular Ca
2+
 channels mediating CICR 
are ryanodine receptors (RYR). Others have previously demonstrated that this mechanism 
contributes to the magnitude of evoked Ca
2+
 transients in some DRG neurons from naïve animals 
(Usachev et al., 1993, Usachev and Thayer, 1999, Eun et al., 2001). It has also been 
demonstrated that CICR is most prominent in large diameter DRG neurons (Jackson and Thayer, 
2006, Lu et al., 2006) and contributes little to the high K
+
-evoked Ca
2+
 transient in the small 
diameter, IB4+, CAP+ cutaneous subpopulation of afferents (Lu et al., 2006). Therefore, any 
change in CICR machinery or the coupling between Ca
2+
 influx via VGCC and CICR in these 
neurons could have a profound influence on the evoked transient, possibly underlying the 
inflammation-induced changes in the Ca
2+
 transient. In Chapter 1 of this dissertation, I assess the 
contribution of CICR to the inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient 
in small diameter putative nociceptive cutaneous DRG neurons. 
The inflammation-induced changes in the duration of the evoked transient could be 
mediated by different buffers, pumps, and/or exchangers. There are many studies that have 
identified marked differences in the relative contribution of buffering mechanisms in DRG 
neurons, but a consensus has not yet been reached. For example, mitochondria, thought to shape 
both the magnitude, via uptake through a Ca
2+
 uniporter, and the decay, via release via 
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mitochondrial NCX (Berridge et al., 2003), have been shown to buffer (> 400 nM) Ca
2+
 loads in 
most DRG neurons (Werth and Thayer, 1994). However, Kostyuk et al demonstrated that 
mitochondria differentially impact the magnitude and decay of evoked Ca
2+
 transients in larger, 
but not small diameter DRG neurons. Furthermore, inhibition of mitochondria in DRG neurons 
resulted in a larger magnitude and slower decay of the high K
+
-evoked Ca
2+
 transient (Shishkin 
et al., 2002) suggesting it may play a role in the presence of inflammation. However, disruption 
of mitochondria would lead to a loss in ATP production, which would in turn disrupt PMCA-
mediated extrusion as well as other ATPase activity underlying resting membrane potential. 
Again, because there is no inflammation-induced change in resting [Ca
2+
]i (Lu and Gold, 2008) 
and no apparent change in cell health, mitochondria are not highly likely to contribute to the 
changes in evoked Ca
2+
.  
The impact of PMCA and NCX in the extrusion of Ca
2+
 has also been controversial. 
Pottorf and Thayer (2002) suggested that PMCA, but not NCX, plays the major role in regulating 
the small (300 nM – 400 nM) evoked Ca2+ transient, while others suggest that the duration of 
depolarization-evoked Ca
2+
 transients in sensory neurons are determined, at least in part, by 
NCX activity (Verdru et al., 1997, Lu et al., 2006). While PMCA function appears to have a 
substantial impact on maintaining resting [Ca
2+
]i (Gemes et al., 2012), there appears to be no 
inflammation-induced change in resting [Ca
2+
]i (Lu and Gold, 2008), thus it is unlikely that 
PMCA is playing a role in the inflammation-induced increase in the durations of the transient. 
Alternatively, NCX is believed to have a low affinity for Ca
2+
 but has very high exchange 
capacity enabling it to function at the initiation of the recovery process to rapidly remove large 
quantities of Ca
2+
 (Khananshvili, 2013). While blocking NCX by removing Na
+
 from the 
extracellular environment does not effect the magnitude, it results in a substantial increase in the 
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duration of the evoked transient (Lu et al., 2006) suggesting that this mechanism could be, at 
least in part, responsible for the inflammation-induced increase in the duration of the 
depolarization-evoked Ca
2+
 transient. Therefore in Chapter 2 and 3 of this dissertation the 
contribution of NCX to Ca
2+
 signaling is assessed in the naïve state and to the inflammation-
induced increase in the high K
+
-evoked Ca
2+
 transient respectively in small diameter putative 
nociceptive cutaneous DRG neurons. 
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2.0  CONTRIBUTION OF ENDOPLASMIC RETICULUM CALCIUM REGULATORY 
MECHANISMS TO THE INFLAMMATION-INDUCED INCREASE IN THE EVOKED 
CALCIUM TRANSIENT IN RAT CUTANEOUS DORSAL ROOT GANGLION NEURONS 
2.1 ABSTRACT 
Persistent inflammation results in an increase in the magnitude and duration of high K
+
-evoked 
Ca
2+
 transients in putative nociceptive cutaneous dorsal root ganglion (DRG) neurons. The 
purpose of the present study was to determine whether recruitment of Ca
2+
-induced Ca
2+
 release 
(CICR) contributes to these inflammation-induced changes. Acutely dissociated, retrogradely 
labeled cutaneous DRG neurons from naïve and complete Freund’s adjuvant inflamed adult male 
Sprague Dawley rats were studied with ratiometric microfluorimetry. Ryanodine only attenuated 
the duration but not magnitude of the high K
+
-evoked Ca
2+
 transient in neurons from inflamed 
rats. However, there was no significant impact of inflammation on the potency or efficacy of 
ryanodine-induced block of the caffeine-evoked Ca
2+
 transient, or the impact of sarco-
endoplasmic reticulum ATPase (SERCA) inhibition on the high K
+
-evoked Ca
2+
 transient. 
Furthermore, while there was no change in the magnitude, an inflammation-induced increase in 
the duration of the caffeine-evoked Ca
2+
 transient was only observed with a prolonged caffeine 
application. In contrast to the high K
+
-evoked Ca
2+
 transient, there was no evidence of direct 
mitrochondrial involvement or that of the Ca
2+
 extrusion mechanism, the Na
+
/Ca
2+
 exchanger, on 
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the caffeine-evoked Ca
2+
 transient, and block of SERCA only increased the duration of this 
transient.  These results indicate the presence of tightly segregated Ca
2+
 regulatory domains in 
cutaneous nociceptive DRG neurons that isolate cytosolic Ca
2+
 increased via influx from release. 
Furthermore, our results suggest that changes in neither CICR machinery nor the coupling 
between Ca
2+
 influx and CICR are primarily responsible for the inflammation-induced changes 
in the evoked Ca
2+
 transient. 
2.2 INTRODUCTION 
We previously demonstrated that persistent inflammation of peripheral tissue is associated with 
an increase in the magnitude and duration of the high K
+
-evoked Ca
2+
 transient in a 
subpopulation of putative nociceptive cutaneous dorsal root ganglion (DRG) neurons (Lu and 
Gold, 2008). Identifying the underlying mechanism(s) of this change in Ca
2+
 signaling is 
important as an alteration in intracellular Ca
2+
 signaling may contribute to the pain and 
hypersensitivity of persistent inflammation both directly via the facilitation of transmitter release 
(Richardson and Vasko, 2002) and indirectly via changes in the regulation of proteins critical for 
the control of neuronal excitability (Zhang et al., 2012b) and/or changes in gene expression 
(Fields et al., 2005).  
In sensory neurons, the high K
+
-evoked increase in the concentration of intracellular Ca
2+
 
([Ca
2+
]i) is initiated by a depolarization-induced activation of voltage-gated Ca
2+
 channels 
(VGCC) and further shaped by Ca
2+
 release from intracellular stores, sequestration into 
organelles, and extrusion from the cell (Usachev and Thayer, 1997, 1999, Jackson and Thayer, 
2006, Lu et al., 2006, Gemes et al., 2011). Thus, there are a number of mechanisms that could 
 19 
contribute to the inflammation-induced change in Ca
2+
 signaling, several likely candidates of 
which we have previously ruled out. In particular, the inflammation-induced change in the high 
K
+
-evoked Ca
2+
 transient was neither the result of increased neuronal excitability nor an increase 
in the magnitude of the high K
+
-evoked depolarization (Lu and Gold, 2008). We subsequently 
ruled out an increase in Ca
2+
 influx via VGCC as current density was selectively suppressed by 
inflammation in putative nociceptive cutaneous DRG neurons (Lu et al., 2010).   
Another mechanism that may contribute to the inflammation-induced change in the 
regulation of [Ca
2+
]i in cutaneous neurons is an increase in the relative contribution of Ca
2+
-
induced Ca
2+
 release (CICR) to the evoked transient. We (Lu et al., 2006) and others (Usachev et 
al., 1993) previously demonstrated that CICR contributes to the magnitude of evoked Ca
2+
 
transients in some DRG neurons from naïve animals. However this mechanism contributes little 
to the high K
+
-evoked Ca
2+
 transient in the subpopulation of afferents defined by a small cell 
body diameter (<30μM), IB4 binding and capsaicin sensitivity. This is also the subpopulation 
primarily impacted by inflammation (Lu and Gold, 2008). Thus, any change in CICR machinery 
or the coupling between Ca
2+
 influx and CICR in these neurons could have a profound influence 
on the evoked transient. Therefore, in the present study we assessed the contribution of CICR to 
the inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient.  
Retrogradely labeled small diameter IB4 binding DRG neurons from naïve and inflamed 
rats were studied with ratiometric Ca
2+
 imaging in combination with a variety of 
pharmacological manipulations to assess the impact of inflammation on the mechanisms 
underlying CICR. 
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2.3 METHODS 
Adult male Sprague-Dawley rats (Harlan, 220-300g) were used for all experiments. Animals 
were housed two per cage in a temperature and humidity controlled animal facility on a 12:12 
light:dark schedule with food and water freely available. All procedures were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee and performed in 
accordance with National Institutes of Health guidelines for the use of laboratory animals in 
research. 
Fourteen to 17 days prior to tissue harvest, the retrograde tracer 1,1’-dioctadecyl-
3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate (DiI, Invitrogen, Carlsbad, CA) was injected 
into the glabrous skin of the hindpaw in order to label cutaneous afferents. The tracer was 
dissolved at 170 mg/mL in dimethylsufoxide (DMSO), diluted 1:10 in 0.9% sterile saline, and 
injected in 3-5 subcutaneous sites using a 30 g needle for a total volume of 10 μL per hindpaw 
under isoflurane (Abbott Laboratories, North Chicago, IL, USA) anesthesia. Three days prior to 
tissue harvest, rats were again anesthetized with isoflurane and inflammation was induced at the 
site of tracer injection in the left hindpaw with a 100 μL subcutaneous injection of complete 
Freud’s adjuvant (CFA, Sigma-Aldrich, St Louis MO), diluted 1:1 in 0.9 % sterile saline). Prior 
to tissue removal, animals were deeply anesthetized with an intraperitoneal injection of a cocktail 
containing ketamine (55 mg/kg), xylazine (5.5 mg/kg) and acepromazine (1.1 mg/kg) and the 
L4-L5 DRG were removed ipsilateral to labeling and CFA-induced inflammation. Ganglia were 
enzymatically treated, mechanically dissociated, and plated on laminin- (Invitrogen, Carlsbad, 
CA; 1mg/ml) and poly-L-ornithine-coated (Sigma-Aldrich; 1 mg/ml) glass cover slips as 
previously described (Lu et al., 2006). All subsequent experiments were performed within 8 h of 
tissue harvest. 
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2.3.1 Calcium imaging 
Neurons were incubated with 2.5 μM Ca2+ indicator fura-2 AM ester with 0.025 % Pluronic F-
127 for 20min at room temperature. Neurons were then labeled with FITC-conjugated IB4 (10 
μg/ml) for 10 min at room temperature. Labeled neurons were placed in a recording chamber and 
continuously superfused via a gravity fed system with normal bath solution (mM: 130 NaCl, 3 
KCl, 2.5 CaCl2, 0.6 MgCl2, 10 HEPES, 10 glucose, pH 7.4, osmolality 325 mOsm) or a ‘Ca2+-
free’ bath solution (mM: 130 NaCl, 3 KCl, 10 MgCl2, 2 EGTA, 10 Hepes, 10 glucose, pH 7.4, 
osmolality 325 mOsm). Fluorescence data were acquired on a PC running Metafluor software 
(Molecular Devices, City State) via a CCD camera (Roper Scientific; model RTE/CCD 1300). 
The ratio (R) of fluorescence emission (510 nm) in response to 340/380nm excitation (controlled 
by a lambda 10–2 filter changer (Sutter Instrument, Novato, CA) was acquired at 1 Hz during 
drug application. [Ca
2+
]i was determined from fura-2 ratio following in situ calibration 
experiments according to the following equation: 

[Ca2]i(nM) Kd (
S f 2
Sb2
)(
R  Rmin
Rmax  R
)  
Where Kd is the dissociation constant for fura-2 for Ca
2+
 at room temperature; Sf2/Sb2 is 
the fluorescence ratio of the emission intensity excited by 380 nm signal in the absence of Ca
2+
; 
Rmin and Rmax are the minimal and maximal fluorescence ratios respectively. Determination of 
these variables has been described in detail previously (Grynkiewicz et al., 1985, Kao et al., 
1994, Lu et al., 2006). All drugs were applied through a computer-controlled perfusion fast-step 
system (switching time <20 ms; Warner Perfusion System, Hamden, CT, USA, Model SF-77B). 
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2.3.2 Chemical and Reagents 
Cyclopiazonic acid (CPA) (10μM, 100mM stock in DMSO) was purchased from Calbiochem 
(La Jolla, CA, USA), 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate (DiI) 
was purchased from Invitrogen (Carlsbad, CA, USA). Fura-2 acetoxymethyl (AM) ester (2.5 
μM) and Pluronic F-127 (0.025 %) were purchased from TEF Laboratories (Austin, TX, USA). 
Ryanodine (1-100 μM, 10 mM stock in DMSO) and H-89 (10μM, 100mM stock in DMSO) were 
purchased from R&D Systems (Minneapolis, MN, USA), FITC-conjugated IB4 (IB4, 10 ug/ml), 
caffeine (10 mM), carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (10μM, 100mM stock in 
DMSO) were obtained from Sigma-Aldrich (St Louis, MO, USA). 
2.3.3 Statistical Analysis 
Data are expressed as mean ± s.e.m. Student’s t test was used for simple comparisons between 
groups. For experiments involving the application of test compounds, vehicle controls were 
always included. A two-way ANOVA was used for analysis of more than two groups with the 
Holm-Sidak test used for post-hoc analysis. The response to repeated caffeine application in the 
presence of different concentrations of ryanodine was assessed with a mixed design 3-way 
ANOVA. Statistical significance was assessed at p < 0.05. 
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2.4 RESULTS 
Data were collected from 315 cutaneous DRG neurons acutely dissociated from 54 male Sprague 
Dawley rats, of which 30 were control and 24 were subject to CFA-induced peripheral 
inflammation. Based on previous results indicating that the inflammation-induced increase in the 
high K
+
-evoked Ca
2+
 transient was primarily manifest in small (<30 μm) diameter, cutaneous, 
IB4 binding, capsaicin sensitive DRG neurons, this subpopulation was the focus of the present 
study and is subsequently referred to as a subpopulation of putative nociceptive cutaneous 
neurons. Consistent with our previous results (Lu and Gold, 2008), inflammation was associated 
with a significant increase in the magnitude (as measured by a change from baseline) and 
duration (as measured by the time to a 50, 75 and 90, but not 25% decrease from peak (T50, T75, 
T90 and T25)) of the high K
+
-evoked Ca
2+
 transient (Figure 1A & B and Table 1). These 
changes in the evoked Ca
2+
 transient were not associated with a change in resting [Ca
2+
]i, which 
was 139.09 ± 4.80 nM (n = 41) and 133.29 ± 6.33 nM (n = 39) in neurons from naïve and 
inflamed rats, respectively (p > 0.05). 
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Table 1: Changes in the decay of the high K
+
-evoked Ca
2+
 transient in putative nociceptive DRG neurons 
Treatment n T25 (s) T50 (s) T75 (s) T90 (s) 
Naïve 41 4.66 ± 0.5 19.43 ± 2.4 50.36 ± 8.2 184.45 ± 21.0 
CFA 36 3.08 ± 0.3** 36.93 ± 5.2** 98.19 ± 13.4** 280.63±26.3** 
Naïve Post CPA 13 15.37 ± 5.9** 82.45 ± 17.0** 167.7 ± 28.2** 273.75 ± 34.8 
CFA Post CPA 12 9.25 ± 3.7 142.56 ± 39.3** 222.07 ± 47.4** 304.6 ± 61.8 
Naïve Post CCCP 11 46.36 ± 6.8** 72.93 ± 11.0** 218.96 ± 58.2** 402 ± 38.7** 
Naïve Post Na
+
 Free 11 4.46 ± 0.6 31.29 ± 5.93 192.62 ± 33.77** 331.33±39.84** 
 
Neurons were challenged with high K
+
 (30 mM, 4s). T25, T50, T75 and T90 are the time to 25, 50, 75 and 90% 
decay of the peak increase evoked with high K
+
. Using a mixed 2-way ANOVA, there is a significant main effect 
associated with time, treatment, and an interaction between the two (p < 0.0001). Post hoc analyses are provided 
within each time domain. * signifies p < 0.05 compared to naïve, Ψ signifies p < 0.05 compared to CFA treatment, 
and § signifies p < 0.05 between treatments (CPA, CCCP). 
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Figure 1: Inflammation increases the magnitude and duration of the high K
+
-evoked Ca
2+
 transient in putative 
nociceptive cutaneous DRG neurons. 
A) Typical high K
+
-evoked Ca
2+
 transients in neurons from naïve (gray trace) and inflamed (black trace) rats. B) 
Pooled data for the magnitude (change from baseline (Δ [Ca2+]i)) and decay (quantified as the time to 50% of peak, 
or T50) of the high K
+
 (30 mM for 4 sec) evoked Ca
2+
 transient in putative nociceptive DRG neurons from naïve (n 
= 32) and inflamed (CFA, n = 29) rats.* p < 0.05. ** p < 0.01. 
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2.4.1 Ryanodine attenuates the duration of the high K+-evoked Ca2+ transient in 
cutaneous neurons from inflamed rats 
To assess the presence of an inflammation-induced change in the relative contribution of CICR 
to the high K
+
-evoked Ca
2+
 transient, high K
+
 (30 mM, 4 sec) was applied to cutaneous neurons 
from naïve and inflamed rats before and after the application of the ryanodine receptor (RyR) 
blocker, ryanodine (10 μM). To establish steady-state RyR block, caffeine (10 mM, 4 sec) was 
applied 4 times with a 2.5 min inter-stimulus interval (ISI) after the application of ryanodine and 
before the last challenge with high K
+
 (Figure 2A). A 4s application of 10mM caffeine was 
chosen based on the results of an analysis of the response to caffeine applied for durations 
ranging between 250 ms and 12 s: the magnitude of the caffeine-evoked Ca
2+
 transient saturated 
in all neurons tested (Δ[Ca2+]i = 453.48 ± 38.9 nM, n = 15) with a duration of application of 4s or 
greater. Of note, this change in magnitude was comparable to that evoked with high K
+
 (Figure 
1). Interestingly, in control experiments in which caffeine was applied 4 times between high K
+
 
applications in the absence of ryanodine, there was an increase in the T50 of decay of the second 
high K
+
-evoked transient (Figure 2A, B and C). The response to high K
+
 is highly reproducible 
with an ISI of at least 5 minutes, therefore, this increase in T50 of decay appears to be due to the 
actions of caffeine, possibly secondary to a shift in resting protein kinase A (PKA) activity as a 
result of caffeine-induced inhibition of phosphodiesterase (Leijten and van Breemen, 1984). To 
assess this possibility, we repeated the experiment with high K
+
 applied before and after repeated 
application of caffeine in neurons pre-incubated (20min) with the PKA inhibitor, H-89 (10 μM). 
Consistent with the suggested involvement of PKA in the caffeine-induced increase in the 
duration of the high K
+
-evoked Ca
2+
 transient, the presence of H-89 resulted in a significant 
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attenuation of the caffeine-induced increase in the duration of the high K
+
-evoked transient from 
164.59 ± 0.34 (n = 9) to 51.3 ± 0.34 (n = 7) %ΔT50 (p < 0.05). Regardless of the mechanism of 
the change in T50, because of its presence, the impact of ryanodine-induced RyR block was 
assessed relative to control neurons treated identically in the absence of ryanodine. Consistent 
with previous results indicating that the contribution of CICR to the high K
+
-evoked transient in 
putative nociceptive cutaneous DRG neurons is minimal (Lu et al., 2006), ryanodine (10 μM) 
had no detectable influence on the magnitude or decay of the high K
+
-evoked transient in 
neurons tested from naïve rats (Figure 2C). Comparable results were obtained with 100 μM 
ryanodine, where the high K
+
-evoked Ca
2+
 transient in the presence of ryanodine (T50 = 60.27 ± 
9.43 s, n = 4) was not different (p > 0.05) from that observed in control neurons the absence of 
ryanodine (T50 = 46.69 ± 11.85 s, n = 9). In contrast, while ryanodine had no significant 
influence on the magnitude of the high K
+
-evoked Ca
2+
 transient in putative nociceptive 
cutaneous neurons from inflamed rats, the T50 of decay was significantly (p < 0.001) attenuated 
(Figure 2C). This observation is consistent with the recruitment of CICR as a mechanism 
contributing to at least part of the inflammation-induced change in the high K
+
-evoked transient. 
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Figure 2: The impact of ryanodine on the inflammation-induced changes of the high K
+
-evoked transient. 
A) Evoked Ca
2+
 transients in neurons from naïve (gray traces) and inflamed (black traces) rats challenged with high 
K
+
 (30 mM, 4 sec) before and after 4 applications of caffeine (10 mM, 4 sec). Neurons were challenged with 
caffeine in the presence (Ryanodine) or absence (Control) of ryanodine (10 μM). Note the increase in the duration of 
the high K
+
-evoked transient in control neurons following repeated caffeine administration. B) The change in the 
magnitude (ΔΔ [Ca2+]i (nM)) and decay (ΔΔ T50 (s)) of the high K
+
-evoked Ca
2+
 transient associated with the 
application of ryanodine (10 μM) was assessed as the difference between the high K+-evoked transients before and 
after the application of ryanodine. Control neurons (open bars, n = 12) treated with an identical protocol revealed a 
caffeine-induced increase in the T50 of decay, therefore, changes associated with ryanodine (black bars, n = 12) 
were assessed relative to control with a two way ANOVA. ** p < 0.01, * p < 0.05 
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Finally, recent evidence suggests that CICR via IP3 receptors contributes to the Ca
2+
 
transient associated with transient receptor potential (TRP) channel activation in DRG neurons 
which appears to occur secondary to a Ca
2+
-dependent activation of phospholipase C (Rohacs, 
2005, Rohacs et al., 2008). Because we have previously demonstrated that IP3 receptor 
activation contributes minimally to the high K
+
-evoked Ca
2+
 transient in putative nociceptive 
DRG neurons from naïve rats (Lu et al., 2006), we sought to rule out the possibility that 
recruitment of an IP3-dependent mechanism contributes to the inflammation-induced increase in 
the high K
+
-evoked Ca
2+
 transient. As we have previously demonstrated that 100 μM 2-APB was 
sufficient to attenuate an UTP-evoked Ca
2+
 transient in DRG neurons (Lu et al., 2006), the same 
concentration of this IP3 receptor blocker was used in the present experiment. We observed no 
significant (p > 0.05, n = 7) difference in either the magnitude (-5.74 ± 0.08 %) or duration 
(11.47 ± 0.11 %) of the high K
+
-evoked Ca
2+
 transient evoked in the presence or absence of 2-
APB, respectively, in putative nociceptive cutaneous neurons from inflamed rats. These results 
argue against a role for IP3 receptor activation in the inflammation-induced changes in the high 
K
+
-evoked Ca
2+
 transient. 
2.4.2 No detectable influence of inflammation on the magnitude or duration of the 
caffeine-evoked Ca
2+
 transient 
Given that CICR reflects the activation of Ca
2+
 activated Ca
2+
 channels (i.e., RyRs) on the 
endoplasmic reticulum (ER) which enable the release of Ca
2+
 loaded into the ER via sarco-
endoplasmic reticulum Ca
2+
 ATPase (SERCA), there are several mechanisms that could account 
for the recruitment of CICR as a contributing factor to the inflammation-induced increase in the 
time of decay of the high K
+
-evoked transient. These include: 1) an increase in releasable Ca
2+
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stored in the ER, 2) a shift in the expression of RyR subtypes from a receptor such as RyR1 with 
a low open channel probability to one such as RyR3 with a high open channel probability 
(Meissner, 1994), 3) a decrease in the rate of SERCA uptake, 4) a shift in the coupling between 
VGCC Ca
2+
 influx and ER store release, and/or 5) a change in a SERCA/CICR-independent 
mechanism that enables the high K
+
-evoked transient to engage CICR to further amplify the 
evoked transient. To address the first possibility, we analyzed caffeine-evoked transients in 
putative nociceptive cutaneous neurons from naïve and inflamed rats.  
Results from the first set of experiments suggested that there was no inflammation-
induced change in the magnitude or decay of the caffeine-evoked transient. An additional set of 
neurons (n = 36 naïve, n = 29 CFA) was used to study the caffeine-evoked transients directly to 
avoid the potential confound associated with an initial challenge with high K
+
. Results with 
caffeine alone were consistent with our initial observations, indicating that there is no detectable 
influence of inflammation on either the magnitude or the decay of the caffeine-evoked transient 
(Figure 3A). To confirm that the caffeine-evoked transient was due to the release of Ca
2+
 from 
internal stores, caffeine was applied to neurons in the presence of Ca
2+
 free bath solution or 
following depletion of Ca
2+
 from the ER with the SERCA inhibitor, cyclopiazonic acid (CPA, 10 
μM) (Figure 3B). In contrast to the results obtained in nodose ganglion neurons (Hoesch et al., 
2001), there was no significant (p > 0.05) difference in the magnitude of the caffeine transient 
evoked in the presence or absence of extracellular Ca
2+
 (Figure 3B and C). Furthermore, the 
caffeine-evoked transient was completely blocked following depletion of ER stores with CPA 
(Figure 3B and C).  
The concentration of caffeine used in these experiments is comparable to that used by 
other investigators (Eun et al., 2001, Lokuta et al., 2002, Cheng et al., 2010). However, to rule 
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out the possibility that inflammation altered either the potency or efficacy of caffeine, 
concentration response data were collected from another group of neurons (n = 15 naïve, n = 14 
CFA). Increasing concentrations of caffeine were applied to each neuron with an ISI of 5 
minutes. Data for each neuron was fitted with a Hill equation to determine the concentration 
resulting in a response 50% of maximal (EC50) as well as the maximal response (Emax). Results 
of this analysis indicated that inflammation has no detectable influence on either the potency or 
efficacy of the caffeine-evoked transient, with EC50’s of 4.09 ± 0.39 and 5.29 ± 0.67 mM and 
Emax of 522.62 ± 58.93 and 500.84 ± 38.52 nM Ca
2+
 in neurons from naïve and inflamed rats, 
respectively (Figure 3D).  
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Figure 3: Inflammation did not change the magnitude or duration of the caffeine-evoked Ca
2+
 transient. 
A) The magnitude (Δ [Ca2+]i) and duration (T50) of caffeine (10 mM for 4 sec) evoked Ca
2+
 transients were 
determined in a manner identical to that used for the high K
+
-evoked transient. Pooled data from putative 
nociceptive cutaneous neurons from naïve (n = 36) and inflamed (n = 29) rats are plotted. B) Top:  Example of 
caffeine-evoked Ca
2+
 transients in a neuron from a naïve rat in the presence (open square) and absence (closed 
square) of Ca
2+
 in the bath solution. Bottom: Example of caffeine-evoked Ca
2+
 transients in a neuron from a naïve 
rat before (open square) and after (closed square) the application of the SERCA inhibitor, CPA. C) Pooled data from 
neurons (n = 8) challenged with caffeine before and after the application Ca
2+
 free bath solution and from a second 
groups of neurons (n = 10) challenged before and after depletion of intracellular Ca
2+
 stores with CPA. D) Pooled 
concentration response data for neurons from naïve (n = 13) and inflamed (n = 14) rats challenged with increasing 
concentrations of caffeine. Data from each neuron were fitted with a modified Hill equation to estimate the maximal 
size of the evoked transient (Emax) and this value was used to normalize data prior to pooling. Pooled data are also 
fitted with a modified Hill equation.  ***p < 0.001  
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2.4.3 Inflammation does not affect the balance of RyR-mediated Ca2+ release and 
SERCA-mediated Ca
2+
 re-uptake 
The rapid decay of the caffeine-evoked Ca
2+
 transient highlights the possibility that a shift in the 
relative balance of Ca
2+
 release to re-uptake contributes to the inflammation-induced increase in 
the high K
+
-evoked Ca
2+
 transient as it suggests that in putative nociceptive cutaneous neurons, 
release and re-uptake are tightly coupled. To determine whether inflammation is associated with 
a shift in the balance of these two processes, we assessed the extent of caffeine-induced depletion 
of intracellular stores in Ca
2+
 free bath solution. Results of this experiment indicated that even 
after 4 applications of 10 mM caffeine in Ca
2+
 free bath solution, there was no significant 
reduction in the caffeine-evoked transient (Figure 4A). Comparable results were obtained in 
neurons from naïve and inflamed rats (Figure 4B), arguing against an inflammation-induced shift 
in the balance of release and re-uptake, at least over a time frame relevant to the high K
+
-evoked 
Ca
2+
 transient.  
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Figure 4: No significant reduction in the magitude of caffeine-evoked transient in the absence of extracellular Ca
2+
. 
A) Caffeine-evoked Ca
2+
 transients in a putative nociceptive cutaneous neuron from a naïve rat. The neuron was 
continuously bathed in Ca
2+
 free bath solution. Caffeine was applied where indicated by the white boxes B) The 
magnitude of the caffeine-evoked Ca
2+
 transient in Ca
2+
 free bath solution was comparable in putative nociceptive 
cutaneous neurons from naïve (n = 37) and inflamed (n = 38) rats. 
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2.4.4 Heterogeneity among cutaneous neurons with respect to function RyR subtypes does 
not contribute to the inflammation-induced changes in Ca
2+
 signaling 
To further determine whether a shift in the balance of functional RyR subtypes contributes to the 
inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient, we assessed the 
concentration dependence of ryanodine-induced block of the caffeine-evoked transient. Caffeine 
(10 mM) was applied before and then 4 times (ISI = 5 minutes) in the presence of 1, 10 or 100 
μM ryanodine in Ca2+ free bath solution. Results of this experiment suggested the presence of at 
least 3 subpopulations of putative nociceptive cutaneous DRG neurons: those that were relatively 
resistant (resistant), those that were sensitive (sensitive), and those that were highly sensitive 
(highly sensitive) to ryanodine-induced block (Figure 5A and B). This difference between 
neurons was most readily apparent in the response to 10 μM ryanodine, depicted by plotting the 
magnitude of the transient evoked in response to the 4
th
 application of caffeine in the presence of 
ryanodine normalized to the response prior to the application of ryanodine (Figure 5B); 10 μM 
ryanodine produced only ~20% block in resistant neurons, ~65% block in sensitive neurons and 
~100% block of highly sensitive neurons. These subpopulations appeared to be less well defined 
in neurons from inflamed rats (Figure 5B). However there was no statistically significant 
difference in the average block produced by 10 μM ryanodine. Plotting the fractional block as a 
function of caffeine application and ryanodine concentration (Figure 5C and D), suggests the 
presence of an inflammation-induced increase in the sensitivity to ryanodine-induced block of 
the caffeine response. However, statistical analysis (mixed design 3 way ANOVA) revealed no 
significant interaction between inflammation and ryanodine concentration despite significant 
main effects associated with caffeine application and ryanodine concentration.  
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To begin to assess the functional consequences of what appeared to be a differential 
distribution of RyRs among putative nociceptive cutaneous neurons, we analyzed the initial 
response to caffeine in subpopulations of neurons defined by their sensitivity to ryanodine-
induced block. This analysis revealed that the magnitude of the Ca
2+
 transient in response to first 
caffeine application was significantly larger in the “highly sensitive” neurons (825.15 ± 113.05 
nM) compared to those that were “sensitive” (501.33 ± 65.92 nM) or “resistant” (480.37 ± 67.38 
nM) to the ryanodine-induced block.  Nevertheless, while these results are consistent with a 
heterogeneous distribution of RyR subtypes among cutaneous nociceptive DRG neurons, there 
does not appear to be an inflammation-induced shift in this distribution.  
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Figure 5: Heterogeneity in the ryanodine receptor activity in neurons from both naive and inflamed rats. 
A) Examples of caffeine (caff)-evoked Ca
2+
 transients in putative nociceptive cutaneous neurons before and after the 
application of 10 μM Ry in Ca2+ free bath. The neuron on the left was relatively resistant to Ry-induced block, while 
that on the right was highly sensitive. B) The percent of Ry-induced block of the caff-evoked Ca
2+
 transient was 
calculated from the response evoked by the 4
th
 caffeine application relative to the response evoked prior to the 
application of Ry. Data from neurons from naïve (n = 15) and inflamed (n = 15) rats challenged with 10 μM Ry are 
plotted. C) Neurons (n = 31) from naïve rats were challenged with caff (10 mM) before and after the application of 1 
of 3 concentrations of Ry. The response to each of 4 successive applications of caff was calculated as a percent of 
the response to caff prior to the application of caff. Pooled data over subsequent challenges are plotted relative to the 
concentration of Ry employed. D) Data from neurons (n = 33) from inflamed rats were collected and plotted as 
described in C. There was no significant interaction between inflammation and Ry concentration despite significant 
main effects associated with caff application and Ry concentration (Mixed 3 way ANOVA, p > 0.05). 
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2.4.5 No evidence of an inflammation-induced change in SERCA activity 
While the results from the caffeine experiments suggest that the inflammation-induced increase 
in high K
+
-evoked Ca
2+
 transients is not due to a change in the relative level of SERCA activity, 
we directly tested this possibility by comparing the magnitude and decay of the high K
+
-evoked 
Ca
2+
 transient before and after the application 10 μM CPA in normal Ca2+-containing bath 
solution. To confirm complete block of SERCA, caffeine (10 mM) was applied after resting 
[Ca
2+
]i levels returned to baseline following CPA application (Figure 6A). Consistent with the 
suggestion that Ca
2+
 released from the ER does not engage the mechanisms underlying the 
inflammation-induced increase in the magnitude of the high K
+
-evoked Ca
2+
 transient, the CPA-
induced Ca
2+
 transient was comparable in neurons from naïve and inflamed rats (p > 0.05, Figure 
6B). There was no significant change in the magnitude of the high K
+
-evoked Ca
2+
 transient in 
neurons from either naïve or inflamed animals in the presence of CPA (Figure 6C). However, in 
both groups of neurons, the T50 of decay was significantly (p < 0.01) increased in the presence 
of CPA. Furthermore, the CPA-induced increase in T50 was significantly greater in neurons 
from inflamed rats than in neurons from naïve (Figure 6D). These results are consistent with our 
previous finding that in this subpopulation of neurons, SERCA plays a far more dominant role in 
the regulation of the duration of the Ca
2+
 transient than in the magnitude. They also argue against 
a role for an inflammation-induced change in SERCA activity as an underlying mechanism of 
the inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient because an 
inflammation-induced decrease in SERCA activity would have attenuated the CPA-induced 
increase in T50 in neurons from inflamed rats. 
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Figure 6: No inflammation-induced change in the influence of SERCA on the high K
+
-evoked transient. 
A) Ca
2+
 transients in neurons from a naïve (grey trace) and inflamed (black trace) rat evoked with high K
+
 before 
and after the application of CPA. Both neurons were challenged with caffeine to confirm depletion of Ca
2+
 from 
intracellular stores. B) The magnitude of the CPA-evoked Ca
2+
 transient was comparable in neurons from naïve (n = 
11) and inflamed (n = 9) rats. C) CPA had no influence on the magnitude of the high K
+
-evoked Ca
2+
 transient, 
despite a significant main effect associated with inflammation (two-way ANOVA). Pooled data are responses 
obtained before (Veh) and after application of CPA. D) The decay of the high K
+
-evoked Ca
2+
 transient was 
calculated, pooled and plotted as in C. There were significant main effects associated with CPA and inflammation 
but no statistically significant interaction (two-way ANOVA). * p < 0.05; ** p < 0.01. 
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2.4.6 Selective influence of inflammation on the decay of the Ca2+ transient evoked with 
prolonged caffeine application 
Having largely ruled out a change in the machinery underlying CICR as a mechanism 
contributing to the inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient, we 
performed an experiment to begin to assess the presence of an inflammation-induced shift in the 
coupling between Ca
2+
 influx and release. The possibility of such a shift in coupling was 
suggested by the observation that the decay of the caffeine-evoked Ca
2+
 transient (average T50 = 
9 sec) is much faster than that of the high K
+
-evoked Ca
2+
 transient (average T50 = 45 sec) 
despite the fact that the magnitude of the transient evoked with these two stimuli were 
comparable (p > 0.05). This observation suggests that very different Ca
2+
 regulatory mechanisms 
are engaged by Ca
2+
 influx and Ca
2+
 release in this subpopulation of sensory neurons. It also 
raises the possibility that increasing the duration of the caffeine application would prolong the 
Ca
2+
 transient sufficiently to enable Ca
2+
 access to the mechanisms altered by inflammation that 
contribute to the inflammation-induced increase in the high K
+
-evoked transient, where negative 
results would be consistent with a change in the association between influx and release. To test 
this possibility, caffeine was applied for 12 seconds to another group of neurons (n = 8 naïve, n = 
10 CFA) (Figure 7A). Consistent with preliminary results indicating that the magnitude of the 
caffeine-evoked Ca
2+
 transient was saturated in response to caffeine applications of 4s or longer, 
there was not difference between a 4s and 12s application of caffeine with respect to the 
magnitude of the evoked transient in neurons from naïve and inflamed rats (Figure 7B). 
Interestingly, however, in contrast to the results obtained in neurons from naïve rats, where the 
T50 of decay to a 4 and 12 second application of caffeine were comparable (p > 0.05, Figure 
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7C), inflammation was associated with a significant (p < 0.05) increase in the T50 of decay in 
response to a 12 second caffeine application (Figure 7C). 
 
 
 
 
Figure 7: Ca
2+
 transients evoked in response to prolonged caffeine application. 
Ca
2+
 transients evoked in a neuron from naïve (grey trace) and inflamed (black trace) rats with a 4 second (closed 
box) or 12 second (open box) application of caffeine (10 mM, ISI = 5 min). Pooled magnitude (B) and duration (C) 
data from neurons from naïve (n = 8) and inflamed (n = 10) rats stimulated with caffeine as described in A are 
plotted. **p < 0.01 
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2.4.7 Different Ca2+ regulatory machinery are engaged with Ca2+ transients evoked with 
caffeine and high K
+
 
The rapid decay of the caffeine-evoked Ca
2+
 transient not only suggests that in putative 
nociceptive cutaneous neurons ER Ca
2+
 release and re-uptake are tightly coupled, but that 
different Ca
2+
 regulatory machinery is engaged by Ca
2+
 influx via VGCC and release from the 
ER. The observation that repeated caffeine application results in an increase in the duration of 
the high K
+
-evoked transient (Figure 2), but no change in the duration of the caffeine-evoked 
transient (with a T50 of decay of 6.2 ± 0.9s after the first application, and 7.0 ± 1.2s after the 
fourth application, p > 0.05, n =10) is also consistent with the suggestion that the Ca
2+
 transients 
evoked by these stimuli engage distinct Ca
2+
 regulatory machinery. To further explore these 
suggestions, we performed three additional experiments: First, caffeine or high K
+
 were applied 
in the presence of 10μM CCCP, a mitochondrial proton pump inhibitor; Second, caffeine was 
applied in the presence of SERCA inhibitor CPA; and third caffeine or high K+ were applied in 
the presence of Na
+
 free bath to inhibit the Na
+
/Ca
2+
 exchanger (NCX).  
For the first experiment, CCCP was co-applied with caffeine or high K
+
 to minimize the 
potential impact of a decrease in ATP on Ca
2+
 regulatory machinery. However, because CCCP 
was associated with a transient increase in intracellular Ca
2+
 which influenced the magnitude of 
the evoked transient relative to baseline, CCCP was first applied alone and the magnitude of the 
CCCP-evoked transient was subtracted from the caffeine or high K
+
-evoked transient prior to 
calculating the percent change from the transient evoked in the absence of CCCP. Results of this 
first experiment indicated that, while the complex decay of the high K
+
-evoked Ca
2+
 transient is 
due in part to mitochondrial buffering, mitochondria do not appear to influence either the 
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magnitude or decay of the caffeine evoked Ca
2+
 transient. That is, both the magnitude (32.85 ± 
0.8%, p < 0.05, n = 7) and decay (p < 0.01, Table 1) of the high K
+
-evoked Ca
2+
 transient were 
significantly increased in the presence of CCCP. Furthermore, not only was the decay of the high 
K
+
-evoked transient significantly increased, most dramatically during the initial phase of decay 
(i.e., at T25, Table 1), but the shape of the transient was dramatically altered, with no evidence of 
a “shoulder” just above the T50 of decay (Figure 8A). In contrast, changes in neither the 
magnitude (-8.2± 0.04%) nor duration (25.13 ± 0.02%) of the caffeine-evoked transient in the 
presence of CCCP, were significant (p > 0.05, n = 6, Figure 8A).  
For the second experiment, caffeine was also co-applied with CPA to prevent depletion 
of the ER that occurs with the pre-treatment protocol used for the high K
+
 experiment (Figure 6). 
Interestingly, the impact of CPA on the caffeine-evoked Ca
2+
 transient was similar to that on the 
high K
+
-evoked Ca
2+
 transient (Figure 6), where there was no influence on the magnitude (-4.59 
± 0.09% of control, p > 0.05, n = 6) but a significant increase in the duration (210.42 ± 0.57% of 
control, p < 0.05) of the caffeine-evoked Ca
2+
 transient (Figure 8B, Table 1). These results 
suggest that the magnitude of the caffeine-evoked Ca
2+
 transient, at least in response to a 
saturating concentration and duration of caffeine, is largely determined by the concentration of 
Ca
2+
 in the ER and the density and distribution of RyRs, while the duration of the transient is 
largely determined by SERCA. 
Finally, the reproducible response to caffeine even in a Ca
2+
 free bath (Figure 4) suggests 
that extrusion mechanisms contribute minimally to both the magnitude and duration of the 
caffeine-evoked transient. In contrast, we have previously demonstrated the Ca
2+
 extrusion via 
NCX influences the duration of the high K
+
-evoked Ca
2+
 transient in putative nociceptive DRG 
neurons (Lu et al., 2006). Therefore, to confirm that extrusion, at least via NCX, contributes 
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minimally to the regulation of the caffeine-evoked transient in cutaneous nociceptive neurons, 
we assessed the response to caffeine before and after block of NCX with zero Na
+
 bath (where 
NaCl was replaced with choline-Cl). The results of this experiment indicated that block of NCX 
had no significant (p > 0.05, n = 6) influence on either the magnitude (-6.07 ± 0.04% of control) 
or duration (-6.4 ± 0.06% of control) of the caffeine-evoked Ca
2+
 transient (Figure 8C, Table 1). 
In contrast, and consistent with our previous results in unlabeled DRG neurons, inhibition of 
NCX had no significant influence on the magnitude of the high K
+
-evoked transient in cutaneous 
nociceptive neurons, but was associated with a significant (p < 0.01, n = 12) increase in the 
duration (490.54 ± 0.89%) of the high K
+
-evoked transient (Figure 8C). 
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Figure 8: High K
+
- and caffeine-evoked Ca
2+
 transients engage distinct Ca
2+
 regulatory machinery. 
Putative nociceptive cutaneous DRG neurons from naive rats were challenged with either high K
+
 (30 mM, 4s, Left 
Traces) or caffeine (10 mM, 4s, Right Traces), before and after the application of CCCP (10 μM, A), CPA (10 μM, 
B), or Na
+
 Free bath (C). Pooled magnitude (peak change in concentration of intracellular Ca
2+
 ([Ca
2+
]i) from 
baseline) and duration (time of decay) data obtained before and after the application of CCCP, CPA and Na
+
 Free 
bath are plotted. For the high K
+
 experiments, the number of neurons studied were 7, 11, and 12, with CCCP, CPA 
and Na
+
 free bath, respectively, while for the caffeine experiments, the number of neurons studied were 6, 6 and 6 
for CCP, CPA and Na
+
 free bath, respectively. Data were analyzed with a mixed design two-way ANOVA: 
differences between before and after the application of CCCP, CPA or Na
+
 Free bath, as well as between high K
+
 
and caffeine are indicated. * is p < 0.05, and ** is p < 0.01. 
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2.5 DISCUSSION 
In the present set of experiments, we sought to determine whether a change in mechanisms 
underlying CICR and/or the association between influx and release of Ca
2+ 
could contribute to 
the inflammation-induced increase in the high K
+
-evoked Ca
2+
 transient. Towards that end, we 
were able to reproduce our previous results indicating inflammation is associated with an 
increase in both the magnitude and duration of the high K
+
-evoked Ca
2+
 transient. While there 
was no evidence for an inflammation-induced recruitment of IP3 receptor mediated release, the 
inflammation-induced increase in duration, but not magnitude of the high K
+
-evoked Ca
2+
 
transient was at least partially blocked by the RyR blocker, ryanodine. Interestingly, however, 
there was no influence of inflammation on either the magnitude or duration of transients evoked 
with a brief (4 second) application of caffeine, or the potency or efficacy of the caffeine-induced 
release of Ca
2+
 from the ER. There was also no influence of inflammation on the response to 
repeated caffeine application in Ca
2+
 free bath solution. Furthermore, there was no detectable 
influence of inflammation on the potency or efficacy of the ryanodine-induced block of the 
caffeine-evoked Ca
2+
 transients. There was also no evidence that inflammation was associated 
with a decrease in SERCA activity. Finally, inflammation was associated with a selective 
increase in the duration of the Ca
2+
 transient in response to prolonged (12 second) caffeine 
application.  
These observations have several interesting implications. Most relevant to the purpose of 
the present study, these data suggest that mechanism(s) other than a change in CICR or the 
coupling between Ca
2+
 influx and CICR underlie the inflammation-induced changes in the high 
K
+
-evoked Ca
2+
 transient. This was most readily demonstrated by a lack of evidence for the 
involvement of CICR in the regulation of the magnitude of the high K
+
-evoked Ca
2+
 transient, in 
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the face of a clear inflammation-induced increase in this parameter. Furthermore, evidence that 
mechanisms underlying CICR are comparable in neurons from naïve and inflamed animals 
leaves only a change in coupling between influx and release as a possible mechanism 
contributing to the inflammation-induced increase in the duration of the high K
+
-evoked Ca
2+
 
transient. However, while we have not conclusively ruled out a shift in the coupling, which 
enabled the Ca
2+
 influx via VGCC to engage CICR, the results from the prolonged caffeine 
application experiment demonstrate that an inflammation-induced change in another Ca
2+
 
regulatory mechanism can now be engaged via Ca
2+
 release from the ER. Given our present 
results with a zero Na
+
 bath, our previous results (Lu et al., 2006) as well as those of others 
(Werth et al., 1996, Pottorf and Thayer, 2002) suggesting that the plasma membrane Ca
2+
-
ATPase (PMCA) and NCX play a greater role in regulating the duration rather than the 
magnitude of the depolarization-induced Ca
2+
 transient, an inflammation-induced decrease in the 
rate of Ca
2+
 extrusion could account for increased duration of the Ca
2+
 transient evoked by both 
depolarization and prolonged release from the ER.  
There are distinct Ca
2+
 regulatory machinery engaged by Ca
2+
 entering the cytosol via 
voltage-gated Ca
2+
 channels versus release from the ER, as suggested by several lines of 
evidence. These include 1) differences in kinetics of the high K
+
 and caffeine-evoked Ca
2+
 
transients despite the comparable magnitude of the transients evoked with these two stimuli, 2) 
the impact of inflammation on the duration (and magnitude) of the high K
+
 but not caffeine-
evoked transient, 3) the impact of an increase in PKA activity on the duration of the high K
+
 but 
not the caffeine-evoked transient, 4) the contribution of mitochondria to the regulation of both 
the magnitude and decay of the high K
+
-evoked transient, but neither the magnitude nor decay of 
the caffeine-evoked transient, and 5) the impact of NCX block on the duration of the high K
+
 but 
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not the caffeine-evoked transient. Of note, while the absence of an inflexion on the falling phase 
of the caffeine-evoked transient, a signature of mitochondria-mediated buffering (Berridge et al., 
2003), in combination with the absence of a detectable influence of CCCP on the caffeine-
evoked transient in putative nociceptive cutaneous DRG neurons argue strongly against a direct 
role for mitochondria in the regulation of the caffeine-evoked transient, these observations are in 
contrast to previous results from unlabeled sensory neurons indicating mitochondria are involved 
in buffering the Ca
2+
 released from the ER (Friel and Tsien, 1994). Nevertheless, we are not the 
first to report that mitochondria are differentially engaged by Ca
2+
 influx and release, as 
comparable results have been previously reported by others in mouse DRG neurons (Svichar et 
al., 1997). We suggest that heterogeneity among DRG neurons is the most likely explanation for 
the apparent difference between out results and those in these previous studies.  
Evidence that caffeine-evoked transients were stable in the presence of Ca
2+
 free bath 
solution and unaffected by NCX block suggests that the majority of Ca
2+
 released during caffeine 
application is pumped back into the ER by SERCA. While we have not collected data on spatial 
segregation, the results appear to be in support of a tightly regulated microdomains (Berridge, 
2006) in putative nociceptive cutaneous neurons through which the magnitude and decay of the 
caffeine-evoked Ca
2+
 transient are determined by the amount of Ca
2+
 in the ER, the density and 
distribution of ryanodine receptors, and SERCA activity. Strikingly, even a 12 second 
application of caffeine to this subpopulation of neurons from naïve rats appeared to be 
insufficient to engage mitochondrial Ca
2+
 buffering. An additional interesting note is that while 
Ca
2+
 influx via VGCC was insufficient to activate RyRs in neurons from naïve rats, SERCA still 
contributes to the regulation of the duration of the high K
+
-evoked Ca
2+
 transient as illustrated by 
the results obtained with CPA. This observation suggests that it is SERCA that largely defines 
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the barrier separating Ca
2+
 influx from release. Given evidence for the dynamic regulation of 
SERCA activity in DRG neurons (Usachev et al., 2006), a SERCA-mediated barrier would 
provide a sensitive mechanism for the modulation of the coupling between Ca
2+
 influx and 
release in these neurons. 
The observation that the inflammation-induced changes in high K
+
-evoked transient are 
manifest despite a decrease in VGCC current density (Lu et al., 2010) argues that regulation of 
the magnitude and duration of the Ca
2+
 transient is largely independent on the magnitude of the 
initial Ca
2+
 influx. Furthermore, the observation that inflammation is associated with an increase 
in both the magnitude and duration of the high K
+
-evoked Ca
2+
 transient, in the face of evidence 
that there are mechanisms such as SERCA and NCX that influence the duration but not the 
magnitude of the high K
+
-evoked Ca
2+
 transient raises the possibility that there are two Ca
2+
 
regulatory processes that are altered in the presence of inflammation. Interestingly, despite recent 
evidence suggesting that Ca
2+
 influx via TRP channels may drive CICR secondary to the 
activation of IP3 receptor (Rohacs et al., 2008), such a mechanism does not appear to contribute 
to the high K
+
-evoked Ca
2+
 transient. While this may be a unique feature of the subpopulation of 
neurons studied here, this difference raises the possibility that Ca
2+
 influx via TRP channels 
engages Ca
2+
 regulatory processes distinct from those engaged by caffeine or high K
+
. While 
future experiments would be needed to address this possibility, the further definition of the 
microdomain engaged following Ca
2+
 influx through VGCC serves to limit the number of 
mechanisms that may ultimately be responsible for the inflammation-induced changes in the high 
K
+
-evoked Ca
2+
 transient.   
While not the focus of the present study, results obtained with CCCP suggest 
mitochondria are not a potential mechanisms contributing to the inflammation-induced change in 
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the high K
+
-evoked Ca
2+
 transient. That is, because CCCP results in a significant increase in the 
duration of the high K
+
-evoked Ca
2+
 transient in cutaneous neurons from naïve rats, albeit with 
altered decay kinetics, one would predict that if a decrease in mitochondrial buffering of the high 
K
+
-evoked transient contributed to the changes observed in the presence of inflammation, the 
impact of CCCP on the high K
+
-evoked Ca
2+
 transient in neurons from inflamed rats should be 
attenuated. Preliminary results with a pre-application protocol similar to that employed 
previously (Lu et al., 2006) suggest that this is not the case, as CCCP (10 μM) was associated 
with an increase in the duration of the high K
+
-evoked transient (T50 = 113.2 ± 14.2 s, n = 9) 
that was, if anything even larger than that observed in neurons from naïve rats (T50 = 72.9 ± 11 
s, n = 11). However, given the complex way in which mitochondria contribute to the regulation 
of [Ca
2+
]i, this issue may need to be addressed more systematically.  
The suggestion that distinct mechanisms underlie the inflammation-induced increase in 
the magnitude and duration of the high K
+
-evoked Ca
2+
 transient raises the possibility that these 
mechanisms are separable within the neuron. The functional implications of this possibility will 
depend on where the changes are manifest. For example, activation of a sustained increase in 
[Ca
2+
]i in central or peripheral afferent terminals would facilitate transmitter release, thus 
augmenting neurogenic inflammation in the periphery or increasing the transmission of 
nociceptive information at the central terminal. A comparable increase in the duration of the 
transient at a spike initiation zone or along an axon where Ca
2+
-dependent K
+
 channels may be 
localized would influence spike pattern or the relative refractory period. In the cell body, the 
dynamics of the Ca
2+
 transient may lead to very different effects on gene expression (Fields et 
al., 2005). Conversely, an increase in the magnitude of the Ca
2+
 transient independent of a 
change in duration may lead to differential activation of regulatory proteins or second messenger 
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pathways based on Ca
2+
 affinity, alternative gene transcription and translation, and/or 
excitotoxicity (Carafoli et al., 2001, Berridge et al., 2003, Fields et al., 2005).  
In contrast to previous results indicating that 10 μM ryanodine is sufficient to completely 
block caffeine-evoked Ca
2+
 transients in sensory neurons (Usachev et al., 1993, Shmigol et al., 
1995, Solovyova et al., 2002), we only observed a ~60% block of the caffeine-evoked transient 
at this concentration in cutaneous DRG neurons. We have previously observed that differences in 
how the neurons were processed and the amount of time in culture prior to study are factors that 
to influence the properties of Ca
2+
 transients in DRG neurons (data not shown). Nevertheless, we 
suggest that the most likely explanation for the difference between our results and previous 
studies is due to heterogeneity among DRG neurons. We have previously reported that there are 
significant differences between subpopulations of DRG neurons with respect to the relative 
impact of CICR to the high K
+
-evoked Ca
2+
 transient (Lu et al., 2006). Furthermore, the results 
of the present study indicate that even within a small subpopulation of cutaneous DRG neurons, 
there is heterogeneity with respect to the impact of ryanodine on the caffeine-evoked Ca
2+
 
transient. Indeed, consistent with these previous results, we observed some neurons in which 10 
μM ryanodine was sufficient to completely block the caffeine-evoked transient, arguing against a 
problem with how the compound was prepared or the neurons were challenged. However, this 
was clearly not the case in all neurons. We also suggest that a differential expression of RyR 
subtypes within the subpopulation of interest is likely to account for this heterogeneity in the 
actions of ryanodine. That is, while RyR 3 is similar to RyR 2 in its threshold of Ca
2+
-induced 
activation (1μM), the two receptors differ in open channel probability (Po) in response to 
comparable levels of Ca
2+
: RyR 3 has a Po of ~1 while that of RyR 2 is ~0.6 and RyR 1 is ~0.15 
at ~100μM Ca2+. Furthermore, RyR 3 is able to maintain its open state and requires higher Ca2+ 
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concentrations for inactivation compared to RyR1 or RyR 2 (Chen et al., 1997, Jeyakumar et al., 
1998, Meissner, 2002). Ryanodine is an open channel blocker, therefore, the difference in Po 
would suggest that RyR 1 is the dominant receptor in neurons “resistant” to ryanodine and RyR 3 
is the dominant receptor in neurons “highly sensitive” to ryanodine. This would also account for 
the larger caffeine-evoked transient in “highly sensitive” neurons. Importantly, a differential 
distribution of RyR subtypes both within and between neurons would result in very different 
responses to stimuli capable of engaging CICR.  
In summary, while our results argue against a change in CICR or the coupling between 
CICR and Ca
2+
 influx via VGCC as the mechanism underlying the inflammation-induced 
increase in the high K
+
-evoked Ca
2+
 transient, we further characterized the regulation of [Ca
2+
]i 
in putative nociceptive cutaneous neurons, revealing several aspects of the Ca
2+
 regulation that 
may have a profound impact on the function of this subpopulation of neurons. This includes 
evidence that mechanisms underlying the inflammation-induced increase in magnitude and 
duration of the high K
+
-evoked transient are distinct, that SERCA serves as a barrier isolating 
Ca
2+
 regulatory domains accessed by release from the ER and influx via VGCC, and that there is 
a differential distribution of RyR subtypes among subpopulations of these neurons. Future 
experiments will be needed to assess the functional consequences of these unique features. 
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3.0  THE PROPERTIES, DISTRIBUTION, AND FUNCTION OF SODIUM CALCIUM 
EXCHANGER ISOFORMS IN RAT CUTANEOUS SENSORY NEURONS 
3.1 ABSTRACT 
The Na
+
/Ca
2+
 exchanger (NCX) appears to play an important role in the regulation of the high 
K
+
-evoked Ca
2+
 transient in putative nociceptive dorsal root ganglion (DRG) neurons. The 
purpose of the present study was to 1) characterize the properties of NCX activity in 
subpopulations of DRG neurons 2) identify the isoform(s) underlying NCX activity, and 3) begin 
to assess the function of this isoform in vivo. In retrogradely labeled neurons from the glabrous 
skin of adult male Sprague-Dawley rats, NCX activity, as assessed with fura-2 based 
microfluorimetry, was only detected in putative nociceptive IB4+ neurons. There appear to be 
two modes of NCX activity: one evoked in response to relatively large and long lasting (~325 
nM for > 12 second) increases in the concentration of intracellular Ca
2+
 ([Ca
2+
]i), and a second 
that is active at resting [Ca
2+
]i > ~150 nM. There also appeared to be two modes of evoked 
activity: one that decayed relatively rapidly (< 5 min) and a second that persisted (>10 min). 
Whereas mRNA encoding all three NCX isoforms (NCX1-3) was detectable in putative 
nociceptive cutaneous neurons with single cell PCR, pharmacological analysis suggested that 
NCX3 was responsible for >70% of total activity in cutaneous neurons, and NCX2 was 
responsible for the remainder. Comparable results were obtained with small interfering RNA 
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(siRNA) knockdown of each isoform in vivo, but with potentially larger role for NCX2 
suggested as well. Western blot analyses suggested that NCX isoforms were differentially 
distributed within sensory neurons. Functional assays of excitability, action potential 
propagation, and nociceptive behavior suggest NCX activity has little influence on excitability 
per se, but instead influences axonal conduction velocity, resting membrane potential, and 
nociceptive threshold. Together these results indicate that the function of NCX in regulation of 
[Ca
2+
]i in putative nociceptive neurons may be unique relative to other cells in which these 
exchanger isoforms have been characterized and it has the potential to influence sensory neuron 
properties at multiple levels. 
3.2 INTRODUCTION 
We have previously demonstrated marked differences among subpopulations of dorsal root 
ganglia (DRG) neurons defined by cell body size, IB4 binding and capsaicin sensitivity with 
respect to the magnitude and decay of depolarization-evoked Ca
2+
 transients that were associated 
with differences in the relative contribution of many of the core components of the Ca
2+
 
signaling toolkit (Berridge et al., 2000). These included voltage gated Ca
2+
 channels, ryanodine 
receptor-mediated Ca
2+
-induced Ca
2+
 release, internal Ca
2+
 store operation mediated by sarco-
endoplasmic reticulum ATPase (SERCA), mitochondria, and store operated Ca
2+
 entry, as well 
as extrusion mechanisms such as the plasma membrane Ca
2+
 ATPase (PMCA) and the Na
+
/Ca
2+
 
exchanger (NCX) (Lu et al., 2006, Scheff et al., 2013) 
There are several reasons to focus on NCX for further analysis in DRG neurons. First, 
there are conflicting results in the literature regarding the extent to which NCX activity is 
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detectable in sensory neurons. Whereas our data (Lu et al., 2006) and those of Verdru and 
colleagues (Verdru et al., 1997), suggest that the duration of depolarization-evoked Ca
2+
 
transients in sensory neurons are determined, at least in part, by NCX activity, others have 
concluded that there is little if any detectable NCX activity in either the sensory neuron cell body 
(Werth and Thayer, 1994) or central terminals (Wan et al., 2012, Shutov et al., 2013). Second, 
there has been no systematic analysis of the biophysical properties of NCX in sensory neurons. 
This is important as available evidence from other systems suggest that while NCX has a higher 
extrusion rate than the PMCA, it should only be active in the presence of higher concentrations 
of intracellular [Ca
2+
]i due to a lower affinity for Ca
2+
 (Blaustein and Lederer, 1999, DiPolo and 
Beauge, 2006). This property could account for the apparent absence of NCX activity in sensory 
neurons, as the Ca
2+
 transients in the “negative” studies were relatively small. Biophysical 
characterization of NCX activity in sensory neurons is also important in light of recent evidence 
that NCX can function in “reverse mode” (Kuroda et al., 2013), that has been suggested to 
contribute to axon injury observed in some forms of peripheral neuropathy (Ma, 2013). Third, 
there is not only evidence of the differential distribution of NCX activity among subpopulations 
of sensory neurons (we were only able to detect NCX activity in putative nociceptive DRG 
neurons (Lu et al., 2006)), there is evidence of the differential distribution of NCX isoforms 
among sensory neurons, where NCX2, the only isoform detectable in sensory neurons, was 
restricted to those with a small cell body diameter (Persson et al., 2010). Thus, the selective 
distribution of NCX isoforms may also contribute to the conflicting results in the literature on 
NCX activity in sensory neurons. Finally, with the exception of data on the duration of evoked 
Ca
2+
 transients and recent evidence suggesting that NCX may act in reverse mode to contribute 
to peripheral nerve injury (Persson et al., 2013), there are no data on how NCX activity 
 56 
influences the normal function of sensory neurons. Therefore, the present study was designed to 
begin to address this relative dearth of information concerning the properties, distribution and 
function of NCX isoforms in sensory neurons. 
A combination of approaches ranging from the microfluorometric and PCR analysis of 
retrogradely labeled isolated sensory neurons in vitro to behavioral analysis following targeted 
knock down of NCX isoforms were employed to address these issues. Our results suggest that 
NCX, more specifically NCX3, plays a significant role in the regulation of decay of the evoked 
change in [Ca
2+
]i at the level of the cell body. However, functional assays of excitability, action 
potential propagation, and nociceptive behavior suggest NCX activity influences axonal [Ca
2+
]i 
levels, resting membrane potential, and nociceptive threshold via a mechanisms likely secondary 
to the regulation of [Ca
2+
]i in afferent terminals. 
3.3 METHODS 
Adult male Sprague-Dawley rats (Harlan, 220-300g) were used for all experiments. Animals 
were housed two per cage in a temperature and humidity controlled animal facility on a 12:12 
light:dark schedule with food and water freely available. All procedures were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee and performed in 
accordance with National Institutes of Health guidelines for the use of laboratory animals in 
research. 
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3.3.1 Tissue labeling 
Fourteen to 17 days prior to tissue harvest, the retrograde tracer 1,1’-dioctadecyl-3,3,3’,3’-
tetramethylindocarbo-cyanine perchlorate (DiI, Invitrogen, Carlsbad, CA) was injected into the 
glabrous skin of the hindpaw to label cutaneous afferents. The tracer was dissolved at 170 
mg/mL in dimethylsufoxide (DMSO, diluted 1:10 in 0.9% sterile saline, and injected in 3-5 
subcutaneous sites using a 30 g needle for a total volume of 10 μL per hindpaw under isoflurane 
(Abbott Laboratories, North Chicago, IL, USA) anesthesia. 
3.3.2 Tissue collection and isolation 
Prior to tissue removal, rats were deeply anesthetized with an intraperitoneal injection of a 
cocktail containing ketamine (55 mg/kg), xylazine (5.5 mg/kg) and acepromazine (1.1 mg/kg). 
For studies involving isolated sensory neurons, the L4-L5 DRG were removed ipsilateral to 
labeling. Ganglia were enzymatically treated, mechanically dissociated, and neurons plated on 
laminin (Invitrogen, Carlsbad, CA; 1mg/ml) and poly-L-ornithine-coated (Sigma-Aldrich; 1 
mg/ml) glass cover slips as previously described (Lu et al., 2006). All subsequent experiments 
were preformed within 8 h of tissue harvest and only neurons containing the retrograde label DiI 
were studied. For isolated nerve recordings, rat sciatic nerves were harvested and prepared for 
compound action potential (CAP) recording as previously described (Yilmaz-Rastoder et al., 
2012). Briefly, sciatic nerves (~30 mm) were quickly dissected and transferred to a dish 
containing ice-cold Locke’s solution of the following composition (in mM): 136 NaCl, 5.6 KCl, 
14.3 NaHCO3, 1.2 NaH2PO4, 2.2 CaCl2, 1.2 MgCl2, 11 glucose, equilibrated continuously with 
95% O2, 5% CO2, pH 7.2–7.4. In ice-cold oxygenated Locke’s solution nerves were trimmed of 
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excess connective under a dissecting microscope. All subsequent experiments were preformed 
within 24 h of tissue harvest. 
3.3.3 Calcium Imaging 
Neurons were incubated with 2.5 μM Ca2+ indicator fura-2 AM ester with 0.025 % Pluronic F-
127 for 20min at room temperature. Neurons were then labeled with FITC-conjugated IB4 (10 
μg/ml) for 10 min at room temperature. Labeled neurons were placed in a recording chamber and 
continuously superfused with normal bath solution (mM: 130 NaCl, 3 KCl, 2.5 CaCl2, 0.6 
MgCl2, 10 HEPES, 10 glucose, pH 7.4, osmolality 325 mOsm) or a ‘Na
+
-free’ bath solution 
(mM: 130 Choline-Cl or LiCl, 3 KCl, 10 MgCl2, 2 EGTA, 10 Hepes, 10 glucose, pH 7.4, 
osmolality 325 mOsm). A Na
+
-free solution was used to block NCX activity by preventing NCX 
from fulfilling the Na
+
 binding requirement for exchange activity (Cook et al., 1998). 
Fluorescence data were acquired on a PC running Metafluor software (Molecular Devices, 
Sunnyvale, CA, USA) via a CCD camera (Roper Scientific; model RTE/CCD 1300). The ratio 
(R) of fluorescence emission (510 nm) in response to 340/380nm excitation (controlled by a 
lambda 10–2 filter changer (Sutter Instrument, Novato, CA)) was acquired at 1 Hz during drug 
application. All drugs were applied through a computer-controlled peizo driven perfusion system 
(switching time <20 ms; Warner Instruments, Hamden, CT, USA, Fast-Step Model SF-77B). 
[Ca
2+
]i was determined from fura-2 ratio following in situ calibration experiment as described in 
detail previously (Grynkiewicz et al., 1985, Kao, 1994, Scheff et al., 2013). 
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3.3.4 Patch Clamp Electrophysiology 
Gramicidin-perforated patch clamp experiments were carried out using a HEKA EPC9 amplifier 
(HEKA Elektronik, Lambrecht/Rhineland-Pfalz, Germany). Glass electrodes (1–4 MΩ) were 
filled with (mM) 110 K-methanesulfonate, 30 KCl, 5 NaCl, 1 CaCl2, 2 MgCl2, 10 HEPES, 11 
EGTA, 2 Mg-ATP, and 1 Li-GTP for current clamp excitability recordings. The pH was adjusted 
with Tris-base to 7.2 and osmolality was adjusted with sucrose to 320 mOsm. 
To obtain whole cell access for patch clamp experiments, a stock solution of gramicidin 
(1.5 mg/100 μl, Sigma–Aldrich) was prepared in DMSO. This was diluted with electrode 
solution at 1:300 to give a final concentration of 50 μg/ml. The gramicidin containing electrode 
solution was vortexed for > 15 s. No filtering was applied. The tip of the electrode was loaded 
with a small volume of gramicidin free electrode solution in order to avoid interference of the 
antibiotic with seal formation. Gramicidin-containing electrode solution was subsequently back 
loaded. The progress of perforation was monitored from a holding potential of -60 mV with a 10 
ms step to -65 mV. Experiments were not started until access resistance was < 7 MΩ.  
Neuronal excitability was assessed in current clamp (Scheff and Gold, 2011) before and 
after a 4 s voltage step from -60 mV to 0 mV to drive an increase in [Ca
2+
]i, and consequently an 
increase in NCX activity. Resulting changes in [Ca
2+
]i were simultaneously monitored with Fura-
2 AM based microfluorimetry. Series resistance compensation (>70%) was employed for all 
voltage-clamp recordings. Five distinct measures of excitability were used: the emergence of 
spontaneous activity, action potential (AP) threshold, rheobase, the response to suprathreshold 
current injection, and following frequency. Spontaneous activity was assessed at resting 
membrane potential (Vrest) for 30 s before and up to 90 s after the application of Na
+
 free Bath. 
The subsequent three measures were determined with a 750 ms depolarizing square-pulse current 
 60 
injection. AP threshold was defined as the greatest depolarization reached before spike 
generation in response to depolarizing current injections. Rheobase was defined as the smallest 
amount of current needed to evoke a single AP. The results to suprathreshold current injection 
was determined by counting the number of action potentials evoked in response to current 2x and 
3x rheobase. As rheobase is positively correlated with cell size, values were normalized with 
respect to membrane capacitance to facilitate comparisons between neurons. Following 
frequency was assessed at 10, 20, and 40 Hz with 1 ms pulses 1.5-fold above threshold 
(determined as with rheobase but with the 1 ms pulse duration). 
3.3.5 Single cell polymerase chain reaction (PCR) 
Isolated neurons were prepared for single cell RT-PCR experiments in a manner identical to that 
used for patch clamp and microfluorimetry experiments. Single neurons were collected with 
large bore (30 μm) glass pipettes and expelled into reaction tube for subsequent cDNA synthesis 
via methods identical to those described previously (Nealen et al., 2003, Zhang et al., 2012a). 
The cDNA generated from each neuron was used as a template for subsequent PCR reactions. To 
confirm successful cell collection and cDNA synthesis, 0.5 μl of the template cDNA was used 
for the amplification of the housekeeping gene, cyclophilin. Negative controls for each round of 
cell collection included two neurons in which no reverse transcriptase was added to the reaction 
mixture and two tubes in which all other procedures were performed as if a neuron was 
collected, except no neuron was collected. Nested PCR primers (Table 1) were used in two 
successive rounds of PCR amplification to assess the expression of NCX 1, 2 and 3, as this 
strategy increases the sensitivity and specificity of the PCR reaction. The “outer” set of primers 
was used in the first round of amplification and 2 μl of this reaction product was used for a 
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second round of amplification with the “inner” set of primers. Thirty five cycles were used for 
both rounds of amplification. Following agarose gel electrophoresis, PCR reaction products were 
visualized with ethidium bromide. 
3.3.6 Western Blot 
L4 and L5 DRG were homogenized with Teflon tube and mortar for less than 10 strokes in ice 
cold radioimmunoprecipitation assay (RIPA) buffer supplied with protease inhibitors (aprotinin, 
leupeptin, pepstatin, E-64, trypsin inhibitor, and phenylmethanesulfonyl fluoride (PMSF), all at a 
final concentration of 2 ng/ml except PMSF, which was used at a final concentration of 1 mM). 
All protease inhibitors were obtained from Sigma–Aldrich. Lysates were collected in 0.5-ml 
tubes. Teflon tubes were rinsed with RIPA buffer and the solutions were combined with the 
lysates previously collected. Lysates were centrifuged for 5 min at 10,000 rpm at 4°C. Protein 
concentration was determined via bicinchoninic acid (BCA) protein assay using a BCA assay kit 
(Thermo scientific, Rockford, IL, USA). Lysates were then mixed with Laemmli buffer (2×, 
400 μl + 100 μL β-mercaptoethanol) and boiled for 5 min before loading. Protein (30 μg) from 
one animal was then loaded per lane and separated on a 7 % SDS–PAGE gel and transferred to 
nitrocellulose membrane. Membranes were blocked with 5% milk for 1 hour at room 
temperature and then incubated with primary antibody at 4°C overnight (1:100 for R3F1 (anti-
NCX1),1:200 for W1C3 (anti-NCX2), and 1:100 for anti-NCX3 (cat # LS-B5775, LifeSpan 
Biosciences, Inc., Seattle WA), diluted with 5% milk/Tris-buffered saline with Tween 20 (TBST, 
Sigma–Aldrich). The blots were washed and then incubated with peroxidase-conjugated 
secondary antibody (1:2000 in 5% milk/TBST, Jackson ImmunoResearch Laboratories Inc. West 
Grove, PA, USA) for an hour at room temperature. An ECL kit (Amersham Biosciences, 
 62 
Piscataway, NJ, USA) was used for detection of immunoreactivity, luminescence data were 
collected on an LAS3000 imager (Fujifilm Inc., Japan), and analyzed with ImageJ (NIH). Both 
antibodies used to detect NCX1 and NCX2 were gifts from Dr. Kenneth Philipson of University 
of California Los Angeles. Both antibodies have been characterized by Dr. Philipson and 
colleagues in heterologous expression systems and hippocampal cultures, where R3F1 (anti-
NCX1) detects a prominent band at 120 kDa and minor bands at 70 kDa and 60 kDa, and W1C3 
(anti-NCX2) detects only one prominent band at 60 kDa. There appears to be no cross reactivity 
between isoforms (Thurneysen et al., 2002b, Papa et al., 2003). Furthermore, the specificity of 
the anti-NCX2 antibody was confirmed in NCX2 null mutant mice (Jeon et al., 2003). 
3.3.7 Compound Action Potential (CAP) Recordings 
Isolated sciatic nerve recording was performed at room temperature. The isolated nerves were 
mounted in a recording chamber such that the distal end was laid over two platinum stimulating 
electrodes isolated from the central portion of the nerve with a grease-gap. A glass suction 
electrode connected to a differential preamplifier (WPI model DAM-80, Sarasota, FL, USA) was 
used to isolate the central end of the nerve. The remainder of the nerve (~15-20 mm) was 
superfused continuously (2-5 ml/min) with oxygenated Locke’s solution with and without drugs 
delivered via a gravity driven perfusion system. CAPs were evoked with electrical pulses 0.2 - 
0.5 ms in duration applied at 0.1 Hz unless otherwise indicated, where the stimulus amplitude 
was ~2x that needed to evoke a maximal amplitude C-fiber component of the CAP. CAP data 
were filtered at 2 kHz and sampled at 20 kHz via a CED 1401 Micro A/D converter, and 
acquired and analyzed using CED Spike 2 version 5 for MS Windows (CED, Cambridge, 
England). CAP data were rectified and the average of 6 consecutive CAPs, were integrated to 
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quantify A- and C-fiber components as area under the curve (AUC). The A-fiber deflection of 
the CAP (A-wave) was easily distinguished from that associated with the C-fiber deflection (C-
wave) because of the time delay between the arrivals of the two waves at the recording electrode. 
3.3.8 siRNA and IB4 saporin injections 
Slc8a ON-TARGETplus SMARTpool siRNAs (Thermo Scientific, Pittsburgh, PA, USA) were 
tested for their ability to knock down expression of individual isoforms of NCX in cultured L4-
L5 DRG neurons where the extent of knockdown was assessed with PCR. Catalog numbers for 
each isoform are as follows: NCX1 (LQ-091320-02), NCX2 (LQ-094819-02), NCX3 (LQ-
094821-02). The siRNA sequence that produced the largest decrease in the expression of the 
targeted isoform was chosen for sciatic nerve injection with the transfection agent, lipofectamine 
(Invitrogen, Carlsbad, CA, USA). At least 7-10 days after DiI injection, rats were deeply 
anesthetized with isoflurane. The hair over the back of the thigh was shaved and blunt dissection 
was used to separate the hamstring muscle exposing the sciatic nerve. A subfasicular injection of 
4-6 μl 1:1 lipofectamine to NCX-targeted siRNA or control siRNA was made using a 33 g 
needle. For Ca
2+
 imaging experiments, DRG were isolated as described above 6 days after 
siRNA injection. The extent of the knockdown was assessed with western blot analysis of the 
sciatic nerve.  
Methodology for the IB4/saporin and siRNA co-injections was adapted from Vulchanova et al 
(2001) (Vulchanova et al., 2001). Under deep anesthesia, the left sciatic nerve was exposed and a 
subfasicular injection of 10 μl consisting of either a mixture of 5 μl control or NCX3 siRNA (1:1 
lipofectamine to siRNA) and 5 μl IB4 conjugated saporin (400 μg/mL) or unconjugated IB4 and 
saporin (2.5 μl IB4 (280 μg/ml, 71%) + 2.5 μl saporin (120 μg/mL, 29%)) was slowly infused 
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using a 33 g needle at a rate of 10 μl/min. IB4+ fiber loss was confirmed using IB4-FITC 
(Sigma-Aldrich) staining of 25 µm sections of the spinal cord lumbar enlargement. 
3.3.9 Nociceptive Behavior 
Testing for each group of rats was initiated at the same time of day with no more than two 
groups (12 rats) being tested on any given day. Rats from each experimental and control group 
were randomized between testing sessions. Rats were habituated to the testing procedure and 
experimenter for three days before the collection of baseline data. Habituation consisted of 
moving the rats from their home room to the testing room, handling the rats, and placing them in 
the testing apparatus for 30 min. The testing apparatus consisted of a row of six clear acrylic 
enclosures (4 inches [~10.2 cm] wide, 7–5/8 inches [19.4 cm] long, and 5 inches [12.7 cm] high). 
Opaque dividers separated the enclosures. On testing days, rats were loaded in their enclosures 
and given 10 min of habituation before the initiation of data collection. 
Von Frey: Acrylic enclosures sat atop anodized aluminum mesh (1/4” [6.4 mm] waffle 
hole). An electronic von Frey anesthesiometer (IITC Plantar Test Analgesia Meter 2390; IITC 
Life Sciences Inc., Woodland Hills, CA) fitted with a rigid tip (1.0-mm tip diameter) was used to 
assess changes in mechanical threshold. The tip was applied to the glabrous skin of the hind paw 
with steady vertical pressure until the rat withdrew from the stimulus or until the paw was lifted 
off the mesh floor (at ~ 70 g). The greatest force generated before withdrawal was recorded. This 
procedure was repeated three times, and the average of the three measures for each paw was 
considered the withdrawal threshold.  
Hargreaves: Thermal withdrawal latency was determined using a plantar analgesia meter 
(IITC Life Sciences, Woodland Hills, CA). Acrylic enclosures sat atop a glass surface 
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maintained at 30°C. A light beam was focused onto the middle of the ventral surface of each 
hind paw and the amount of time lapsed until the animal withdrawals the paw cut-off (20 sec) 
was reached. 
3.3.10 Chemicals and Reagents 
DiI 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate was purchased from 
Invitrogen (Carlsbad, CA, USA). Fura-2 acetoxymethyl (AM) ester (2.5 mM stock in DMSO) 
and Pluronic F-127 (0.025 % in water) were purchased from TEF Laboratories (Austin, TX, 
USA). Isolectin B4 (IB4) was purchased from Sigma (St Louis, MO, USA). KB-R7943 and SN-
6 were purchased from R&D Systems, Inc (Minneapolis, MN, USA) and SEA0400 was 
purchased from ChemScene, LLC (Monmouth Junction, NJ, USA). All NCX inhibitors were 
dissolved to 100mM stock concentration in DMSO (Sigma-Aldrich, St Louis, MO, USA). 
Saporin (unconjugated and IB4-conjugated) was purchased from Advanced Targeting Systems 
(San Diego, CA, USA). 
3.3.11 Statistical Analysis 
Data are expressed as mean ± s.e.m. Student’s t test was used for simple comparison between 
groups. For experiments involving the application of test compounds, vehicle controls were 
always included. Concentration-response data for NCX blockers were fitted with a modified Hill 
equation: Emax*D
n
/(D
n
 + EC50
n
), where Emax is the maximal increase in the duration of the 
evoked Ca
2+
 transient, D is the concentration of NCX blocker, EC50 is the concentration of NCX 
blocker producing a response 50% of maximal, and n is the Hill coefficient. One and two-way 
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ANOVA was used for analysis of more than two groups with the Holm-Sidak test used for post-
hoc analysis. Statistical significance was assessed at p < 0.05. 
3.4 RESULTS 
3.4.1 NCX contributes to the decay of the evoked Ca2+ transient in IB4+ small diameter 
cutaneous DRG neurons 
We initially screened cutaneous (DiI+) DRG neurons for the presence of NCX activity by 
comparing high K
+
 (30 mM, 4s)-evoked Ca
2+
 transients before and after blocking NCX using 
Na
+
 free bath solution (Figure 9A). A neuron was considered to have NCX activity if application 
of Na
+
 free bath produced an increase in the duration of the evoked Ca
2+
 transient, assessed as 
time to decay to 50% of the peak, or T50, following, >20%. Consistent with our previous results 
in unlabeled DRG neurons (Lu et al., 2006), NCX activity was only detected in a subpopulation 
of the cutaneous neurons: those with a small cell body diameter (≤ 30 μm), that were IB4+, and 
were, in general (29/34), responsive to 500nM capsaicin. In this subpopulation of IB4+ (n = 34) 
neurons, blocking NCX activity had no effect on the magnitude of the evoked Ca
2+
 transient, but 
was associated with a significant increase in duration (529.22 ± 12.68 %, Figure 9B). In contrast, 
blocking NCX activity in IB4- neurons (n = 15) had no effect on either the magnitude or duration 
of the evoked Ca
2+
 transient (Figure 9B). Failure to detect NCX activity was not due to 
differences in the magnitude of Ca
2+ 
transient used to assess the presence of activity (Figure 9B). 
Comparable results were obtained with Na
+
 free bath solution in which Na
+
 was replaced with 
Li
+
 or choline (Figure 9C), arguing against non-specific effects of Li
+
 on the regulation of 
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[Ca
2+
]i. Lastly, there was no significant difference between IB4+ and IB4- neurons with respect 
to resting [Ca
2+
]i which was 104.02 ± 4.31 nM and 111.04 ± 3.98 nM, respectively.  
 
 
 
 
Figure 9: NCX activity in isolated cutaneous DRG neurons 
A) High K
+
 (30 mM) evoked Ca
2+
 transients in small diameter (≤ 30 µm) retrogradely labeled (DiI+), capsaicin 
sensitive (Cap+), IB4+ (top trace) and IB4- (bottom trace) DRG neurons before and after NCX block with a bath 
solution in which Na
+
 was replaced with Li
+
. B) Pooled magnitude (Δ[Ca2+]i) and decay (time to 50% decay from 
peak, or T50) of high K
+
 evoked Ca
2+
 transient data from the two populations of neurons illustrated in (A) (DiI+ 
small diameter Cap+ neurons that were either IB4+ (n = 34) or IB4- (n = 15)). The increase in the duration of the 
evoked transient was only observed in IB4+ neurons. C) Pooled magnitude and decay of high K
+
 evoked Ca
2+
 
transient data from DiI+/IB4+ neurons before (Na
+
) and after block of NCX with Li
+
 (n = 20) or choline (Cho+, n = 
14) replacement. ** p<0.01 
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3.4.2 Biophysical properties of NCX in putative nociceptive cutaneous neurons 
NCX is described as a low affinity Ca
2+
 extrusion mechanism and evidence from other systems 
suggest that it is only activated with relatively large increases in [Ca
2+
]i (Blaustein and Lederer, 
1999, Hilge, 2012). Furthermore, if NCX has a relatively high threshold for activation in sensory 
neurons, this biophysical property could explain the apparent inconsistencies among previous 
studies of sensory neurons as to whether NCX contributes to the regulation of evoked Ca
2+
 
transients (Verdru et al., 1997, Thayer et al., 2002, Lu et al., 2006, Usachev et al., 2006). We 
therefore sought to characterize the relationship between [Ca
2+
]i and NCX activity in putative 
nociceptive cutaneous neurons. To address this issue, neurons (n = 20 to 40) were challenged 
with high K
+
 applied at durations increasing from 250 ms to 4 s, before and after Li
+
-induced 
block of NCX (Fig 10A). The stimulus duration-dependent increase in the peak of the evoked 
Ca
2+
 transient was well described by a single exponential with a time constant of 1.25 ± 0.08 sec, 
and this was not changed by NCX block (Fig 10B). The stimulus duration-dependent increase in 
the decay of the evoked transient was more complex, with a marked increase in transient 
duration detectable as the duration of high K
+
 application was increased from 1 to 2 s. This 
transition was further highlighted by NCX block (Fig 10C), where a Li
+
-induced increase in 
transient duration was readily apparent in response to a 2 s high K
+
 application. Consistent with 
our previous results indicating that there are distinct mechanisms in sensory neurons responsible 
for the regulation of the magnitude and duration of evoked Ca
2+
 transients, the magnitude of the 
evoked transient was saturated by a 2 s high K
+
 application, at 403.7 ± 20.9 nM, while there was 
still a ~ 60% increase in duration of the evoked transient between 2 and 4 s of application.  
Interestingly, even within the IB4+ subpopulation of small diameter cutaneous neurons, 
there was heterogeneity with respect to the duration of high K
+
 application at which an influence 
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of Li
+
 application was detectable. To illustrate this point, we plotted the percentage of neurons 
responsive to block of NCX, as determined by an increase in high K
+
-evoked transient duration 
in Na
+
 Free bath, as a function of the duration of high K
+
 application (Fig 10D). While NCX 
activity was detectable in all neurons following a 4 s high K
+
 application, NCX activity was only 
detectable in 62% of these with a 2 s high K
+
 application. Not surprisingly, there was no 
difference with respect to the magnitude of the Ca
2+
 transient evoked between neurons in which 
NCX activity was (2s-responder) or was not (2s-non-responder) detected with a 2 s high K
+
 
application (Fig 10E; 267.25 ± 15.03 nM and 265.06 ± 17.61 nM, respectively). However, there 
was a significant difference between 2s-responders and 2s-non-responders with respect to the 
duration of the 2 s high K
+
-evoked transient (Fig 10F; 27.42 ± 2.11 s and 12.39 ± 1.74 s, 
respectively; p < 0.05). 
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Figure 10: Properties of the Ca
2+
 transient necessary for the detection of NCX activity. 
A) High K
+
 (30 mM) was applied to a cutaneous putative nociceptive neuron for stimulus durations ranging between 
250 ms and 4 s, before and after NCX block with Na
+
 free bath solution (dashed line). The open rectangles indicate 
the first of three fixed-duration pulses of High K
+
 (30 mM). B) The peak evoked response from neurons (n = 40) 
stimulated as in (A) before (Na
+
) and after (Li
+
) NCX block, plotted as a function of the high K
+
 application 
duration. C) The duration, as assessed with the T50, of the evoked response of the neurons plotted in B, before (Na
+
) 
and after (Li
+
) block of NCX. D) A cumulative histogram of the neurons illustrated in B and C, analyzed as a 
percent of neurons studied (n = 32) in which NCX block resulted in an increase in the transient duration (% 
Responders to Li
+
) plotted as a function of the stimulus duration. A neuron was considered a responder if NCX 
block resulted in a 20% increase in the evoked transient duration (T50) over the baseline response. Because there 
appeared to be a group of neurons in which application of Li
+
 resulted in an increase in baseline [Ca
2+
]i and we were 
originally interested in evoked NCX activity, these neurons were not included in this analysis.  Scatter plots of the 
magnitude (E) and decay (F) of the evoked Ca
2+
 transient in neurons with (2s-Resp, n = 20) and without (2s-Non-
Resp, n = 14) evidence of NCX activity in response to a 2 s application of high K
+
. 
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  We performed a more detailed analysis of the evoked Ca
2+
 transient in 2s-responder and 
2s-non-responder neurons to determine whether it was possible to define a “threshold” for NCX 
activation. Because the duration of the Ca
2+
 transient in 2s-responders was so much longer than 
that in 2s-non-responders (Fig 11A), we analyzed Ca
2+
 transients for each neuron as a function of 
the duration at which the transient was at or above an [Ca
2+
]i ranging from 275 to 400 nM. 
Increments of 25 nM Ca
2+
 were used, as they appeared to provide sufficient resolution to detect a 
separation between subpopulations of neurons. For example, there was a separation in the time 
spent at or above 325 nM Ca
2+ 
between 2s-responders and 2s-non-responders as the transient in 
2s-responders was at or above 325 nM Ca
2+
 for 13.4 ± 2.5 s (n = 20), compared to 7.00 ± 2.2 s (n 
= 14) in 2s-non-responders (p < 0.01, Fig 11B). This separation was further increased in Na
+
 free 
bath. Since the 2s-non-responders became responders with a 4 s high K
+
 application, we repeated 
this analysis for 2s-non-responder comparing the response to 2 s and 4 s high K
+
 applications to 
determine if the “threshold” of NCX activation was comparable in this group of neurons to that 
of the 2s responders (Fig 11C). An [Ca
2+
]i at or above 325 nM was again the separation point for 
the amplitude-duration plots (which increased from 4.0 ± 0.9 s to 12.0 ± 2.9 s (n = 10) with 2 and 
4 s of high K
+
, respectively). This separation was again further augmented in the presence of Na
+
 
free bath. Both sets of data suggest that NCX activity may be evoked in putative nociceptive 
cutaneous neurons with Ca
2+
 transients ≥ 325 nM for a duration of ≥ 12 s. 
In our initial analysis of the 2 s high K
+
 data set, we identified a subset of 2s-responsders 
(8/20) that had evoked Ca
2+
 transients in normal bath solution with parameters comparable to 
those of 2s-non-responders (i.e., note the overlap in the scatter plot in Figure 10F). However, the 
resting [Ca
2+
]i appeared to be the unique feature in this group of 2s-responders as it was 
increased following application of Li
+
 bath (Figure 11D). Pooled data indicate that this increase 
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in resting [Ca
2+
]i was significantly (p < 0.01) greater than changes observed in the other 2s-
responder or 2s-non-responders (Fig 11E). In this “Li+ recruited” group of neurons, the evoked 
transient amplitude-duration plot again revealed a significant increase in the duration of the 
transient at or above 325 nM Ca
2+
 in the presence of Li
+
 (Figure 11F). In these Li
+
 recruited 
neurons, the 2 s-evoked Ca
2+
 transient resembled a “non-responder”, such that it did not fulfill 
the amplitude-duration criteria that appears to be necessary to engage NCX activity. However, 
the Li
+
-induced increase in [Ca
2+
]i enabled a 2 s depolarization to engage NCX. This group of 
neurons provided the first evidence of two modes of NCX activity: one evoked in response to 
relatively large and long-lasting Ca
2+
 transients and a second in which a resting activity 
contributes to the maintenance of the baseline or resting [Ca
2+
]i.  
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Figure 11: Ca
2+
 transient parameters associated with evoked NCX activity. 
A) High K
+
 evoked Ca
2+
 transients from an IB4+ (solid trace) and an IB4- (dashed trace) cutaneous DRG neuron, in 
which bins used to determine the transient amplitude-duration relationship for each neuron are illustrated. B) Pooled 
transient amplitude-duration (time elapsed at or above an [Ca
2+
]i) data for the 2s-Responders and 2s-Non-
Responders analyzed in Figure 2 E and F, where transient duration data before and after Li
+
 application are plotted. 
C) Data for the 2s-Non-Responders in B (in response to the 2 s high K
+
 application) are replotted along with the 
average amplitude-duration data for these neurons in response to the 4 s high K
+
 application, before (Na
+
) and after 
(Li
+
) NCX block. D) Evoked NCX activity was detected in a third subset of neurons in which application if Li
+
 
resulted in an increase in resting [Ca
2+
]i (arrow). Inset: Evoked Ca
2+
 transients before (dashed line) and after (solid 
line) NCX block. E) Pooled data demonstrating the significant shift increase in resting [Ca
2+
]i with application of Li
+ 
in a subset of neurons (p < 0.01, n = 8) in which evoked NCX activity was subsequently detected. F) Pooled 
amplitude-duration data for the subset of neurons in which the Li
+
 induced increase in resting [Ca
2+
]i resulted in the 
recruitment of evoked NCX activity. 
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We next sought to determine whether NCX activity persists once activated, and if so, for 
how long. We assumed that, as with PMCA, which appears to be constitutively active in sensory 
neurons to counter what appears to be a persistent Ca
2+
 leak (Rigaud et al., 2009), inhibition of 
NCX would result in an increase in [Ca
2+
]i. We could then monitor the duration of NCX activity 
following high K
+
 application with brief (60 sec) applications of Li
+
 to temporally inactivate 
NCX if present (Figure 12A). Li
+
 bath was applied before and at 5 min intervals after two 
consecutive high K
+
-induced transients until Li
+
 application resulted in no change in [Ca
2+
]i. This 
protocol revealed two subsets of neurons: those with a Li
+
-induced increase in [Ca
2+
]i prior to 4s 
depolarization (Resting NCX activity n = 14) and those without (n = 24). Furthermore, within the 
no resting NCX activity subset, there was a group of neurons (14/24) in which the evoked NCX 
activity recovered relatively rapidly so that Li
+
 challenge before and after the high K
+
-evoked 
transient resulted in no change in [Ca
2+
]i. The remaining neurons in the no resting activity subset 
(10/24), appeared to have evoked NCX activity that persisted well beyond full recovery to 
baseline [Ca
2+
]i levels so that Li
+
-evoked transients were detectable for up to 10 min after the 4 s 
stimulus (Figure 4A and B). Within the subset of neurons with resting NCX activity, there as a 
group of neurons (9/14) in which evoked NCX activity appeared to recover rapidly: a Li
+
-evoked 
Ca
2+
 transient was clearly detectable prior to high K
+
 challenge, but there was no change in the 
magnitude of the Li
+
-evoked transient after the 4 s stimulus (Figure 12B). Finally, in the 
remaining neurons in the subset with resting NCX activity (5/14), there was evidence of both 
resting NCX activity (i.e., a Li
+
 transient prior to high K
+
 challenge) and persistent evoked 
activity in which there was an increase in the magnitude of the Li
+
-evoked transient after the 4 s 
stimulus (Figure 12A and B). Analysis of the resting [Ca
2+
]i in these four subpopulations of 
neurons indicated that resting NCX activity was present in neurons with baseline [Ca
2+
]i > 150 
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nM (Figure 12C). Interestingly, despite the fact that the Li
+
-evoked transients were no longer 
detectable 15 min after high K
+
 challenge in neurons in which evoked NCX activity appeared to 
persist (Figure 4B), there was no evidence of recovery of resting [Ca
2+
]i to baseline levels in this 
subpopulation (Figure 12C). Similarly, there was no significant increase in resting [Ca
2+
]i in 
neurons with resting NCX activity in which there appeared to be a persistent evoked NCX 
activity. Taken together, these data lend further support to the suggestion that there are at least 
two distinct pools of NCX in putative nociceptive sensory neurons. 
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Figure 12: Characterization of "Resting" NCX activity in putative nociceptive cutaneous DRG neurons. 
A) Examples of neurons in which Ca
2+
 transients were evoked with Li
+
. In one neuron (Top Trace), Li
+
 (1 min) 
evoked transients were only detected after stimulating the neuron with high K
+
 and the amplitude of these transients 
decayed over time. In the second (Bottom Trace), Li
+
 evoked transients were evoked before and after stimulating the 
neuron with high K
+
. In this neuron, the amplitude of the Li
+
 evoked transient increased following high K
+
 
stimulation, but decayed to baseline levels over time. B) The amplitude of the Li
+
 evoked transient in 4 types of 
putative nociceptive cutaneous DRG neurons are plotted as a function of time relative to high K
+
 stimulation as 
illustrated in A, where 0 is before and 15 indicates 15 min after high K
+
-induced depolarization. C) Resting [Ca
2+
]i 
data for the four groups of neurons plotted in B, where resting [Ca
2+
]i was determined 10 sec prior to Li
+
 application. 
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3.4.3 NCX expression in isolated cutaneous sensory neurons 
The results of our biophysical characterization of NCX activity in putative nociceptive cutaneous 
neurons suggested that there is considerable heterogeneity in the properties of NCX both within 
and between putative nociceptive cutaneous neurons. Because of evidence suggesting that NCX 
isoforms have different properties (Thurneysen et al., 2002b, Jeon et al., 2003, Molinaro et al., 
2011), we next sought to determine whether the heterogeneity in functional properties might be 
due, at least in part, to a differential expression of NCX isoforms. PCR analysis of NCX isoform 
expression of mRNA extracted for whole DRG indicated that not only are all three isoforms 
expressed in DRG, but at least two splice variants of NCX1 and NCX3 were detectable as well 
(Figure 13). To confirm NCX expression in putative nociceptive neurons, single cell PCR 
analysis was performed. Results of this analysis indicated that mRNA encoding all 3 NCX 
isoforms is present in the vast majority of DRG neurons from L4/L5 DRG (Figure 13) including 
two splice variants of NCX1 and two of the three splice variants of NCX3. 
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Table 2: Fully nested NCX PCR primers for single cell PCR 
Target Gene Position Start Sequence 
NCX1 NM_001270778.1 
Outer 
1771 
2075 
F: AGGGGAGGACTTTGAGGACA 
R: TCCTCCTCCTCTTTGCTGGT 
Inner 
1779 
2068 
F: GGAGGACTTTGAGGACACCTG 
R: TCCTCTTTGCTGGTCAGTGG 
NCX2 NM_078619.1 
Outer 
1954 
2379 
F: TTCTTGGGGAGAACTGTCGC 
R: GCAAACGTGTCAGGGATGGA 
Inner 
2065 
2270 
F: CACTCATGGAGGGAGCAGTTT 
R: AGGATGCAGACACCAAAGCA 
NCX3 NM_078620.1 
Outer 
2681 
3263 
F: TGCCCTTGGTGAACCGAAAT 
R: CATACACATCCTGCAGGGCA 
Inner 
2763 
3263 
F: ATGGAGGAAGAGGAGGCCAA 
R: CATACACATCCTGCAGGGCA 
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Figure 13: NCX isoform expression in DRG 
RT-PCR was used to screen for the presence of NCX1, 2 and 3 in mRNA extracted from whole ganglia and isolated 
putative nociceptive cutaneous DRG neurons. Images of ethidium bromide stained agarose gel loaded with 
molecular weight marker (lane 1) and then as indicated where Control 1 is a no-cell control and Control 2 is a single 
neuron in which no reverse transcriptase was included in the reverse transcriptase reaction prior to PCR 
amplification, and Cells 1 – 5 are products from single putative nociceptive cutaneous DRG neurons. 
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Because the presence of mRNA does not necessarily indicate the presence of functional 
protein, we next sought to determine which isoforms were functional within the isolated cell 
body. High K
+
 was applied for 4 s to putative nociceptive cutaneous neurons before and after 
application of three different NCX inhibitors, KB-R7943, SEA0400, and SN-6 (Figure 14A). 
These inhibitors were chosen based on their relative selectivity for individual isoforms. In 
transfected fibroblasts, when NCX is functioning in the reverse mode, KB-R7943 has shown 
been to block NCX3 with a higher potency than NCX1 or 2, whereas SEA0400 and SN-6 have 
been shown to block NCX1 with higher potency than NCX2 and 3 (Iwamoto and Shigekawa, 
1998, Watanabe et al., 2006). There is currently no commercially available NCX2 selective 
blocker. KB-R7943 produced a concentration-dependent increase in the duration of the high K
+
-
evoked transient (Emax = 107.25 ± 20.36 s; EC50 = 0.045 ± 0.01 μM, Figure 14B). The impact of 
KB-R7943 on the duration of the evoked Ca
2+
 transient appeared to be specific for NCX block as 
the application of KB-R7943 (100 nM) in the presence of Li
+
 bath resulted in no further change 
in the duration of the evoked transient (-2.26 ± 1.58 %, n = 8). While 100 nM was not quite a 
saturating concentration of KB-R7943 in cutaneous putative nociceptive neurons, this 
concentration was used in subsequent experiments for two main reasons. First, because NCX 
blocker “selectivity” is concentration-dependent, we wanted to use a concentration that was 
likely to provide the best combination of block and selectivity based on results previously 
reported by Kuroda and colleagues (Kuroda et al., 2013). Second, we observed what appeared to 
be non-specific effects of all 3 blockers at concentrations >5 μM, as had been described by 
others (Iwamoto et al., 1996, Birinyi et al., 2005, Niu et al., 2007). Thus, we also sought to 
minimize the potential for non-specific actions of the blocker. To estimate the fraction of total 
NCX activity blocked by KB-R943, we compared the maximal increase in the decay of the 
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evoked Ca
2+
 transient to that produced by Na
+
 free block. At 100nM, KB-R7943 inhibited 67.4 ± 
0.1 % of total NCX (Figure 14C). Neither SEA0400 nor SN-6 produced a detectable change in 
resting Ca
2+
 (Figure 14A) or the evoked (Figure 14B) Ca
2+
 transient at concentrations between 1 
nM and 1 μM, at and above those thought to be specific for NCX1.  
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Figure 14: Pharmacological analysis of NCX activity in putative nociceptive cutaneous DRG neurons 
A) Hi K
+
 evoked Ca
2+
 transients in putative nociceptive cutaneous neurons before and in the presence of increasing 
concentrations of the NCX3 selective blocker KB-R7943 (Top trace), the NCX1 selective blocker SEA0400 (Middle 
trace), and a second NCX1 selective blocker SN-6 (Bottom trace). B) Pooled concentration-response data from 
neurons treated with KB-R7943 (n = 25), SEA0400 (n = 11) or SN-6 (n = 10). Data were analyzed as an increase in 
transient duration (T50) relative to the transient duration in the presence of vehicle. KB-R7943 data were well fitted 
with a Hill equation, yielding an Emax = 107.25 ± 20.36 s and EC50 = 0.045 ± 0.01 μM. C) The maximal change in 
transient duration in the presence of blocker was analyzed as a % of the total block of NCX activity represented by 
the maximal change in duration observed in Na
+
 free bath, Data for each blocker was pooled and plotted. 
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Previous studies suggest that Li
+
 bath activates NCX in the reverse mode (Annunziato et 
al., 2004). However, as suggested earlier, we attributed the change in baseline resting [Ca
2+
]i 
with application of Li
+
 bath (Figure 11D) to inhibition of resting NCX activity and a subsequent 
build-up of Ca
2+
 from a persistent Ca
2+
 leak. In support of this hypothesis, application of 100 nM 
KB-R7943 also resulted in a ≥ 20 % increase in baseline resting [Ca2+]i (Δ[Ca
2+
]i = 31.16 ± 4.8 
nM) in 15 of the 29 neurons tested (Figure 15). 
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Figure 15: NCX contributes to the regulation of resting [Ca
2+
]i in a subpopulation of putative nociceptive 
cutaneous neurons. 
A. Examples of neurons in which application of Li
+
 Bath (Top Trace) or KB-R7943 (Bottom Trace) resulted in an 
increase in resting [Ca
2+
]i (Indicated by arrow). B. Pooled change in T50 (ΔT50) data, calculated as the difference 
between the T50 in the presence of NCX block and the baseline response, for neurons in which NCX was blocked 
with Li
+
 bath (Li
+
 Bath) or KB-R7943 (100 nM). Data for each group of neurons was separated according to 
whether NCX block was associated with an increase in resting [Ca
2+
]i (+, n = 14 and 15 for Li
+
 and KB-R7943 
groups, respectively), relative to those in which there was no detectable change in resting [Ca
2+
]i associated with 
NCX block (-, n = 24 and 14 for Li
+
 and KB-R7943 groups, respectively) following NCX block. * is p < 0.05. 
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To further assess the relative contribution of NCX isoforms to resting and evoked NCX 
activity, we used siRNA to selectively knock down expression of each isoform. Targeted or 
control siRNA was injected into the sciatic nerve 6 days prior to the harvest and dissociation of 
DRG neurons for assessment of NCX activity. The extent of the knockdown was estimated using 
western blot analysis of the sciatic nerve (Figure 16A). A single intraneural injection of targeted 
siRNA resulted in a decrease in NCX protein of 57.44 ± 3.36%. Importantly, Western blot 
analysis confirmed the specificity of each siRNA construct, where the only significant change in 
each isoform was in response to the appropriately targeted siRNA (Figure 16A). Consistent with 
results obtained with SEA0400 and SN-6, NCX1 knockdown was associated with no detectable 
changes in resting or evoked Ca
2+
 transients, or in the changes observed in response to Na
+
 free 
bath
 
or 100nM KB-R7943 application (T50 = 100.55 ± 11.8 s and 65.9 ± 12.1 s respectively) 
compared to the effect of NCX inhibition in neurons from naïve or control-targeted siRNA-
treated rats (Figure 16B). Results with NCX3 knockdown were also consistent with 
pharmacological results, where, in contrast to NCX1 siRNA-treated rats, evidence of evoked 
NCX activity in putative nociceptive cutaneous neurons was significantly attenuated (Figure 
16B). NCX3 knockdown was also associated with a significant suppression of the effects of 
100nM KB-R7943 (Figure 16B). Strikingly, in contrast to assumptions made about the 
concentration-dependent specificity of inhibitors, there was a significant suppression of the 
increase in T50 associated with both Li
+
 bath and KB-R7943 in neurons from NCX2 siRNA-
treated rats (Figure 16B). 
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Figure 16: Targeted siRNA knockdown of NCX isoforms on high K
+
-evoked Ca
2+
-transients in cutaneous neurons. 
A) Western blot analysis of protein extracted from the sciatic nerve proximal to the site of siRNA injection was used 
to quantify the extent of the knock down 6 days after siRNA treatment. Typical blots from animals treated with 
siRNA targeted to NCX1, 2 and 3. Pooled data from 4 animals per condition demonstrate specificity of siRNA 
sequences, where relative density of each isoform is plotted for tissue obtained under 4 conditions: naïve, NCX1-
siRNA, NCX2-siRNA, and NCX3-siRNA treated. Antibodies for NCX1 and NCX3 detected multiple bands and all 
were quantified. Solid bars represent pooled data for higher molecular weight (70kDa) band and hatched bars 
represent pooled data for lower molecular weight (50 kDa) band. Data were normalized with respect to GAPDH and 
plotted. B) Pooled high K
+
-evoked transient duration (T50) data for neurons from control and NCX isoform targeted 
siRNA treated rats, before (Na
+
 bath) and after block of NCX with Na
+
 free (Li+ Bath) or KB-R7943 (100 nM). ** p 
< 0.01 relative to control siRNA treated and ## p < 0.01 relative to NCX1 siRNA treated. 
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3.4.4 Differential distribution of NCX isoforms within sensory tissues 
The presence of mRNA encoding all three NCX isoforms in sensory neurons and in the face of 
evidence that only NCX3 and/or both NCX2 and NCX3 are functional in the sensory neuron cell 
body raises the possibility that NCX isoforms are differentially distributed within sensory 
neurons. To begin to address this possibility, we assessed the relative protein density of NCX 
isoforms in the spinal cord, dorsal root, DRG, and sciatic nerve (Figure 17). Consistent with the 
literature (Schulze et al., 2002, Quednau et al., 2004), antibodies for NCX1 (Figure 17A) and 
NCX3 (Figure 17C) detected multiple bands. Only the most robust bands were quantified across 
tissues. Consistent with the functional data showing dominant activity from NCX3, NCX3-like 
immunreactivity (LI) was greatest in the DRG and sciatic nerve relative to the spinal cord 
suggesting trafficking of NCX3 towards the periphery. In contrast, there was substantially more 
NCX1-LI in the spinal cord (n = 4) compared to peripheral tissues. NCX2 (Figure 17B) appeared 
to be equally distributed among peripheral tissues, but only weakly expressed in the spinal cord. 
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Figure 17: Distribution of NCX isoform-like immunoreactivity (LI)  
Protein extracted from spinal cord, central segment of the sensory nerve, DRG and sciatic nerve. Pooled data (n = 4) 
and representative blots demonstrating the relative density of expression of NCX1 (A), NCX2 (B), and NCX3 (C) in 
spinal cord, central nerve, DRG, and sciatic nerve tissues. Band intensity at each molecular weight was normalized 
to that for GAPDH. For the representative blots different protein amounts were loaded in each lane to facilitate 
visualization of the bands in each tissue type. 
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3.4.5 NCX plays a limited role in the regulation of primary afferent excitability 
NCX activity may influence excitability directly and/or indirectly. Because the exchanger is 
electrogenic, a direct influence of NCX on excitability would be through depolarizing inward 
Na
+
 current associated with exchanger activity in forward mode. The most proximal indirect 
influence of NCX activity on excitability would be via an influence on [Ca
2+
]i, which may 
influence the activity of other ion channels. We therefore sought to assess the impact of NCX 
activity on the excitability of putative nociceptive cutaneous DRG neurons. To minimize the 
impact of recording on the regulation of intracellular Ca
2+
 and consequently, NCX activity, we 
used gramicidin perforated-patch to obtain whole cell access for current clamp recording. 
Neurons were first loaded with Fura-2 AM to enable simultaneous recording of membrane 
potential and [Ca
2+
]i. The impact of NCX on the excitability was assessed with direct current 
injection protocols designed to enable determination of AP threshold, rheobase, and the response 
to suprathreshold stimuli (2x and 3x rheobase) in which each parameter was assessed under 4 
different conditions: in the absence and presence of Li
+
 bath, and before and after activating 
NCX with a 4 s voltage-step to 0 mV to drive an increase in [Ca
2+
]i. The Ca
2+
 transient evoked 
with a voltage step was comparable to that evoked with a 4 s application of high K
+ 
(the peak 
magnitude was 467.77 ± 23.3 nM and T50 of decay was 24.57 ± 6.5 s (n = 9)). Furthermore, as 
evidence that this Ca
2+
 transient was sufficient to activate NCX, block of NCX with Li
+
 resulted 
in a 276.96 ± 75% increase in T50 of the depolarization-evoked transient. Excitability data under 
each of these four experimental conditions are summarized in Table 2 and Figure 18 (A-C). 
Analyzing excitability data with a two-way ANOVA revealed a main effect associated with 
NCX activation (depolarization) on rheobase (p < 0.05; Figure 18A) and the response to 
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suprathreshold stimulation (p < 0.05; Figure 18C). However, there was no significant effect of 
NCX block (Li
+
 bath) on these parameters, nor was there an interaction between depolarization 
and Li
+
 bath (p > 0.05). There was, however, a significant (p < 0.05) main effect of Li
+
 bath on 
action potential threshold (Figure 18B), but no significant influence of depolarization, or an 
interaction between depolarization and Li
+
 bath, on this parameter. Comparable analysis of 
passive and active electrophysiological properties (Table 2) revealed a main effect of Li
+
 bath on 
resting membrane potential (RMP), and AP overshoot. Additionally there was a main effect of 
depolarization on afterhyperpolarization (AHP) and AP overshoot (Table 2). However, there was 
no interaction between depolarization and Li
+
 bath on any parameter assessed.  
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Table 3: Changes in passive and active electrophysiological properties with NCX inhibition 
  
  
Baseline Depolarization-induced Activity 
Na
+
 Bath Li
+
 Bath Na
+
 Bath Li
+
 Bath 
Diameter (μM) 23.74 ± 1.3 
RMP (mV) -67.47 ± 2.0 -61.67 ± 1.6 -70.14 ± 2.5 -63.50 ± 3.0 
Rin (mΩ) 1143.06 ± 179.2 1050.40 ± 333.6 603.70 ± 180.4 445.08 ± 42.6 
AP Overshoot 50.54 ± 1.6 47.11 ± 2.1 42.18 ± 1.6 35.35 ± 2.5 
AP Duration (ms) 3.02 ± 0.3 2.72 ± 0.03 2.61 ± 0.2 2.67 ± 0.2 
AHP Magnitude 
(mV) 
21.56 ± 0.7 20.47 ± 1.9 18.74 ± 1.1 15.97 ± 2.1 
AHP τ Decay (ms) 70.90 ± 7.4 54.40 ± 8.5 48.90 ± 6.5 38.24 ± 9.5 
Values are expressed as means ± SE. Depolarization consisted of a 4 s voltage step from -60 mV to 0 mV. Na
+
 Bath 
values were collected in the presence of Na
+
 in the bath solution. Li
+
 Bath values were collected in the absence of 
Na
+
 and presence of Li
+
 in the bath solution. RMP, resting membrane potential; Rin, input resistance; AP, action 
potential; AHP, afterhyperpolarization; τ, time constant. Data were analyzed with a two-way ANOVA to assess the 
impact of NCX block (with Li
+
 Bath) and depolarization-induced activation of NCX (Depolarization), or the 
interaction between the two. Results revealed a significant influence of Li
+
 Bath on both RMP (p < 0.05) and AP 
overshoot (p < 0.05), but no significant influence of Depolarization (p > 0.05) or a significant interaction between 
Li
+
 Bath and Depolarization (p > 0.05). There was a main effect of Depolarization on AHP and AP overshoot (p < 
0.05) but no significant impact of Li
+
 Bath on these parameters (p > 0.05), or a significant interaction between 
Depolarization and Li
+
 Bath (p > 0.05). 
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As a second measure of excitability, we assessed following frequency of neurons in the 
presence or absence of Li
+
 bath. Following frequency was assessed with a train of 20 
depolarizing current injections (1 ms at 1.5 x current threshold) delivered at 10, 20 and 40 Hz. It 
was not necessary to use the 4 s depolarization protocol for this measure, as a 20 Hz stimulus 
was able to evoke a Ca
2+
 transient (Figure 18D (peak magnitude was 412.66 ± 23.1 nM and T50 
of decay was 22.33 ± 5.5 s)) similar to a 4 s high-K
+
-evoked transient (p > 0.05). Furthermore, a 
20 Hz stimulus was sufficient to evoke NCX activity as indicated by the impact of Li
+
 which 
resulted in a significant 254.30 ± 84.3 % increase in the T50 of decay (Figure 18E).  
Current threshold was determined for each neuron in the presence and absence of Li
+
 for 
a 1 ms depolarizing current step in a manner identical to that used for determination of rheobase. 
Li
+
 bath was associated with a 16.59 ± 4.7 % increase in the amount of current necessary to 
evoke an AP relative to that in Na+ bath (p < 0.05, data not shown). Nevertheless, there was no 
detectable influence of Li
+
 on the following frequency at 10 and 20 Hz stimulation. However, at 
40Hz, there was a significant increase in the failure rate following NCX block from 5.0 ± 2.5% 
to 38.1 ± 6.0% (Figure 18F, p < 0.01, paired t-test). 
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Figure 18: The impact of NCX on the excitability of putative nociceptive cutaneous DRG neurons 
Using gramicidin-perforated patch configuration, excitability was assessed with a square-wave current injection as 
described in methods to enable determination of rheobase (A), action potential threshold (B), and the response to 
suprathreshold current injection (at 2 and 3x rheobase) (C). Excitability was assessed for each neuron (n = 6) before 
(Na
+
) and after (Li
+
) NCX block under resting [Ca
2+
]i (Baseline) and after a depolarization (4 s to 0 mV)-induced 
increase in [Ca
2+
]i. The impact of depolarization was significant (p < 0.05, two-way ANOVA) on both rheobase and 
AP threshold (i.e., decrease in excitability). However, there was no significant (p > 0.05) effect of NCX block on 
these parameters, nor was there a significant (p > 0.05) interaction between depolarization and NCX block. D) 
Representative Ca
2+
 trace (inset) and pooled data showing average magnitude ([Ca
2+
]i) and decay (T50) of Ca
2+
 
transients evoked with 20 pulses of depolarizing current injection delivered at 10, 20, 40 Hz. E) Representative Ca
2+
 
trace (inset) and pooled data (n = 8) for the change in the magnitude (Δ[Ca2+]i) and duration of the Ca
2+
 transient 
evoked with 20 pulses of depolarizing current injection delivered at 20 Hz before (Na
+
) and after (Li
+
) block of 
NCX. There was a significant (p < 0.01) interaction between stimulation frequency and NCX block on the duration 
of the evoked transient, where post-hoc analysis indicated that the increase in duration for both the 20 Hz and 40 Hz 
(not shown), but not the 10 Hz stimulation frequency (not shown), were significant. F) The 20 pulse current 
injection protocol was used to assess following frequency. Inset: Typical voltage traces of a neuron stimulated at 40 
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Hz before (in Na
+
) and after (in Li
+
) block of NCX. Pooled following frequency data (n = 8), where the failure rate 
(# of failed action potentials/train of 20 stimuli) before (Na
+
) and after (Li
+
) block of NCX is plotted for stimulation 
frequencies of at 10, 20, and 40 Hz. There was a significant (p < 0.01, two-way ANOVA) interaction between 
stimulation frequency and NCX block on the failure rate, where post-hoc analysis confirmed the increase in failure 
rate observed at 40 Hz was significant. ** is p < 0.01. 
 
 
 
3.4.6 Compound action potentials and NCX activity 
Given recent evidence suggesting that NCX functioning in reverse-mode contributes to axon 
damage in small fiber peripheral neuropathy (Persson et al., 2013), we next sought to determine 
whether the NCX protein observed in the peripheral nerve might be functional in the absence of 
tissue injury. To do this, compound action potential (CAP) recording was performed on isolated 
sciatic nerves in the presence and absence of Li
+
 or 100 nM KB-R7943. The CAP was evoked at 
0.1 Hz to assess “resting” NCX activity and following 100 pulses at 5 Hz and 2x the intensity 
required to evoke a maximal C-wave, to assess “evoked” NCX activity (Figure 19A). Li+ bath 
had no significant effect on the AUC (a measure of the number of fibers contributing to the 
CAP) or conduction velocity (CV) of the CAP A-wave (0.36 ± 1.6% and 1.91 ± 0.8 % of 
baseline, respectively). Similarly, at 0.1 Hz stimulation, neither Li
+
 nor KB-R7943 had a 
significant influence on the AUC of the CAP C-wave. However, the application of KB-R7942 
(Figure 11A), but not Li
+
, resulted in a significant increase (20.31 ± 5.3 %, p < 0.05, n = 7) in the 
CV of the C-wave (C-CAP) (Figure 19B). Five Hz stimulation, used to assess “evoked activity,” 
resulted in a decrease in CV in the CAP C-wave. This decrease was significantly (p < 0.05) 
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attenuated in Li
+
 bath (Figure 19C). KB-R7943 further reduced the activity-dependent decrease 
in CV such that there was no net change in CV in the presence of KB-R7943 at 5Hz stimulation. 
Control nerves sampled every 10 min for 1 hour (Na
+
 bar, Figure 19B) showed very little change 
in CV with time (0.78 + 4.25 %). Because the impact of KB-R7943 on CV was roughly 
comparable at 0.1 and 5 Hz, we performed an additional experiment to determine whether the 
NCX contribution to the regulation of CV was already saturated at 0.1 Hz stimulation. Two 
nerves were stimulated at 0.017 Hz before and after Li
+
 application. With this frequency of 
stimulation, Li
+
 bath resulted in a 24.88% decrease in CV (data not shown). 
 96 
 
Figure 19: Impact of NCX on the compound action potential (CAP) in the sciatic nerve 
A) Compound action potentials were evoked in the sciatic nerve before (black trace) and after (grey trace) block of 
NCX with Li
+
. The sciatic nerve is long enough that the A- and C-waves are easily distinguished. Inset: C-wave re-
plotted on a more appropriate scale. B) No changes in the A-wave or the area of the C-wave were detected. 
However, there appeared to be an increase in the conduction velocity of the C-wave following block of NCX. 
Pooled data analyzed as a percent change from baseline were analyzed over time (Na
+
) relative to that associated 
with NCX block with Li
+
 bath (Li
+
) or KB-R79423 (100 nM). Control nerves were sampled every 10 min for 1 hour 
(Na
+
 bar). C) Pooled data indicating that 5 Hz stimulation resulted in activity-dependent slowing of the nerve, which 
was significantly attenuated in the presence of Li
+
 (n = 6) and 100 nM KB-R7943 (n = 6). * is p<0.05 and ** is p < 
0.01.  
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3.4.7 Loss of NCX3 in IB4+ fibers decreases nociceptive thresholds 
The restricted distribution of NCX activity in putative nociceptive cutaneous afferents suggests 
that this exchanger may play a particularly important role in nociceptive processing. Therefore, 
as a final test of NCX function, we assessed the impact of targeted siRNA knock down of NCX 
isoforms on nociceptive threshold. A single intrasciatic nerve injection of targeted or control 
siRNA was used to knock down NCX in the afferents innervating the glabrous skin of the 
hindpaw. Changes in mechanical nociceptive threshold were assessed with an electronic von 
Frey and changes in thermal nociceptive threshold were assessed with a Hargreaves apparatus. 
The extent of NCX knockdown was assessed with Western blot as shown in Figure 15. 
Interestingly, knockdown of NCX3, but not NCX1 of NCX2 resulted in a significant reduction in 
both mechanical (Figure 20A) and thermal (Figure 20B) threshold. Changes in threshold were 
detectable at 5 days and returned to baseline levels by 10 days post siRNA injection. Western 
blot analysis at day 10 shows no change in protein compared to baseline levels (data not shown, 
p > 0.05) suggesting natural recovery from siRNA.  
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Figure 20: Nociceptive threshold changes in response to knockdown of NCX isoforms 
A) Mechanical nociceptive threshold as determined with an electronic von Frey, was assessed once daily in naïve 
animals (n = 6) and in animals before and after a single sciatic nerve injection with control (n = 6) or targeted siRNA 
against NCX1 (n = 12), 2 (n = 12) or 3 (n = 18). B) Thermal nociceptive threshold was determined with a 
Hargreaves device in the same groups of animals. Knockdown was confirmed using Western blot analysis as 
indicated in Figure 7. (* p < 0.05 ** p < 0.01). 
 
 
 
 Lastly, we sought to determine if the significant reduction in both mechanical and 
thermal thresholds were due to loss of NCX3 in IB4+ fibers, based on our in vitro results 
indicating that NCX activity is only present IB4+ neurons. Using the cytotoxin, saporin, 
conjugated to IB4 (IB4/SAP) to specifically ablate the IB4+ fiber population (Vulchanova et al., 
2001, Tarpley et al., 2004). We injected the sciatic nerve with a combination of the unconjugated 
or conjugated form of saporin (IB4/SAP) with either NCX3-targeted or control non-targeted 
siRNA. The co-injection of IB4/SAP and control-siRNA (IB4/SAP + Ctrl-siRNA) or NCX3-
siRNA (IB4/SAP + NCX3-siRNA) significantly elevated mechanical (Figure 21A) and thermal 
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(Figure 21B) thresholds (p < 0.05, n = 6). Unconjugated saporin with control-siRNA (Unconj + 
Ctrl-siRNA) had no significant effect on nociceptive behavior compared to naïve animals (p > 
0.05, n = 6). Unconjugated saporin co-injected with NCX3-siRNA (Unconj + NCX3-siRNA) 
resulted in decrease in both mechanical (Figure 21A) and thermal (Figure 21B) thresholds, 
consistent with NCX3-siRNA alone (n = 6). The change in nociceptive threshold over time was 
analyzed as an area under the curve (AUC) where data on day 0 was used to assess the change in 
threshold for each animal on days 0 through 10. The results confirms that there was no 
significant difference between IB4/SAP + Ctrl-siRNA and IB4/SAP + NCX3-siRNA (Figure 
21C) suggesting that loss of IB4+ fibers attenuates the siRNA-induced hypersensitivity seen in 
the Unconj + NCX3-siRNA treated group. To confirm the loss of IB4 fibers following IB4/SAP 
treatment, we analyzed the pattern of IB4 staining in the spinal cord of IB4/SAP and control 
treated rats. Consistent with previous studies using IB4/SAP (Vulchanova et al., 2001, Tarpley et 
al., 2004), there was a dramatic decrease in IB4+ staining in the superficial dorsal horn of L4 and 
L5 spinal segments in rats treated with the conjugated saporin (IB4/SAP + Ctrl-siRNA and 
IB4/SAP + NCX3-siRNA) (Figure 21D). The loss of IB4 staining was restricted to the medial 
portion of the dorsal horn thought to be the zone of innervation of the sciatic nerve. No 
significant loss of IB4 staining was detected in those rats treated with the unconjugated saporin 
(Figure 21D). 
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Figure 21: Assessment of the relative contribution of IB4+ fibers to the changes in nociceptive behavior 
associated with NCX3-targeted knockdown 
The IB4+ population of sensory neurons in the sciatic nerve was ablated with an intra-sciatic injection of IB4 
conjugated to the toxin, saporin (IB4/SAP). The control for this was an injection of unconjugated IB4 and saporin 
(Unconj). Groups of rats (n = 6 per group) received injections of either IB4/SAP or Unconj with either control 
siRNA (Ctrl) or NCX3-siRNA (NCX3). Mechanical (A) and thermal (B) nociceptive thresholds were determined as 
in Figure 11 before and after sciatic nerve injections. C) The change from baseline over time in each group was 
analyzed as an area under the curve (AUC) for both mechanical (top graph) and thermal (bottom graph) data. D) The 
extent of IB4 fiber ablation was assessed in spinal cord sections stained with IB4-FITC as described in Methods. 
Consistent with the termination pattern of afferents in the sciatic nerve, there is almost a complete loss of IB4 
binding in the medial superficial dorsal horn of IB4/SAP treated animals. ** p < 0.01 relative to unconj + Ctrl and 
## p < 0.01 relative to unconj + NCX3. 
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3.5 DISCUSSION 
The purpose of this study was to characterize the biophysical properties of NCX among 
subpopulations of sensory neurons, identify the NCX isoform(s) underlying NCX activity, and to 
begin to determine the function of this exchanger in sensory neurons. We have confirmed our 
previous results indicating NCX activity is restricted to a subpopulation of putative nociceptive 
neurons, which extends to cutaneous neurons innervating the glabrous skin of the hindpaw. 
There appear to be two modes of NCX activity: one evoked in response to relatively large and 
long lasting (~325 nM for > 12 second) increases in [Ca
2+
]i, and a second that is active at resting 
[Ca
2+
]i > ~150 nM. There also appeared to be two modes of evoked activity: one that decayed 
relatively rapidly (< 5 min) and a second that persisted (>10 min). While NCX activity was 
detected in all IB4+ small diameter cutaneous neurons, there was heterogeneity in this 
subpopulation of neurons with respect to the different modes of NCX activity present. 
Pharmacological data suggest that NCX3 accounts for ~70% of the NCX activity in sensory 
neurons with NCX2 accounting for the remaining 30%. Knockdown using targeted siRNA of 
NCX isoforms yielded results consistent with the pharmacological data, but suggested a larger 
role of NCX2. Additionally, mRNA encoding all three isoforms was detectable in putative 
nociceptive cutaneous neurons, with evidence for the differential distribution of splice variants of 
NCX1 and 3. Western blot analysis confirmed the presence of all three isoforms in sensory 
neuron and spinal cord tissue and they appeared to be differentially distributed among these 
tissues. While NCX appears to contribute to the regulation of resting [Ca
2+
]i in a small 
subpopulation of neurons, it appears to play a much more dominant role in regulating the decay 
rate of evoked Ca
2+
 transients. Additionally, NCX appears to have a minor role in the regulation 
of neuronal excitability, where the only detectable influence was on the following frequency of 
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neurons at relatively high (40 Hz) rates of stimulation. We also obtained evidence of NCX 
activity in C-fiber axons, where block of the exchanger resulted in a small increase in conduction 
velocity. Furthermore, knockdown of NCX3 but not NCX1 or 2 resulted in a significant decrease 
in nociceptive threshold. Using IB4 conjugated to the toxin saporin, we obtained evidence 
consistent with the suggestion that the shift in nociceptive thresholds is due to the loss of NCX3 
in the IB4+ fiber population. Together, these data show that NCX, most likely NCX3, plays an 
important role in the regulation of [Ca
2+
]i within the primary sensory neurons. 
3.5.1 Biophysical properties: Evoked activity 
The primary approaches used to assess the presence of NCX activity in the first half of this study 
were largely indirect, inferred from changes in [Ca
2+
]i secondary to the removal of extracellular 
Na
+
 needed for exchange activity (Cook et al., 1998) or the application of NCX inhibitors. Li
+
 
was used in the majority of experiments as the replacement for Na
+
 because it is voltage-gated 
Na
+
 channel permeable (Hille, 1972, Gold and Thut, 2001b), and does not block the 
mitochondrial Na
+
/Ca
2+
 exchanger (Palty et al., 2010). We acknowledge, however, that the use 
of Li
+
 is potentially problematic for the assessment of NCX activity, particularly with the 
indirect approach used due to the variety of other proteins that may be affected and result in a 
secondary influence on [Ca
2+
]i including other pumps (Tolkovsky and Richards, 1987, Hermans 
et al., 1997), exchangers (Herbert et al., 2004, Palty et al., 2010), and ion channels (Vaughn and 
Gold, 2010, Zhang et al., 2010b). Nevertheless, while there may have been off-target effects of 
Li
+
 in these experiments, we propose that the Li
+
-induced changes in resting and evoked Ca
2+
 
transients were due predominantly to block of NCX, and therefore reflect NCX activity for two 
reasons. First, comparable changes in resting and evoked Ca
2+
 transients were observed with Li
+
, 
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choline, and the relatively NCX-specific blocker, KB-R7943. Second, siRNA-induced 
knockdown of NCX occluded the Li
+
-induced changes to the evoked Ca
2+
 transient.  
In most tissues, NCX is considered a low affinity exchanger requiring a high [Ca
2+
]i for 
activation. The present results were generally consistent with this model, where in putative 
nociceptive neurons, an increase in [Ca
2+
]i to ~325 nM for at least 12 seconds was required to 
evoke NCX activity. That is, despite evidence that NCX was present and functional in all 
putative nociceptive neurons, NCX activity was only detected in these neurons if the evoked 
transient met this threshold. At first pass, it appeared paradoxical that the evoked transient in 
neurons, such as the 2s-responders, in which NCX had been activated, decayed more slowly than 
the 2s-non-responders in which NCX had not been activated. The implication of this observation 
is that 2s-responders are less able to handle large Ca
2+
 loads with other Ca
2+
 regulatory 
mechanisms, such that Ca
2+
 influx associated with the 2 s high K
+
 application overwhelms the 
available buffering capacity, and NCX is engaged.  
3.5.2 Biophysical properties: Resting activity 
We were also able to detect resting NCX activity in 35% of the putative nociceptive neurons 
tested. There are at least two likely explanations for the presence of resting NCX activity in a 
subpopulation of sensory neurons. First, as suggested above for the persistent evoked activity, 
microdomains of elevated [Ca
2+
]i above the threshold of activation could account for the 
presence of resting NCX activity in a subpopulation of neurons. Second, there is evidence that 
the Ca
2+
 affinity for NCX activation depends on splice variants within the intracellular loop that 
makes up two distinct Ca
2+
 binding domains (CBD1 and 2). The primary Ca
2+
 sensor responsible 
for Ca
2+
 activation, CBD1, has a higher affinity for binding (~ Kd = 100 – 600 nM) (Hilgemann 
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et al., 1992), whereas CBD2 has a low affinity for Ca
2+
 (~ Kd = 250 nM – 20 μM). Thus, a splice 
variant with only CBD1 may have activity at an [Ca
2+
]i comparable to that observed in the 
present study. Similarly, a combination of CBD1 and CBD2 in some neurons may result in a 
pattern of NCX activity that requires a high [Ca
2+
]i for full activity, as well as partial activity at 
considerably lower [Ca
2+
]i. Consistent with this suggestion, data from cardiomyocytes indicates 
that ~5% of the maximal NCX current is detected at resting [Ca
2+
]i levels, whereas full activity 
requires a the rise of [Ca
2+
]i to 1-2 μM (Boyman et al., 2011). 
Our biophysical characterization of NCX as a low affinity exchanger is consistent with 
Verdru et al (1997) who found that removal of external Na
+
 dramatically slowed the [Ca
2+
]i 
decay in a subpopulation of DRG neurons in which the average peak was > 400 nM. 
Furthermore, they also detected a shift in baseline [Ca
2+
]i with the block of NCX activity in 85% 
of the DRG neurons tested (Verdru et al., 1997). Shutov and colleagues found that inhibition of 
NCX in synaptic terminals resulted in a small but significant increase in [Ca
2+
]i (Shutov et al., 
2013) suggesting there is some resting NCX activity in the central terminals as well as the cell 
body. In contrast, others have failed to detect a significant contribution of NCX to the regulation 
of either resting or evoked Ca
2+
 (Thayer and Miller, 1990, Usachev et al., 2006, Gemes et al., 
2012) leading the authors of these studies to conclude that NCX does not contribute to the 
regulation [Ca
2+
]i in sensory neurons. We suggest, however, that the presence of NCX was likely 
missed in these previous studies because of the relatively small Ca
2+
 transients evoked (all less 
than 300 nM) and/or because of the relatively limited number of neurons in which NCX appears 
to function.  
Another possible explanation for the presence of “resting” NCX activity is that it is 
actually NCX working in “reverse” mode where the exchanger is thought to extrude Na+ in 
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exchange for an increase in [Ca
2+
]i. This was the suggested explanation for the small increase in 
resting [Ca
2+
]i observed after removal of extracellular Na
+
 in rat and mouse DRG (Duchen, 1990, 
Verdru et al., 1997). NCX exchange depends on the driving force on the exchanged ions defined 
as the difference between the membrane potential and the “equilibrium potential” for Na+ and 
Ca
2+
 across the exchanger (ENa/Ca). ENa/Ca is estimated by the Nernst potentials for the Na
+
 and 
Ca
2+
 and the net flux of ions by the exchanger: three Na
+
 in one direction for every one Ca
2+
 in 
the other (Fang et al., 1998). Under physiological conditions ENa/Ca is ~ -26 mV, resulting in a 
driving force that enables the exchanger to function in forward mode at membrane potentials 
more negative than -26 mV. Theoretically, with increases in intracellular Na
+
, as may occur with 
high levels of neural activity, ENa/Ca may hyperpolarize to a potential less than the resting 
membrane potential. As a result, the driving force on the exchanger would enable it to function 
in reverse mode. By this reasoning, the Na
+
 free bath used to assess the presence of resting NCX 
activity should result in an ENa/Ca that is very negative to the resting membrane potential, 
generating a tremendous driving force on the exchanger to work in reverse mode. However, there 
are at least three observations that argue against the possibility that NCX functioning in reverse 
mode accounts for the increase in [Ca
2+
]i observed following application of Na
+
 free bath. First, 
we failed to detect the evidence of resting NCX activity in the majority of putative nociceptive 
neurons tested despite evidence of functional NCX in all of these neurons. Second, we observed 
“resting activity” that was not only activated, but resolved in neurons with evidence of persistent 
evoked activity. Third, as shown in Figure 7, we detected an increase in [Ca
2+
]i NCX specific 
blocker, KB-R7943 comparable to that observed in Na+ free bath. Thus, rather than NCX acting 
in reverse mode, we would suggest that the increase in [Ca
2+
]i observed in the presence of 0 Na
+
 
bath or KB-R7943 is due to Ca
2+
 leak that is no longer being attenuated by the NCX activity in 
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forward mode. Nevertheless, conclusively ruling out the possibility of NCX functioning in 
reverse mode in sensory neurons will require more direct measurements of NCX function under 
conditions in which the concentrations of Na
+
 and Ca
2+
 on either side of the membrane are better 
controlled. 
3.5.3 Isoform(s) underlying NCX activity in the isolated neuron 
We used complementary strategies to determine which isoforms contribute to resting and 
evoked NCX activity in sensory neurons. Consistent with the suggestion that differential 
expression of the three NCX isoforms accounts for the heterogeneity in the biophysical 
properties of NCX in sensory neurons, pharmacological analysis of NCX suggested that NCX2 
and 3 contributed to both resting and evoked NCX activity. Also consistent with this finding, 
PCR analysis indicated the presence of mRNA encoding both NCX2 and NCX3 in putative 
nociceptive sensory neurons and our siRNA data indicating that knock down of NCX2 or 3 was 
sufficient to occlude the actions of 0 Na
+
 bath.  
Contrary to our PCR analysis suggesting NCX1 mRNA is expressed in putative 
nociceptive neurons, we failed to detect evidence of NCX1 activity in the isolated sensory 
neuron cell body with the relatively selective NCX1 selective blocker SEA0400 (Iwamoto and 
Shigekawa, 1998) or with siRNA-induced knockdown of NCX1. This was even more surprising 
in light of evidence that NCX1 appears to be ubiquitous with splice variants found in brain, 
heart, kidney, and pancreas (Philipson et al., 1993). And while incomplete knockdown could 
explain the negative results with NCX1 targeted siRNA, inhibition of [Na
+
]i-dependent 
45
Ca
2+
 
uptake (i.e. reverse mode) in fibroblasts (Iwamoto and Shigekawa, 1998) suggests that the 
concentration of SEA0400 used here should have been sufficient to enable detection of NCX1 
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activity in sensory neurons. We therefore suggest that the failure to detect evidence of functional 
NCX1 activity in sensory neurons is due to one of three likely possibilities: 1) the [Ca
2+
]i 
generated in response to high K
+
 was insufficient to activate NCX1 in the cell body, 2) the 
protein is synthesized and trafficked out of the cell body consistent with the Western blot data 
discussed below and/or 3) the mRNA does not result in functional protein, although this is least 
likely given our western blot analysis. Additional experiments will be needed to distinguish 
between these possibilities. 
There was also an apparent discrepancy between results obtained with the relatively 
selective NCX3 blocker, KB-R7943 and siRNA-induced knockdown of NCX2 and NCX3. 
While there is evidence to suggest that the potency of KB-R7943-induced block of NCX is 
comparable when the exchanger is functioning in forward or reverse mode under conditions 
enabling bi-directional exchanger activity (Watanabe et al., 2006), the relative potency of these 
compounds was determined in reverse mode (Iwamoto and Shigekawa, 1998). Thus, it is 
possible even the limited selectivity for NCX3 over NCX1 or NCX2 reported for KB-R7943 in 
reverse mode, is lost in forward mode. Furthermore, with only three times higher potency for 
NCX3 over NCX1 and 2, there should be at least some block of NCX2 at all concentrations of 
KB-R7943. Therefore, we have likely underestimated the relative contribution of NCX2 with the 
combination of blockers employed. More perplexing however, was the observation that knocking 
down either NCX2 or NCX3 rendered the T50 insensitive to KB-R7943. This observation raises 
the possibility that full NCX activity requires the interaction of both NCX2 and NCX3 isoforms. 
It is also possible that there are compensatory changes associated with siRNA knockdown of a 
protein such as NCX that is critical for cell homeostasis which masked our ability to fully 
characterize relative contribution of NCX isoforms. Consistent with this last possibility, was the 
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observation that following siRNA knockdown of NCX2 or 3, there was no increase in the 
duration of the evoked transient as is observed following acute block of NCX activity. This 
suggests an increase in other Ca
2+
 regulatory mechanisms such as PMCA or SERCA may have 
been recruited to compensate for the loss of NCX activity. 
3.5.4 Identification of NCX isoforms within sensory tissues 
The results of our PCR experiments are consistent with the presence of splice variants for 
both NCX1 and NCX3 in sensory neurons. In contrast, there was no evidence of NCX2 splice 
variants at either the mRNA or protein level, consistent with previous results (Kofuji et al., 1994, 
Quednau et al., 2004). The PCR analysis focused on exons A and B, which have previously been 
shown to be mutually exclusive, whereas the four other exons (C, D, E, and F) in the splicing 
region are thought to be cassette exons (Kofuji et al., 1994). The present data are consistent with 
the expression of at least six out of the 17 possible variants that have been identified for NCX1. 
Three of the possible five NCX3 variants identified in brain are denoted NCX3-AC, NCX3-B, 
and NCX3-BC. The PCR product sizes we detected at the single cell level are consistent with the 
presence of NCX3-AC and NCX3-B splice variants (Quednau et al., 1997, Michel et al., 2014). 
The size of the splicing region within the intracellular loop is relatively small consisting 
of ~ 250 amino acids and the mutually exclusive exons A and B do not differ much in the 
relative number of base pairs. Therefore, it would be very difficult to differentiate between 
isoform splice variants at the protein level. Nevertheless, multiple NCX1- and NCX3-, but not 
NCX2-LI bands were detected with western blot analysis of peripheral neural tissue. The 
additional bands larger than the predicted molecular weight of NCX1 suggest the possibility of 
tissue-dependent post-translational modifications, as a number of putative glycosylation sites are 
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present on putative extracellular regions of all three isoforms. The bands below the predicted 
NCX molecular weight are likely cleavage products as the bands appear to be the size of the 
large intracellular loop, a region particularly prone to proteolytic cleavage by endogenous 
proteases (Linck et al., 1998, Thurneysen et al., 2002b). While confirmation that these additional 
bands are in fact NCX protein will ultimately be necessary, it is important to note that the bands 
detected in the present study are comparable to those previously reported with the antibodies 
used for all three isoforms and at least NCX2 and NCX3 specificity has been confirmed in 
knockout mice (Jeon et al., 2003, Molinaro et al., 2011). Thus, if reflective of differential 
processing and/or protein cleavage, results from the present analysis of tissue from the dorsal 
horn to the peripheral nerve suggest that there is a differential distribution of NCX isoforms.  
The expression and distribution of NCX has yet to be extensively characterized in the 
peripheral nervous system. Consistent with the results of the present study, previous expression 
analysis indicates mRNA for all three NCX isoforms is detectable in sensory neurons (Kuroda et 
al., 2013, Shutov et al., 2013). Other immunohistochemical (IHC) data indicating that NCX1-LI 
protein is only detectable in satellite cells within the DRG are also consistent with the results of 
the present study (Persson et al., 2010). In contrast, however, previous IHC data on the 
distribution of NCX2 and 3 suggests that NCX2 is the dominant isoform in putative nociceptive 
neurons and NCX3 is more widely distributed but at much lower levels (Persson et al., 2010). To 
begin to explore the basis for the apparent difference between these previous results and those of 
the present study, we probed protein from DRG, sciatic nerve and skin with the anti-NCX2 
antibody used in this previous study. However, we were only able to detect a band at 36 kDa (not 
shown), suggestive of an NCX ancillary protein (Michaelis et al., 1992) as the estimated size of 
NCX2 protein is 102 kDa. However, the present results with an antibody obtained from Dr. 
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Philipson at UCLA were consistent with previous results in brain tissue (Thurneysen et al., 
2002a, Papa et al., 2003). 
3.5.5 Functional Implications: Somal Excitability, CAP, and Nociceptive Behavior 
The results of our functional analysis of NCX suggests that beyond the regulation of the 
Ca
2+
 transient and possibly resting Ca
2+
 in the soma of a small subpopulation of neurons, NCX 
contributes minimally to the regulation of excitability. As noted above, there are two primary 
ways NCX is likely to influence neuronal excitability. We have previously demonstrated that 
Ca
2+
-dependent K
+
 currents are present at relatively high density in putative nociceptive 
cutaneous neurons (Zhang et al., 2010a), suggesting that, as with the direct influence of NCX 
activity in forward mode, an indirect influence would also be excitatory, secondary to the net 
suppression of these K
+
 channels. Consistent with the suggestion that Ca
2+
-dependent K
+
 
channels have a dominant influence on the excitability of putative nociceptive neurons following 
an increase in [Ca
2+
]i, the depolarization-induced increase in [Ca
2+
]i was associated with a 
decrease in excitability. Our largely negative results in the cell body excitability experiments 
suggest that mechanisms other than those influenced by NCX play a much more dominant role in 
the regulation of the excitability of the isolated cell body. Consistent with this suggestion, it was 
only under relatively extreme conditions (40 Hz stimulation), that a weak excitatory influence of 
NCX could be detected. 
The impact of NCX on action potential propagation in the isolated sciatic nerve was 
consistent with the mechanisms described in the cell body, but suggested that NCX is active even 
at relatively low levels of activity. That is, if both direct and indirect actions of NCX activity are 
associated with membrane depolarization, this depolarization would lead to the inactivation of 
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voltage-gated Na
+
 channels, and a concomitant decrease in CV. Conversely, block of NCX 
should result in membrane hyperpolarization, the relief of Na
+
 channel inactivation and an 
increase in CV. Li
+
 bath was associated with a relatively large (~24%) decrease in the C-wave 
CV when the CAP was evoked at a very low frequency (i.e., 0.017 Hz). We suggest that this 
decrease in CV is not due to NCX block, but instead due to what is equivalent to a partial block 
of voltage-gated Na
+
 channels that reflects the slightly lower permeability (85%) of Li
+
 
compared to Na
+
 through voltage-gated Na
+
 channels (Gold and Thut, 2001a). There is also 
evidence that there may be CV slowing due to a block of the Na
+
/K
+
 ATPase (De Col et al., 
2008), resulting in further membrane depolarization and a further reduction in Na
+
 channel 
density due to Na
+
 channel inactivation. Thus, in the face of Li
+
-induced CV slowing via 
mechanisms independent of an action on NCX, we suggest that absence of a change in CV with 
Li
+
 at 0.1 Hz stimulation, actually reflects a significant increase in CV due to NCX block. That 
this effect appears to be attenuated at 5 Hz stimulation, would suggest that NCX activity is close 
to maximal even at 0.1 Hz stimulation. Consistent with this suggestion, KB-R7943 produced a 
significant increase in CV at 0.1 Hz but only reversed the activity-dependent slowing observed at 
5 Hz.  
Lastly, given evidence in support of a contribution of both NCX2 and 3 to the regulation 
of [Ca
2+
]i in putative nociceptive cutaneous neurons, it was surprising that hypersensitivity to 
mechanical and thermal stimuli was only observed following knockdown of NCX3. While this 
observation is consistent with our pharmacological data implicating a dominant role for NCX3 in 
putative nociceptive neurons, this result may also suggest that the functional role of these 
isoforms in sensory neurons may be dissociable. Importantly, the timing of the changes observed 
is consistent with previous studies using similar siRNA based strategies (Xie et al., 2013, Acosta 
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et al., 2014), and recovery of the behavior corresponded with recovery of NCX3 protein in the 
ganglia.  
The decrease in nociceptive threshold observed following NCX3 knockdown was larger 
than expected given the relatively small number of fibers in which our results suggested NCX3 
should be functional. However, the observation that nociceptive behavior of rats treated with 
both NCX3 siRNA and IB4 conjugated to saporin (IB4/SAP) resembled the rats treated with 
control siRNA and IB4/SAP, suggests that the loss of IB4 fibers attenuated the NCX3 siRNA-
induced hypersensitivity. If the hypersensitivity had been due to dysregulation of fibers in 
addition to the IB4+ population, one would have expected an additive effect in which the 
increase in nociceptive threshold observed with IB4/SAP would have been significantly 
attenuated by the NCX3 siRNA. Nevertheless, it is possible that the antinociception associated 
with the loss of IB4+ fibers caused a ceiling effect, masking the NCX3 siRNA-induced 
hypersensitivity. We consider this possibility unlikely, however, as the IB4/SAP-induced thermal 
antinociception detected was far from 20 s cut off employed.  
There are several possible explanations for the hypersensitivity observed following 
knockdown of NCX3. However, we suggest the simplest explanation is a loss of NCX-mediated 
regulation of [Ca
2+
]i in the central terminals. This would result in an increase in the duration of 
evoked Ca
2+
 transients and, consequently, an increase in transmitter release, and thus 
hypersensitivity. While such a mechanism is often proposed in the literature (Maggi et al., 1990, 
Evans et al., 1996, Neher and Sakaba, 2008, Xie et al., 2013, Acosta et al., 2014), there is, 
unfortunately little direct evidence for a role of NCX in synaptic transmission. However, in the 
only study of which we are aware addressing a role of NCX in the central terminals of putative 
nociceptive afferents, it was demonstrated that mitochondria and PMCA, but not NCX, are 
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involved in presynaptic Ca
2+
 regulation; NCX appeared to contribute to the regulation of resting 
Ca
2+
 levels and only 12% of the decay of evoked transients (Shutov et al., 2013). Unfortunately, 
the impact of NCX block on post-synaptic responses was not determined in this study, so the 
contribution of NCX to transmitter release from central terminals of nociceptive afferents has yet 
to be determined. 
In summary, the results of the present study indicate that NCX isoforms contribute to the 
regulation of the duration of the evoked Ca
2+
 transient in putative nociceptive neurons from 
naïve animals, and in a subpopulation of these neurons NCX contributes to the regulation of 
resting [Ca
2+
]i. In the absence of tissue injury, NCX appears to have little influence on 
excitability per se, but contributes to both determination of the action potential conduction 
velocity in C-fiber axons as well as the establishment of nociceptive threshold. Our 
characterization of this protein in tissue from naïve animals suggests that it is poised to play an 
important role in tissue injury and repair. Indeed, it has been suggested the NCX contributes to 
nerve injury observed in small fiber polyneuropathies (Ma, 2013) and there is evidence to 
suggest it is important for neurite outgrowth during regeneration (Persson et al., 2013). Now, 
with a better mechanistic understanding of NCX in sensory neurons, there is a framework with 
which to interpret changes observed following injury. Future experiments will need to assess the 
function of NCX in the presence of injury and/or chronic pain states. 
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4.0  PERSISTENT INFLAMMATION-INDUCED INCREASE IN THE TRAFFICKING OF 
SODIUM CALCIUM EXCHANGER TO PERIPHERAL TERMINALS IN A 
SUBPOPULATION OF CUTANEOUS RAT DRG NEURONS 
4.1 ABSTRACT 
We have previously reported that persistent inflammation results in an increase in the magnitude 
and duration of depolarization-evoked Ca
2+
 transients in putative nociceptive afferents. These 
changes were neither the result of increased neuronal excitability nor an increase in the 
magnitude of depolarization driven by a high K
+
 application. Subsequent data also ruled out an 
increase in Ca
2+
 influx via voltage-gated Ca
2+
 currents and recruitment of Ca
2+
-induced Ca
2+
 
release. Parametric studies indicated that the inflammation-induced increase in the duration of 
the evoked Ca
2+
 transient required a relatively large and long lasting increase in the 
concentration of intracellular Ca
2+
 ([Ca
2+
]i) implicating the Na
+
/Ca
2+
 exchanger (NCX), a major 
Ca
2+
 extrusion mechanism activated with high intracellular Ca
2+
 loads. The functional 
contribution of NCX was tested using fura-2AM imaging and electrophysiological recordings. 
Changes in NCX expression and protein were assessed with real-time PCR and western blot 
analysis respectively. Results indicated a significant inflammation-induced decrease in NCX 
activity in a subpopulation of putative nociceptive neurons innervating the site of inflammation. 
The time-course of the decrease in NCX activity paralleled that of the inflammation-induced 
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changes in nociceptive behavior. While there were no detectable changes in NCX mRNA at the 
whole ganglia level, there was a decrease in NCX3 protein detectable in the DRG by 3 days after 
the CFA injection. The change in NCX3 in the cell body was associated with a significant 
decrease in NCX3 protein in the ganglia, a significant increase in the peripheral nerve (sciatic), 
yet no change in the central nerve root. These data suggest altered trafficking of NCX3 that may 
serve as a compensatory mechanism to attenuate pro-nociceptive processes associated with 
inflammation. 
4.2 INTRODUCTION 
Tissue inflammation is associated with an increase in the magnitude and duration of the evoked 
Ca
2+
 transient in a subpopulation of putative nociceptive cutaneous DRG neurons (Lu and Gold, 
2008). Alterations in intracellular Ca
2+
 ([Ca
2+
]i) signaling can increase afferent excitability 
(Zhang et al., 2012a), facilitate transmitter release (Flake and Gold, 2005), and/or lead to 
changes in gene expression (Fields et al., 2005), all functions that may contribute to the pain and 
hypersensitivity of persistent inflammation.  
The magnitude and duration of evoked Ca
2+
 transients are determined by the combined 
action of channels, buffers, pumps and exchangers (Berridge et al., 2000). Therefore, there are a 
number of mechanisms that could contribute to the inflammation-induced increase in the 
depolarization-induced Ca
2+
 transient. We have previously ruled out many mechanisms, 
including an increase in the magnitude of depolarization (Lu and Gold, 2008) and density of 
voltage-gated Ca
2+
 channels (Lu et al., 2010), the recruitment of Ca
2+
-induced Ca
2+
 release, a 
change in sarco-endoplasmic reticulum ATPase (SERCA) function, and mitochondrial-
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dependent Ca
2+
 buffering (Scheff et al., 2013). Furthermore, because the inflammation-induced 
change in Ca
2+
 signaling is not associated with an increase in resting Ca
2+
 (Lu and Gold, 2008), 
and the available evidence suggests that the plasma-membrane Ca
2+
 ATPase contributes to 
resting Ca
2+
 levels (Wanaverbecq et al., 2003, Gemes et al., 2012), we predicted that the 
inflammation-induced changes in the evoked Ca
2+
 transient were not due to a decrease in PMCA 
activity. However, as we have described previously (Scheff et al., 2014), the Na
+
/Ca
2+
 exchanger 
(NCX), a relatively low affinity Ca
2+
 extrusion mechanism, is only active in the IB4-binding 
(IB4+) subset of small diameter capsaicin-responsive cutaneous neurons; the same population in 
which the inflammation-induced increase in the duration of the evoked transient is manifest (Lu 
and Gold, 2008). We have also recently demonstrated that NCX activity in this population of 
putative nociceptive cutaneous neurons influences the duration of the evoked Ca
2+
 transient, but 
not the magnitude (Lu et al., 2006). Therefore, we hypothesized that NCX contributes, at least in 
part, to the inflammation-induced increase in the duration of the depolarization-evoked Ca
2+
 
transient.  
To test this hypothesis, retrogradely labeled small diameter IB4+ DRG neurons from 
naïve and complete Freund’s adjuvant (CFA)-inflamed rats were studied with ratiometric Ca2+ 
imaging and voltage clamp electrophysiology in combination with a variety of pharmacological 
manipulations. The potential mechanisms underlying an inflammation-induced decrease in NCX 
activity were assessed with sqRT-PCR, western blot analysis and immunohistochemistry. Our 
results suggest that the inflammation-induced increase in the duration of the evoked Ca
2+
 
transient is due to a decrease in NCX activity. This appears to be due to an increase in trafficking 
of the exchanger to the peripheral, but not central terminals of these putative nociceptors. 
Experiments to determine the functional implications of this finding are currently underway. 
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4.3 METHODS 
Adult male Sprague-Dawley rats (Harlan, 220-300g) were used for all experiments. Animals 
were housed two per cage in a temperature and humidity controlled animal facility on a 12:12 
light:dark schedule with food and water freely available. All procedures were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee and performed in 
accordance with National Institutes of Health guidelines for the use of laboratory animals in 
research. 
Fourteen to 17 days prior to tissue harvest, the retrograde tracer 1,1’-dioctadecyl-
3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate (DiI, Invitrogen, Carlsbad, CA)) was injected 
into the glabrous skin of the hindpaw to label cutaneous afferents. The tracer was dissolved at 
170 mg/mL in dimethylsufoxide (DMSO, diluted 1:10 in 0.9% sterile saline, and injected in 3-5 
subcutaneous sites using a 30 g needle for a total volume of 10 μL per hindpaw under isoflurane 
(Abbott Laboratories, North Chicago, IL, USA) anesthesia. Three days prior to tissue harvest, 
rats were again anesthetized with isoflurane and inflammation was induced at the site of tracer 
injection in the left hindpaw with a 100 μL subcutaneous injection of complete Freud’s adjuvant 
(CFA, (Sigma-Aldrich, St Louis MO), diluted 1:1 in 0.9 % sterile saline). Prior to tissue removal, 
animals were deeply anesthetized with an intraperitoneal injection of rat cocktail containing 
ketamine (55 mg/kg), xylazine (5.5 mg/kg) and acepromazine (1.1 mg/kg) and the L4-L5 DRG 
were removed ipsilateral to labeling and CFA-induced inflammation. Ganglia were 
enzymatically treated, mechanically dissociated, and plated on laminin (Invitrogen, Carlsbad, 
CA; 1mg/ml) and poly-L-ornithine-coated (Sigma-Aldrich; 1 mg/ml) glass cover slips as 
previously described (Lu et al., 2006). All subsequent experiments were preformed within 8 h of 
tissue harvest. 
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4.3.1 Ca2+ Imaging 
Neurons were incubated with 2.5 μM Ca2+ indicator fura-2 AM ester with 0.025 % Pluronic F-
127 for 20min at room temperature. Neurons were then labeled with FITC-conjugated IB4 (10 
μg/ml) for 10 min at room temperature. Labeled neurons were placed in a recording chamber and 
continuously superfused with normal bath solution (mM: 130 NaCl, 3 KCl, 2.5 CaCl2, 0.6 
MgCl2, 10 HEPES, 10 glucose, pH 7.4, osmolality 325 mOsm) or a ‘Na
+
-free’ bath solution 
(mM: 130 Choline-Cl or LiCl, 3 KCl, 10 MgCl2, 2 EGTA, 10 Hepes, 10 glucose, pH 7.4, 
osmolality 325 mOsm). A Na
+
-free solution was used to block NCX activity by preventing NCX 
from fulfilling the Na
+
 binding requirement for exchange activity (Cook et al., 1998). 
Fluorescence data were acquired on a PC running Metafluor software (Molecular Devices, 
Sunnyvale, CA, USA) via a CCD camera (Roper Scientific; model RTE/CCD 1300). The ratio 
(R) of fluorescence emission (510 nm) in response to 340/380nm excitation (controlled by a 
lambda 10–2 filter changer (Sutter Instrument, Novato, CA)) was acquired at 1 Hz during drug 
application. All drugs were applied through a computer-controlled peizo driven perfusion system 
(switching time <20 ms; Warner Instruments, Hamden, CT, USA, Fast-Step Model SF-77B). 
[Ca
2+
]i was determined from fura-2 ratio following in situ calibration experiment as described in 
detail previously (Grynkiewicz et al., 1985, Scheff et al., 2013). 
4.3.2 Voltage Clamp Electrophysiology 
Perforated patch clamp experiments were carried out using a HEKA EPC9 amplifier (HEKA 
Elektronik, Lambrecht/Rhineland-Pfalz, Germany). Glass electrodes (1–4 MΩ) were filled with 
(mM) 100 Cesium-methanesulfonate, 5 NaCl, 40 TEA-Cl, 0.1 CaCl2, 2 MgCl2 1 EGTA and the 
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pH adjusted with Tris-base to 7.2. Osmolality was adjusted to 320 mOsm with sucrose.  A 
normal bath solution or “Na+-Free” bath solution were used as mentioned in microfluorimetry 
experiments. The pH was adjusted with Tris-base to 7.4 and osmolality was adjusted with 
sucrose to 320 mOsm. 
Gramicidin (Sigma–Aldrich)-perforated patch was used for all voltage clamp recordings. 
A stock solution of gramicidin (1.5 mg/100 μl) was prepared in DMSO. This was diluted with 
electrode solution in a 1:300 ratio to give a final concentration of 50 μg/ml. The gramicidin 
containing electrode solution was vortexed for 15 s. No filtering was applied. The tip of the 
electrode was loaded with a small volume of gramicidin-free electrode solution in order to avoid 
interference of the antibiotic with seal formation. Gramicidin-containing electrode solution was 
back loaded. The progress of perforation was monitored with the capacitative transient to a 5 mV 
step. Experiments were not started until access resistance was less than 7 MΩ. 
Series resistance compensation (>70%) was employed for all voltage-clamp recording. A 
4s voltage step from -60mV to 0mV was used to evoked a Ca
2+
 transient. Fura-2AM based 
microfluorimetry was used in succession with all experiments in order to track the decay rate of 
the voltage step-evoked Ca
2+
 transient. A computer-controlled perfusion fast-step system was 
used to apply a Na
+
 free bath solution while clamping the membrane at -60 mV to measure the 
amount of Na
+
-sensitive current throughout the decay period.  
4.3.3 Polymerase chain reaction (PCR) 
DRG from anesthetized rats were harvested in a manner identical to that used for neuron 
isolation and plating. PCR was used to amplify specific sequences within the cDNA generated 
from mRNA extracted from selected cutaneous afferents. Single neurons were collected with 
 120 
large bore (30 μm) glass pipettes and expelled into reaction tube for subsequent cDNA synthesis 
via an anchored oligo-dT primed reverse transcription reaction with Superscript II, as previously 
described (Nealen et al., 2003). The cDNA generated from each neuron was used as a template 
for subsequent PCR reactions. To confirm successful cell collection and cDNA synthesis, 0.5 μl 
of the template cDNA was used for the amplification of cyclophilin. Negative controls for each 
round of cell collection included two neurons in which no reverse transcriptase was added to the 
reaction mixture and two tubes in which all other procedures were performed as if a neuron was 
collected, except no neuron was collected.  Nested PCR was used to assess the expression of 
NCX 1, 2 and 3, as this strategy increases the sensitivity and specificity of the PCR reaction. 
Two sets of primers specific for each target were used, where 30 cycles were used for the first 
round of amplification with the “outer” set of primers (Table 1), and 2 μl of this reaction product 
was used for a second round of amplification for 30 more cycles with the “inner” set of primers 
(Table 1). Following agarose gel electrophoresis, PCR reaction products were visualized with 
ethidium bromide. 
4.3.4 Western Blot 
L4 and L5 DRG were homogenized with Teflon tube and mortar for less than 10 strokes in ice 
cold radioimmunoprecipitation assay (RIPA) buffer supplied with protease inhibitors (aprotinin, 
leupeptin, pepstatin, E-64, trypsin inhibitor, and phenylmethanesulfonyl fluoride (PMSF), all at a 
final concentration of 2 ng/ml except PMSF, which was used at a final concentration of 1 mM). 
All protease inhibitors were obtained from Sigma–Aldrich. Lysates were collected in 0.5-ml 
tubes. Teflon tubes were rinsed with RIPA buffer and the solutions were combined with the 
lysates previously collected. Lysates were centrifuged for 5 min at 10,000 rpm at 4°C. Protein 
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concentration was determined via bicinchoninic acid (BCA) protein assay using a BCA assay kit 
(Thermo scientific, Rockford, IL, USA). Lysates were then mixed with Laemmli buffer (2×, 
400 μl + 100 μL β-mercaptoethanol) and boiled for 5 min before loading. Protein (30 μg) from 
one animal was then loaded per lane and separated on a 7 % SDS–PAGE gel and transferred to 
nitrocellulose membrane. Membranes were blocked with 5% milk for 1 hour at room 
temperature and then incubated with primary antibody at 4°C overnight (1:100 for R3F1 (anti-
NCX1),1:200 for W1C3 (anti-NCX2), and 1:100 for anti-NCX3 (cat # LS-B5775, LifeSpan 
Biosciences, Inc., Seattle WA), diluted with 5% milk/Tris-buffered saline with Tween 20 (TBST, 
Sigma–Aldrich). The blots were washed and then incubated with peroxidase-conjugated 
secondary antibody (1:2000 in 5% milk/TBST, Jackson ImmunoResearch Laboratories Inc. West 
Grove, PA, USA) for an hour at room temperature. An ECL kit (Amersham Biosciences, 
Piscataway, NJ, USA) was used for detection of immunoreactivity, luminescence data were 
collected on an LAS3000 imager (Fujifilm Inc., Japan), and analyzed with ImageJ (NIH). Both 
antibodies used to detect NCX1 and NCX2 were gifts from Dr. Kenneth Philipson of University 
of California Los Angeles. Both antibodies have been characterized by Dr. Philipson and 
colleagues in heterologous expression systems and hippocampal cultures, where R3F1 (anti-
NCX1) detects a prominent band at 120 kDa and minor bands at 70 kDa and 60 kDa, and W1C3 
(anti-NCX2) detects only one prominent band at 60 kDa. There appears to be no cross reactivity 
between isoforms (Thurneysen et al., 2002b, Papa et al., 2003). Furthermore, the specificity of 
the anti-NCX2 antibody was confirmed in NCX2 null mutant mice (Jeon et al., 2003). 
4.3.5 Immunohistochemistry 
Animals were deeply anesthetized with an intraperitoneal injection of anesthetic cocktail 
 122 
(55 mg/kg ketamine, 5.5 mg/kg xylazine, and 1.1 mg/kg acepromazine), and transcardially 
perfused with ice cold 1× phosphate-buffered saline (PBS; pH 7.2). Sciatic nerves were dissected 
and cryoprotected with 30% sucrose for 48 hr at 4
o
C, embedded in OCT (Tissue Tek, Torrance, 
CA, USA), cryostat sectioned at 16 µm and thaw-mounted on SuperFrost plus slides (Fisher 
Scientific) prior to staining. Slides were heated to 50°C on a hot-plate, for 1 hr, rehydrated with 
PBS, and post-fixed for 10 min with ice cold 4% paraformaldehyde. Slides were extensively 
washed in PBS and blocked with PBS containing 3% normal donkey serum, 0.03% Triton X-
100, and 1% BSA for 1 hr at room temperature. Subsequently slides were incubated in rabbit 
anti-NCX3 (1:500, Lifespan Biosciences, Seattle, WA) in PBS containing 1% BSA overnight at 
4°C. Slides were extensively washed in PBS and incubated in donkey anti-rabbit secondary 
antibodies conjugated to cyanine 3 (Jackson ImmunoResearch, West Grove, PA, USA) in 
blocking solution at 1:500 for 2.5 hours, extensively washed, and coverslipped with 
Fluoromount-G (Southern Biotech, Birmingham, AL). Slides were photographed under 
epifluorescence with a Leica DM4000B upright (Leica, Wetzlar, Germany). Images were 
captured using a Leica DFC300FX camera and processed for brightness and contrast with 
ImageJ (NIH). 
4.3.6 Sciatic Nerve Ligations 
Two days after induction of inflammation in the hindpaw, rats were deeply anesthetized with 
isoflurane. The hair over the back of the thigh was shaved and blunt dissection was used to 
separate the hamstring muscle exposing the sciatic nerve. Two tight ligatures were placed around 
the exposed nerve ~ 1 cm apart using sterile 6.0 silk sutures. Subsequently, 24 hr after ligation, 
animals were deeply anesthetized with anesthetic cocktail and sciatic nerves were removed and 
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processed for immunohistochemistry as described above.  Quantification of protein trafficking 
was done using Image J software (NIH). Regions of interest (ROIs) were selected as a square 
area as close the top of the first ligature as possible. ROI area was kept consistent across images 
and pixel density within the ROI was quantified. To quantify the increase in NCX3-LI, nerves 
from naïve and inflamed rats were processed in parallel and images were acquired under 
identical conditions. The density of staining was then assessed in a 4 mm
2
 region centered over 
the middle of the nerve 1 mm from the middle of the center of the constriction left by the 
ligature. The mean pixel density over the region was measured. Three sections per nerve were 
averaged to obtain a value per rat and the average value from naïve and inflamed rats were 
compared. 
4.3.7 Chemicals and Reagents 
DiI 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate was purchased from 
Invitrogen (Carlsbad, CA, USA). Fura-2 acetoxymethyl (AM) ester (2.5 mM stock in DMSO) 
and Pluronic F-127 (0.025 % in water) were purchased from TEF Laboratories (Austin, TX, 
USA). KB-R7943 was purchased from R&D Systems, Inc (Minneapolis, MN, USA) and was 
dissolved to 100mM stock concentration in DMSO (Sigma-Aldrich, St Louis, MO, USA). 
4.3.8 Statistical Analysis 
Data are expressed as mean ± s.e.m. Student’s t test was used for simple comparison between 
groups two groups. For experiments involving the application of test compounds, vehicle 
controls were always included. A two-way ANOVA was used for analysis of more than two 
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groups with the Holm-Sidak test used for post-hoc analysis. p < 0.05 was considered statistically 
significant. 
4.4 RESULTS 
Ca
2+
 imaging data were collected from 367 cutaneous DRG neurons acutely dissociated from 32 
male Sprague Dawley rats, of which 18 were control and 30 were inflamed. Based on previous 
results indicating that the inflammation-induced increase in the 4 s 30 mM KCl (high K
+
)-evoked 
Ca
2+
 transient was primarily manifest in small (< 30 μm) diameter, cutaneous, IB4+, capsaicin-
sensitive DRG neurons, this subpopulation was the focus of the present study and is 
subsequently referred to as a subpopulation of putative nociceptive cutaneous neurons. 
Consistent with our previous results (Lu and Gold, 2008, Scheff et al., 2013), inflammation was 
associated with a significant increase in the magnitude (as measured by a change from baseline) 
and duration (as measured by the time to a 50 % decrease from peak (T50)) of the high K
+
-
evoked Ca
2+
 transient (Figure 22A). These changes were not associated with a change in resting 
Ca
2+
, 120.47 ± 4.09 nM (n = 39) and 125.74 ± 5.88 nM (n = 49) in neurons from naïve and 
inflamed rats, respectively (p > 0.05). 
A parametric experiment using DiI+ neurons was used to determine the stimulus duration 
at which it was possible to detect an inflammation-induced increase in the duration of the evoked 
transient. Neurons from naïve (n = 24) and inflamed (n = 43) rats were stimulated with high K
+
, 
applied for durations ranging between 250 ms and 4 s (Figure 22A). Analysis of the magnitude 
(Figure 22B) and T50 (Figure 22C) of decay versus the stimulus duration indicates that a 
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significant difference between naïve and inflamed neurons emerges with a stimulus duration ≥ 
4s.  
 
 
 
 
Figure 22: The inflammation-induced increase in the magnitude and duration of the evoked Ca2+ transient 
are only manifest with long duration stimuli 
A) Putative nociceptive cutaneous neurons from naïve (black trace) and inflamed (3 days post CFA injection, red 
trace) rats were stimulated with 30 mM KCl (high K
+
), applied for durations ranging between 250 ms and 4 s. 
Pooled data indicate that in neurons from both naïve (black bars, n = 24) and inflamed (red bars, n = 43) rats are 
similar in both magnitude (B), as measured by a change from baseline (Δ[Ca2+]i), and duration (C), as measured by 
the time to 50 % decrease from peak magnitude (T50), with a 1 and 2 s stimuli but the inflammation-induced 
changes in both parameters are revealed with a 4 s stimulus of high K
+
. ** p < 0.01  
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4.4.1 Inflammation is associated with a decrease in NCX activity 
To determine whether an inflammation-induced decrease in NCX activity may contribute to the 
increase in the duration of the evoked Ca
2+
 transient, we measured the transient duration in 
response to a 4 sec application of high K
+
 before and after inhibition of NCX activity using a Na
+
 
free bath in which Na
+
 was replaced with Li
+
 or choline (Figure 23A). Consistent with our 
previous results in unlabeled DRG neurons (Lu et al., 2006) and cutaneous neurons (Scheff et al., 
2014), block of NCX resulted in no change in the magnitude (260.3 ± 13.29 and 250.2 ± 16.17 
nM respectively), but was associated with a significant increase in duration (529.22 ± 12.68% 
increase in T50, Figure 23B) of the evoked transient in neurons from naïve rats. In neurons from 
inflamed rats, however, there was no change in either the magnitude (387.8 ± 29.6 n = 35, and 
389.3 ± 37.2, respectively, p < 0.05) or duration (42.5 ± 4.9, n = 35 and 57.7 ± 8.5 s, 
respectively, p > 0.05) of the evoked Ca
2+
 transient associated with NCX block (Figure 23B). 
The absence of an increase in the duration of the evoked Ca
2+
 transient in the presence of 0 mM 
Na
+
 in the bath, is consistent with a loss of NCX activity in neurons from inflamed rats. To 
confirm the apparent loss of NCX activity with inflammation, two additional experiments were 
performed. In the first, we tested the efficacy of NCX3-selective blocker, KB-R7943, in the 
presence of inflammation, based on previous data suggesting that NCX3 underlies the majority 
of NCX activity in this subpopulation of sensory neurons (Scheff et al., 2014). In neurons from 
naïve animals, 100nM KB-R7943 significantly prolonged the duration of the transient 237.2 ± 
46.7 % (p < 0.05, Figure 22). However, consistent with results using 0 mM Na
+ 
bath, the NCX3-
selective blocker had no detectable influence on the duration of the evoked Ca
2+
 transient (5.1 ± 
0.23%, p > 0.05) in neurons from CFA-treated rats. 
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Figure 23: Inflammation is associated with loss of NCX activity in putative nociceptive cutaneous neurons 
High K
+
 (30 mM) evoked Ca
2+
 transients in small diameter (≤ 30 µm) retrogradely labeled (DiI+), capsaicin 
sensitive (Cap+), IB4+ neurons from naïve (black top traces) and inflamed  (red bottom traces) rats before and after 
NCX block with a bath solution in which Na
+
 was replaced with Li
+
 (A) or 100nM KB-R7943 (B). C) Pooled 
magnitude (top) and duration (bottom) transient data from DiI+/IB4+ neurons from naïve and inflamed rats, before 
(Na
+
) and after block of NCX with 0 mM Na
+
 bath in which Na
+
 was replaced with Li
+
 or choline, or KB-R7943 
(KB-R) replacement. 36 and 34 neurons were studied with 0 mM Na
+
 from naïve and inflamed rats respectively, 
while 21 and 23 neurons from naïve and inflamed rats were studied with KB-R7943, respectively. ** p<0.01 
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In the second set of experiments, we sought to directly measure the inward current 
generated from NCX activity in neurons from naïve and CFA-treated animals. The gramicidin-
perforated patch configuration was used for whole cell voltage clamp recording in order to 
simultaneously assess changes in membrane current and [Ca
2+
]i with fura-2 AM imaging. A 4 s 
depolarization to 0 mV was used to evoke Ca
2+
 influx and consequently, a Ca
2+
 transient. We 
have demonstrated previously that the transient evoked with this stimulus is similar in magnitude 
and duration to that evoked with 4s application of high K
+
 (Scheff et al., 2014). In the presence 
of 130 mM [Na
+
]o and ≥ 350 nM [Ca
2+
]i, the exchanger is in Ca
2+ 
efflux mode transporting 3 Na
+ 
in for each Ca
2+ 
extruded out at a rate thought to be roughly 5000 sec
-1 
(DiPolo and Beauge, 
2006). Therefore, inhibition of exchange activity with the application of 0 mM Na
+
 bath, should 
result in the block of the NCX mediated inward current. There was no detectable change in 
membrane current or [Ca
2+
]i in response to a 4 s application of 0 mM Na
+
 bath prior to evoking a 
Ca
2+
 transient in any of the 12 putative nociceptive cutaneous neurons tested (data not shown). 
However, following the voltage step to 0 mV, 4s application of 0 mM Na
+
 bath resulted in a 
decrease in inward current, the magnitude of which decreased in association with the decay of 
the evoked Ca
2+
 transient (Figure 24A). Pooled data from 6 neurons from naïve rats indicated 
that just after the peak of the evoked Ca
2+
 transient, associated with a [Ca
2+
]i of 223.61 ± 9.5 nM, 
the 0 mM Na
+
 bath-sensitive current was 28.73 ± 1.8 pA (Figure 24B). Despite the fact that the 
depolarization-evoked transient in neurons from inflamed rats (352.72 ± 27.9 nM, n = 6) was 
significantly (p < 0.01) larger than that of neurons from naïve rats, the 0 mM Na
+
- bath sensitive 
current was significantly smaller in these neurons (5.10 ± 1.88 pA, p < 0.05, Figure 24B), 
consistent with an inflammation-induced loss in NCX activity in the isolated cell body.  
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Figure 24: Inflammation-induced decrease in NCX current 
A) A combination of perforated patch recording and Ca
2+
 imaging was used to assess the Ca
2+
 transient (top trace) 
evoked in response to a 4 s voltage step to 0 mV. The Ca
2+
 current (bottom trace), resulted in an increase in 0 mM 
Na
+
 sensitive current (inset), which decayed in association with the decay of the Ca
2+
 transient. Typical 0 mM Na
+
 
sensitive current traces from a neuron from inflamed rats are shown in red. B) Pooled peak 0 mM Na
+
 sensitive 
current data from neurons (n = 6 in each group) from naïve and inflamed rats. ** p < 0.01. 
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4.4.2 Time course of inflammation-induced changes in NCX activity 
To begin to explore both the basis for the inflammation-induced decrease in NCX activity in 
putative nociceptive neurons and whether these changes might contribute to the onset or 
resolution of the inflammatory response, we assessed the time course of the inflammation-
induced changes in NCX activity. In order to correlate changes in Ca
2+
 regulation with changes 
the inflammation-induced thermal and mechanical sensitivity, we first assessed the time course 
of inflammation-induced changes in nociceptive behavior. A significant decrease in both 
mechanical (p < 0.01, Figure 25A) and thermal (p < 0.01, Figure 25B) threshold was fully 
manifest by 24 hrs after the injection of CFA, was relatively stable for up to 72 hrs post CFA, 
and then returned to baseline over the subsequent 4 – 10 days. 
Our initial assessment of the inflammation-induced changes in the evoked Ca
2+
 
transient and NCX activity utilized neurons harvested 72 hrs after the injection of CFA. We 
therefore, assessed the onset of changes in neurons harvested 24 and 48 hrs after the induction of 
inflammation, and resolution at 7 and 14 days after the induction of inflammation. Results of this 
analysis indicate that a significant increase in the magnitude of the evoked transient was 
detectable at 48 hrs, that the increase peaked at 72 hrs post CFA, and was still significantly 
elevated at 7 days post CFA (Figure 25C). In contrast, the inflammation-induced increase in 
evoked Ca
2+
 transient duration peaked at 48 hrs post CFA and had resolved by 7 days post CFA 
(Figure 25D). The inflammation-induced loss of NCX activity followed this same trajectory with 
a significant decrease in the impact of Li
+
 bath on the Ca
2+
 transient duration that peaked at 48 
hours.  However, there was still a significant decrease in the impact of Li
+
 bath on day 7 (Figure 
25D), suggesting other mechanisms contribute to the normalization of the evoked Ca
2+
 transient.    
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Figure 25: Time-dependent changes in the evoked Ca
2+
 transient and nociceptive behavior 
The time course for the inflammation-induced changes in the magnitude (A) and duration (B) of the evoked Ca
2+
 
transient, closely parallel that of the inflammation-induced changes in nociceptive threshold (C). The change in 
nociceptive threshold was manifest in the paw ipsilateral (inflamed) but not contralateral (Contra) to the CFA 
injection. Block of NCX with 0 mM Na
+
 bath (Li
+
 Bath), had no influence on the magnitude of the evoked transient, 
but increased the duration, a change that was completely occluded 2 and 3 days post-CFA. * p < 0.05 ** p < 0.01 for 
Na
+
-containing bath and # p < 0.05 ## p < 0.01 for Li
+
-containing bath.  
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4.4.3 The inflammation-induced decrease in NCX activity is due to an increase in 
trafficking of NCX3 toward peripheral terminals 
To explore the basis for the inflammation-induced decrease in NCX activity, we first assessed 
the impact of inflammation on the expression levels of NCX isoforms in DRG (Table 4). 
Negative results from this experiment should be viewed with caution because the inflammation-
induced change in NCX activity is only present in a subset of neurons that innervate the site of 
inflammation, which are a subpopulation of the total cells in the L4 and L5 DRG (that give rise 
to the innervation of the hindpaw). Nevertheless, because others have detected inflammation-
induced increases (Lu et al., 2010, DeBerry et al., 2014) and decreases (Zhang et al., 1998, 
Marsh et al., 2012) in the expression of a number of different molecules, we felt it was still worth 
assessing changes in NCX expression. However, despite a significant decrease in NCX activity, 
mRNA extracted from L4 - L5 DRG harvested from naïve (n = 8) and 3 day CFA-treated (n = 7) 
rats revealed no detectable change any of the isoforms tested (Figure 26A). Next, because 
mRNA levels do not directly reflect density of protein, we assessed the impact of inflammation 
on NCX isoform protein levels. Results of this analysis revealed a significant decrease in the 
relative density of NCX3, but not NCX1 or NCX2 (Figure 26B) in DRG 72 hrs after the 
induction of inflammation. We have recently demonstrated that NCX3 is the isoform primarily 
responsible for NCX activity in putative nociceptive DRG neurons (Scheff et al., 2014). 
Furthermore, pharmacological results of the present study suggesting that a decrease in NCX3 
accounts for the inflammation-induced decrease in NCX activity. 
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Table 4: Fully nested NCX SqRT-PCR primers 
Target Gene Position Start Sequence 
 
NCX1 
NM_001270778.1 
Outer 
2372 
2620 
F: TTTGCCTTCGTCCCACCTACAGAA 
R: AAGACATTCACAGCGTTGCTTCCG 
Inner 
2515 
2588 
F: TGCAGTTGTGTTTGTCGCTCTTGG 
R: TGCCTATGGACGCATCTGCATACT 
 
NCX2 
NM_078619.1 
Outer 
2266 
2569 
F: ATCCTGGTCATTGGTCTGCTCACT 
R: ACGGTGAACAGTGTGACCGAGAA 
Inner 
2382 
2461 
F: CATCCCTGACACGTTTGCCA 
R: TCCAATGCGGTGAACGTGTT 
 
NCX3 
NM_078620.1 
Outer 
2343 
2890 
F: AATAGTCTTCCTTTGCCACGGGCT 
R: CCACAACCAATGCCAGGTTTGTCT 
Inner 
2553 
2679 
F: AAGGGTGGTGGTGAGGACTTTGAA 
R: ATTGCCCTTGGTGAACCGAAATGG 
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Figure 26: Inflammation was associated with a decrease in NCX protein but not mRNA 
A) SqRT-PCR was used to screen for changes in NCX1, 2 and 3 mRNA extracted from whole L4 and L5 DRG. The 
fold change in NCX isoform in inflamed rats (n = 4) relative to that in naïve (n = 4) was assessed relative to that of 
GAPDH. B) Western blot analysis of inflammation (CFA)-induced changes in NCX isoforms in total protein 
extracted from L4 and L5 DRG. Pooled data for inflamed rats (n = 6) are plotted as a percent change from the 
average band intensity in naïve rats (n = 3), where only the 120 kDa and 70 kDa band for NCX1 and 3 respectively 
were included in the analysis. * p < 0.05. 
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Therefore, we focused on NCX3 in an expanded analysis of the inflammation-induced changes 
in NCX protein in which we included both the time course of the changes and whether the 
decrease was uniform throughout the sensory neuron. Protein was extracted from central nerve, 
DRG, and sciatic nerve, and analyzed for the relative density of NCX3 at 1, 3, 7 and 14 days 
after the induction of inflammation. Results of this analysis indicated that changes over time in 
NCX3 protein in the DRG mirror that of the inflammation-induced decrease in NCX activity 
observed in isolated putative nociceptive DRG neurons with a decrease that peaks at day 3 post 
CFA and that rebounded significantly above baseline levels (n = 4, p < 0.05) by day 7 post CFA 
treatment (Figure 27A). In contrast, however, there was a robust inflammation-induced increase 
in NCX3 protein in the sciatic nerve that peaked at day 3 post CFA and resolved by day 7 post 
CFA (p < 0.01 Figure 27B). Interestingly, there was no inflammation-induced change in NCX3 
in the central nerve (p > 0.05 Figure 27C). This loss of protein in the ganglia and an increase in 
the peripheral nerve only, near the peak of inflammation-induced loss of NCX activity, is 
suggestive of differential trafficking. 
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Figure 27: Time-dependent changes in NCX3 protein at three major sites in the nerve 
Western blot analysis of total protein extracted from the L4 – L5 DRG (A), sciatic nerve (B), and central nerve (C) 
at 1, 3, 7, and 14 days the induction of inflammation with subcutaneous injection of CFA. Data were first 
normalized with respect to GAPDH, and then plotted as a percent change from naïve. Typical blots from animals 
treated with CFA after 1, 3 and 7 are shown. Pooled data are from 3 rats per time point. * p < 0.05, ** p < 0.01 
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To further test the hypothesis that the changes in NCX3 in the DRG and sciatic nerve 
were due to a change in trafficking of the exchanger, we employed a dual ligation of the sciatic 
nerve ipsilateral to the site of CFA injection in order to clearly differentiate trafficked protein 
from that synthesized locally. Ligatures were placed on the sciatic nerve of naïve rats (n = 4), or 
on that of rats (n = 4) 48 hrs after the induction of inflammation. The nerves were removed 24 
hours after ligation and processed for immunohistochemical analysis. The ligation alone did not 
produce any detectable changes in NCX3-like immunoreactivity (LI) (Figure 28A). However, in 
the presence of inflammation, there was a robust increase in NCX3-LI proximal to the first 
ligature (Figure 28B). Pooled data confirm that the NCX3-LI proximal to the ligature was 
significantly greater in nerves from inflamed rats than that in nerves from naïve controls (Figure 
28C, p < 0.01).  
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Figure 28: Inflammation-induced increase in NCX3 trafficking to the periphery 
Immunohistochemical analysis of NCX3 like-immunreactivity (LI) in the sciatic nerve from a naïve rat (A), or from 
a rat three days after the induction of inflammation with CFA (B). Low powered micrographs (4x magnification, 
left) illustrate the double ligature sites. Higher powered micrographs (10x magnification, right) are of the proximal 
ligature site. Ligatures were placed 24 hr prior to tissue harvest. Scale bars in both 4x and 10x images are 200 μm C) 
Pooled densitometry data of nerve from control (black, n = 4) and inflamed (red, n = 4) rats. ** p < 0.01. 
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Finally, in order to determine if NCX3 protein was shipped to the terminals innervating 
the site of injury, western blot analysis was done to assess changes in NCX3 protein in the 
glabrous skin ipsilateral to CFA injection (n = 8). Results showed a significant increase in NCX3 
in the skin from rats 3 days after CFA injection (p < 0.01 Figure 29).    
 
 
 
 
Figure 29: Inflammation-induced increase in NCX3 at the site of inflammation 
The glabrous skin of naïve (n = 8) and inflamed (n = 8) rats 3 days after CFA injection was harvested and total 
protein was processed for western blot analysis of NCX3 content. Both GAPDH and the neural marker PGP9.5 were 
used as loading controls. To control for inflammation-induced increase in sprouting, pooled data were normalized to 
PGP9.5. A typical block is shown below the pooled data. ** p < 0.01 
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4.5 DISCUSSION 
In the present study, we sought to test the hypothesis that a decrease in NCX activity contributes 
to the inflammation-induced increase in the duration of the depolarization-evoked Ca
2+
 transient 
in putative nociceptive cutaneous DRG neurons. Consistent with our previous results (Lu and 
Gold, 2008), inflammation was associated with an increase in both the magnitude and duration of 
the depolarization-evoked Ca
2+
 transient in the IB4+ subset of putative nociceptive cutaneous 
neurons. Also consistent with previous results, block of NCX in the IB4+ subset of putative 
nociceptive neurons from naïve rats by replacing Na
+
 in the bath with either Li
+
 or choline, or 
with the NCX3 blocker, KB-R7943, resulted in a significant increase in the duration of the 
evoked Ca
2+
 transient (Scheff et al., 2014). However, in neurons harvested from rats three days 
after the induction of inflammation, these manipulations had no detectable influence on the 
transient duration. Comparable data were obtained with electrophysiological analysis of the 0 
mM Na
+
 bath-sensitive current in this population of neurons. Analysis of the time course of these 
changes indicated that they developed over the first three days after the induction of 
inflammation and resolved over the subsequent four to ten days. This trajectory mirrored the 
changes in CFA-induced nociceptive behavior. These changes in NCX activity in the isolated 
cell body were not associated with a detectable change in NCX expression. They were, however, 
associated with a significant decrease in NCX3, but not NCX1 or NCX2 protein in the cell body 
and an increase in NCX3 protein in the sciatic nerve. Sciatic nerve ligation at 48 hours after 
induction of inflammation resulted in a buildup of NCX3-LI proximal to the ligation site. 
Finally, there was a significant increase in NCX3-LI in the glabrous skin ipsilateral to CFA 
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injection. These results are consistent with our initial hypothesis and suggest that the decrease in 
NCX activity observed in the cell body is due to an increase in the trafficking of NCX3 to the 
site of inflammation. 
The initial parametric experiment designed to establish the relationship between stimulus 
duration and the manifestation of the inflammation-induced changes in the evoked transient, 
indicated that mechanisms underlying the increase in both the magnitude and duration of the 
evoked transient had a high threshold for activation, requiring at least 4 s of depolarization. With 
respect to the duration of the evoked transient, these results were the first that were consistent 
with the hypothesis, that the inflammation-induced increase in transient duration is due to a 
decrease in NCX activity as NCX has been shown to be a low affinity mechanism requiring large 
[Ca
2+
]i for activation. Furthermore, these results argue against a role of PMCA, a higher affinity 
protein thought to mediate Ca
2+
 homeostasis that should be revealed, if not at rest, than with a 
much shorter stimulus duration.  
It is clear that there are Ca
2+
 regulatory mechanisms that can influence the magnitude, 
duration and/or both aspects of the evoked Ca
2+
 transient (Lu et al., 2006). Nevertheless, results 
of the present study indicate that the inflammation-induced increase in the evoked Ca
2+
 transient 
reflect changes in at least two Ca
2+
 distinct regulatory processes. That is, the increase in transient 
duration reflects a decrease in NCX activity. However, because NCX activity has no detectable 
influence on the magnitude of the evoked Ca
2+
 transient, the increase in magnitude must reflect 
another mechanism. Interestingly, this mechanism must account for the increase in the 
magnitude of the evoked transient in addition to a decrease in voltage-gated Ca
2+
 channel 
(VGCC) current density (Lu et al., 2010). This implies a shift in coupling between the initial 
Ca
2+
 influx via VGCCs, and an amplification system that ultimately influences the transient 
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magnitude. While ryanodine receptor mediated Ca
2+
-induced Ca
2+
 release is a well described 
transient amplification system (Berridge, 2006), we were unable to implicate this system as a 
potential underlying mechanism of the inflammation-induced increase in the magnitude (Scheff 
et al., 2013). Furthermore, with evidence against a change in mitochondrial Ca
2+
 buffering as a 
potential mechanism of the increase in magnitude (Scheff et al., 2013), we are left suggesting far 
less conventional mechanisms may ultimately be responsible for this change. One such 
mechanism includes the sensitization of channels typically activated by exogenous stimuli such 
as ligand-gated transient receptor potential vanilloid 1 (TRPV1) or ankyrin 1 (TRPA1) receptors. 
TRPV1 in particular demonstrates some voltage-dependence (Matta and Ahern, 2007), and is not 
only upregulated in the presence of inflammation, but is sensitized (Julius, 2013). Thus, a 
depolarization-induced recruitment of TRPV1 could contribute to the inflammation-induced 
increase in the magnitude of the evoked transient.  
It was striking that despite a relatively complete loss of NCX activity in neurons from 
CFA-treated rats, the duration of the evoked Ca
2+
 transient in the presence of inflammation was 
smaller than that observed following complete block of NCX activity in neurons from naïve rats 
with either 0 mM Na
+ 
bath or the almost complete block of NCX with KB-R7943. While one 
might have predicted that a complete loss of NCX activity in the presence of inflammation 
would have resulted in a transient duration comparable to that observed in neurons from naïve 
animals following NCX block. This mismatch underscores the complex nature of Ca
2+
 regulatory 
processes. Even a small shift in the relative distribution of Ca
2+
 regulatory mechanisms can have 
a profound influence on the properties of the evoked transient, and as noted above, inflammation 
is associated with marked changes in at least three distinct Ca
2+
 regulatory processes. In previous 
studies we have attempted to rule out additional Ca
2+
 regulatory mechanisms through individual 
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assessment of different components of the Ca
2+
 signaling toolkit. It is possible, however, that the 
inflammation-induced increase in the duration of the transient due to the loss of NCX, or the 
mechanisms underlying the increase in magnitude or both could result in changes in the relative 
balance of other Ca
2+
 regulatory processes and thus the engagement of other proteins not 
normally involved in depolarization-evoked Ca
2+
 regulation. This concept has been demonstrated 
previously, in which a prolonged release of Ca
2+
 from ryanodine receptors normally buffered by 
the ER ATPase (SERCA) was shown to engage NCX-mediated extrusion in the presence of 
inflammation but not in the naïve state (Scheff et al., 2014). Thus, it is possible that the increase 
in the magnitude and duration of the evoked transient has activated additional processes such as 
a SERCA-uptake into the ER or additional mitochondrial buffering resulting in the attenuation of 
the evoked transient in the presence of a significant loss in NCX activity. 
With several notable exceptions, the time course of the inflammation-induced changes in 
the evoked Ca
2+
 transient mirrors that of the inflammation-induced hypersensitivity. The 
observation that the time course of the increase in magnitude of the transient is not identical to 
that of the increase in duration (the former is still significantly elevated at 7 days post CFA, 
while the latter has fully recovered) lends further support to the suggestion that distinct 
mechanisms underlie these two changes. More interestingly, however, is that the significant 
increase in duration of the evoked transient fully recovered at a time point at which animals are 
still quite hypersensitive. This separation is also reflected in protein content, where there is a 
significant decrease in NCX3 protein in the DRG on day 3 post-CFA, which is not detectable at 
later time points. This suggests that the change in NCX might be more relevant for the initiation 
and maintenance but not the resolution of inflammation.  
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While the negative expression data should be interpreted with caution, the initial decrease 
in NCX activity and protein in the cell body could simply be due to protein turnover. However, 
the most likely explanation is protein trafficking. This is well supported by the increase in 
protein in the sciatic nerve at 3 days post-CFA and the increase in NCX-LI in the ligation 
experiment demonstrating that the increase in NCX3 is in the nerve and that the increase 
observed with western blot is not due to an infiltration of immune cells, previously shown to 
express NCX3 (Boscia et al., 2013, Staiano et al., 2013). The increase in NCX3 protein detected 
in the cell body at 7 days post-CFA injection in the absence of a detectable change in NCX 
activity in the isolated cell body suggests the increase in protein does not reflect functional 
protein. Instead, we propose that NCX activity in the cell body is relatively tightly regulated, 
with spare protein ready to be trafficked if needed. Furthermore, the normalization of NCX in the 
sciatic nerve lends additional support to the suggestion that NCX only contributes to the earlier 
stages of the inflammatory response.  
While available evidence indicates that both the 70 kDa and 60 kDa bands detected by 
the NCX3 antibody reflect proteolytic cleavage products of NCX3 (Linck et al., 1998, 
Thurneysen et al., 2002b), it is interesting to note that the inflammation-induced changes in 
protein density were restricted to the 70 kDa band. The basis for this distinction is unclear, but 
may reflect differences in the relative stability of the two cleavage products thought to be the 
intracellular loop (60 kDa) cleaved from the remainder of the protein. It is possible that the 
inflammation-induced change in excitability (Zhang et al., 2012a) results in an activity-
dependent increase in NCX turnover rate reflected as an CFA-induced increase cleavage 
products. We suggest this possibility, is unlikely, however, in the absence of a detectable change 
in NCX mRNA, and a decrease in NCX activity in the cell body that parallels the loss of NCX-
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LI. Thus, a more likely possibility is that the trafficked NCX is processed differently that the 
NCX remaining in the cell body, resulting in the differential pattern of NCX3-LI.   
Axonal transport of receptors has historically been found to be bidirectional and 
microtubule dependent: receptors are associated with vesicles that are externalized and 
internalized at the nerve terminals, and possibly recycled in the cell body (Laduron and Castel, 
1990). Altered trafficking in response to paw inflammation has also been shown to occur with 
both receptors (Hassan et al., 1993) and peptides (Donnerer et al., 1992). The redistribution of 
NCX3 out of the DRG and toward the peripheral terminals but not the central terminals 
resembles the alterations reported with TRPV1 in the presence of inflammation (Ji et al., 2002) 
and the voltage gated sodium channel 1.8 (NaV1.8) after peripheral nerve injury (Novakovic et 
al., 1998) suggesting some sorting mechanism must be present within the primary afferent to 
achieve such directed traffic. Furthermore, there was no detection of significant change in 
retrograde transport of NCX back to the ganglia suggesting unidirectional transport to the site of 
inflammation.  
Ultimately, the physiological impact of inflammation-induced trafficking depends on 
NCX function in the terminals and cell body. A decrease in exchanger activity at the cell body 
results in a change in the duration of the evoked transient. Given evidence that Ca
2+
 is the 
integrator underlying activity-dependent changes in gene expression (Fields et al., 2005), a 
change in the properties of the evoked Ca
2+
 transient should result in a change in gene 
expression. The trend toward the decrease in NCX3 in the central terminals, should, if anything, 
result in an increase in transmitter release from the central terminals. While there is no direct 
evidence of NCX-mediated regulation of neurotransmitter release to date, although many have 
speculated (Blaustein and Lederer, 1999, Jeon et al., 2003, Khananshvili, 2013), we hypothesize 
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that this was the most likely explanation for the hyperalgesia observed following siRNA-induced 
knock down of NCX3 (Scheff et al., 2014). In contrast, the increase in NCX in peripheral 
terminals should result in a decrease in transmitter release. While peptidergic fibers are generally 
considered in the context of peripheral transmitter release and neurogenic inflammation, there is 
growing evidence for functional glutamate receptors in the periphery, which may be either pro- 
or anti-nociceptive (Miller et al., 2011). Alternatively, a decrease in the duration of evoked Ca
2+
 
transients in the periphery as a result of the increase in NCX activity may influence the 
excitability of the peripheral endings if the Ca
2+
 transient is coupled to a Ca
2+
-dependent ion 
channel. For example, a decrease in Ca
2+
-dependent K
+
 channel activity should result in an 
increase in excitability, while a decrease in Ca
2+
-dependent Cl
-
 channel activity should result in a 
decrease in excitability. Because trafficking of NCX3 occurs between days 4 and 7 in the time 
course of inflammation, one might speculate that this is an anti-nociceptive mechanism in which 
NCX is sent to the terminals to aid in the regulation of the inflammation-induced increase in 
activity where it may also limit Ca
2+
-induced excitotoxicity that could result from ongoing 
activity in a subpopulation of afferents that are normally inactive. Thus, the impact of the change 
in NCX3 in the peripheral terminals will be highly context-dependent and likely to be highly 
dynamic. 
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5.0  DISCUSSION 
5.1 INFLAMMATION-INDUCED DYSREGULATION OF INTRACELLULAR 
CALCIUM 
I set out with the goal to determine the underlying mechanisms of the inflammation-
induced changes in the magnitude and duration of the depolarization-evoked Ca
2+
 transient. I 
have made significant progress towards achieving this goal with the identification of machinery 
underlying, at least in part, the inflammation-induced increase in the duration of the evoked 
transient. Furthermore, while the Ca
2+
 regulatory system underlying the inflammation-induced 
increase in magnitude is still at large, I was able to rule out important additional mechanisms.  
In the work described in Chapter 2, I hypothesized that inflammation-induced coupling of 
influx and release from intracellular stores would engage CICR and subsequently increase the 
magnitude of the evoked Ca
2+
 signal.  However, results from these studies demonstrate that 
CICR does not appear to be engaged in the subpopulation of cutaneous putative nociceptive 
neurons with the largest inflammation-induced change in the evoked Ca
2+
 transient. Furthermore, 
there does not appear to be any inflammation-induced changes in SERCA function or 
mitochondrial buffering. I did, however, discover what appears to be the presence of tightly 
segregated Ca
2+
 regulatory domains that isolate cytosolic Ca
2+
 increased via influx from release. 
Furthermore, there appeared to be an inflammation-induced shift in the regulatory domains so 
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that prolonged Ca
2+
 release from ryanodine receptors engaged an additional extrusion 
mechanism, thought to be the Na
+
/Ca
2+
 exchanger (NCX).  
 In Chapter 3, an extensive characterization of NCX in cutaneous putative 
nociceptive neurons from naïve rats was completed, encompassing biophysical properties, 
isoforms present, location within the neuron, and functional implications of NCX activity. In 
putative nonpeptidergic neurons only, there appear to be two modes of NCX activity: one evoked 
in response to relatively large and long lasting increases in the concentration of intracellular Ca
2+
 
([Ca
2+
]i), and a second that is active at resting [Ca
2+
]i. While mRNA encoding all three NCX 
isoforms (NCX1-3) was detectable with single cell PCR, pharmacological analysis suggested 
that NCX3 was responsible for the majority of activity in cutaneous neurons. Functional assays 
of excitability, action potential propagation, and nociceptive behavior suggest NCX activity has 
little influence on excitability, but instead influences axonal conduction velocity, resting 
membrane potential, and nociceptive threshold.  
 The last set of analyses focused on the impact of inflammation on NCX activity. 
Results indicated a significant inflammation-induced decrease in NCX activity in a 
subpopulation of putative nociceptive neurons innervating the site of inflammation. A time 
course of NCX activity in the isolated cell body and protein levels throughout the primary 
afferent suggested altered unidirectional trafficking of NCX3 to the peripheral terminals only. 
While the impact of an increase in NCX activity in the terminals at the site of injury is currently 
unknown, the inflammation-induced decrease in NCX activity at the level of cell body accounts 
for, at least in part, the inflammation-induced increase in the duration of the evoked Ca
2+
 
transient in cutaneous putative nociceptive neurons.  
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The mechanism underlying the increase in magnitude is still unknown in this 
subpopulation of nociceptors. Previous work by Lu and colleagues demonstrate that the two 
mechanisms are most likely dissociable so that it is likely that whatever the mechanism turn out 
to be, it only influence the magnitude but not the duration of the evoked transient (Lu et al., 
2006). As discussed in the Introduction, there are a number of influx and release mechanisms 
that add to the magnitude of the evoked Ca
2+
 transient. A decrease in VGCC current has been 
identified, and furthermore, it appears that neither release from ER through ryanodine receptors 
(Scheff et al., 2013) nor IP3 receptors (Lu et al., 2006) influence the depolarization-induced 
transient. While inflammation-induced changes in several potential ligand gated Ca
2+
 influx 
pathways (e.g. TRPV1 and TRPA1) have been identified (Ji et al., 2002, Shimosato et al., 2005, 
DeBerry et al., 2014), it is unlikely that these other influx pathways contribute to the increase in 
the depolarization-induced Ca
2+
 transient in sensory neurons which largely depends on the 
activation of VGCC. Although CICR does not appear to be engaged, preliminary data suggests 
that the increase in the magnitude of the evoked transient might be due to the recruitment of a 
pharmacologically distinct channel to store-operated Ca
2+
 entry (SOCE), thought to normally 
function as a mechanism for refilling intracellular Ca
2+
 stores. This is suggested by the 
observation that SOCE, as assessed with a brief application of extracellular Ca
2+
 following 
depletion of intracellular stores, is significantly increased in cutaneous putative nociceptive 
neurons from inflamed rats. Additional experiments will need to be done to understand how this 
mechanism contributes to the depolarization-induced Ca
2+
 transient in the absence of CICR. 
 The approach to study the different Ca
2+
 regulatory mechanisms has been to 
assess the function of each component individually. Furthermore, data presented here suggest 
that in the presence of inflammation there is a potential shift in the organization of cytosolic 
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microdomains such that mechanisms underlying influx and release can now interact. Without a 
good understanding of the spatial orientation or all of the components involved in these 
microdomains at the level of the cell body, it is possible that I may have missed inflammation-
induced changes in regulatory components with this experimental approach. Therefore, to better 
understand the underlying mechanism of intracellular Ca
2+
 regulation both in the naïve state and 
in the presence of injury, it might be useful to study the interaction of Ca
2+
 machinery or 
mechanisms in combination, instead of the how the system functions in the absence of a single 
mechanism. 
5.2 A ROLE FOR NCX IN INFLAMMATORY PAIN SIGNALING 
Tissue inflammation is associated with ongoing pain and hyperalgesia that is reflected in 
three major components: 1) an increase in primary afferent excitability resulting in an increase in 
input to the central nervous system 2) a change in gene expression secondary to altered Ca
2+
 
signaling in the cell body, and 3) an increase in neurotransmitter release in the periphery 
resulting in a neurogenic inflammatory response. I hypothesize that the inflammation-induced 
trafficking of NCX3 to the periphery plays a role in all three of these mechanisms.  
 A lack of inflammation-induced trafficking of NCX3 to the central terminals 
during the initiation of the inflammation suggests an undeterred increase in neurotransmitter 
release into the dorsal horn. Previous data from this lab has demonstrated that inflammation is 
associated with a significant decrease in VGCC current density at the level of the cell body, and 
furthermore, this loss of VGCC current is thought to result in a decrease Ca
2+
-dependent K
+
 
(BK) currents, which normally serve to repolarize the membrane potential following an action 
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potential (AP) and to mediate adaptation in response to sustained membrane depolarization 
(Zhang et al., 2012a). A loss of BK current in response to a decrease in VGCC current is thought 
to contribute to the inflammation-induced afferent sensitization and subsequently an increase in 
excitability. The loss in VGCC current is, at least in part, due to trafficking of α2δ1 and CaV2.2 
protein to the central terminal. Inflammation-induced increase in excitability in the presence of 
an increase in VGCC current in the central terminals, but without a subsequent increase in the 
major Ca
2+
 extrusion protein, NCX, will most likely result in an increase in neurotransmitter 
release into the central nervous system and ultimately more pain. 
 Adaptive responses of neurons often require changes in gene expression and there 
have been numerous accounts of differential changes in gene expression in response to tissue 
inflammation (Qiu et al., 2012, Schwartz et al., 2013). Because information in the environment is 
coded in the patterns of AP firing, adaptive changes in gene expression must be regulated by the 
pattern of APs. Furthermore, studies have shown that AP-mediated Ca
2+
 mobilization, when 
delivered at an appropriate temporal interval, can be effective in regulating the transcription of 
genes (Fields et al., 2005). The temporal dynamics of [Ca
2+
]i can be more important than the 
magnitude of the Ca
2+
 change in decoding AP firing, therefore, a loss of NCX activity at the 
level of the cell body resulting in an increase in the duration of the Ca
2+
 signal should result in 
changes in gene transcription in the presence of inflammation.  
 Lastly, tissue inflammation is associated with an increase in the release of 
neuropeptides and glutamate into the periphery to cause neurogenic inflammation and 
sensitization of surrounding afferent terminals respectively (Skerry and Genever, 2001, Carozzi 
et al., 2008). Glutamate has been demonstrated to produce nociceptive effects in animals and 
humans when injected directly (Miller et al., 2011) and indirectly influencing efferent release of 
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CGRP, ATP and nitric oxide as well through glutamate receptors expressed on peptidergic fibers 
and resident microglia (Jackson and Hargreaves, 1999, Beirith et al., 2002). Inflammation-
induced trafficking of NCX3 to the peripheral terminals will aid in the control of activity-
induced increase [Ca
2+
]i at the terminals. The trafficking of NCX only appears to occur in IB4+, 
putative nonpeptidergic fibers, thus an increase in NCX activity will result in a decrease in 
efferent glutamate release.  
All together, these data suggest a mechanism in which NCX is trafficked to the peripheral 
terminals to regulate activity and in response, there is an increase in Ca
2+
 transient duration in the 
cell body, most likely an increase in neurotransmitter release into the central nervous system, 
although this has not been tested directly. The time course of this mechanism appears to 
normalize as nociceptive sensitivity resolves suggesting that prolonged peripheral activity in the 
absence of NCX transport to the terminals to regulate [Ca
2+
]i might result in extended neurogenic 
inflammation and immune response, and excitotoxic levels of glutamate resulting in a persistent 
inflammatory state. 
5.3 IMPLICATIONS FOR DIFFERENT MODELS OF INFLAMMATION 
There is an inflammatory component associated with many different pain types, such as 
nerve injury, cancer pain, pancreatitis, and migraine. Furthermore, the degree of inflammation 
and the underlying mechanisms responsible for the inflammation vary. It is possible that the 
mechanism underlying the initiation of inflammation dictates the signaling cascade (e.g. TLR4, 
NGF, MCP-1) and subsequently the changes in [Ca
2+
]i. Complete freud’s adjuvant (CFA) is the 
model used to drive persistent peripheral inflammation resulting in the inflammation-induced 
 153 
changes in the depolarization-evoked Ca
2+
 transient. However, it is unclear whether the 
underlying signaling initiating the changes in Ca
2+
 regulation and subsequently NCX trafficking 
will occur with lesser stimuli, across species, or with other types of peripheral inflammation. The 
peripheral CFA-induced inflammation model is an effective means for stimulation of a local 
innate immune response through heat shock protein-induced activation of the toll-like receptor 4 
(TLR4) signaling cascades (Billiau and Matthys, 2001) similar to the action of 
lipopolysaccharides (LPS) released from gram-negative bacteria. It is important to note that the 
CFA model resembles more closely a model for bacterial infection than other models of 
inflammation such as intra-dermal injection of individual endogenous algogens such as 
bradykinin (Rang et al., 1991), models of autoimmune inflammation (Tian et al., 2013), 
inflammation associated with tissue damage (osteoarthritis model with tendon cut) (Fernihough 
et al., 2004), or even other forms of infection (yeast vs bacteria) (Watkins et al., 2007). 
Therefore, it is likely that the changes seen with CFA-induced inflammation will not apply to all 
types of inflammation. For example, despite the inflammatory component to peripheral nerve 
injury, the dysregulation in [Ca
2+
]i in the presence of nerve injury does not share many 
similarities with those seen in the presence of inflammation. The spinal nerve ligation model of 
painful nerve injury results in a decrease in resting [Ca
2+
]i, depleted intracellular Ca
2+
 stores and 
an increase in PMCA activity in small and medium diameter neurons (Rigaud et al., 2009). 
However, the inflammation-increase in the magnitude and duration of the depolarization-evoked 
Ca
2+
 transient appeared to be a common response to persistent inflammation across specifics, as 
similar changes were observed in retrogradely labeled neurons from mice in association 
caerulein-induced inflammation of the pancreas (Schwartz et al., 2013), and cyclophosphamide-
induced inflammation of the bladder (DeBerry et al., 2014).  
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A common quality of most inflammatory models is the interaction with the immune 
system, recruitment of immune cells and subsequent release of both pro- and anti-inflammatory 
mediators. While I have focused on persistent inflammation-induced regulation of NCX, there is 
evidence that NCX isoforms are regulated by second messenger cascades activated by a variety 
of inflammatory mediators. In non-neuronal cell systems, exposure to pro-inflammatory 
cytokines, TNFα and IL-13, resulted in an increase in NCX expression, protein, and function, 
whereas inhibition of NCX function occurred following histamine stimulation (Sathish et al., 
2011). Nerve growth factor (NGF), a prototypical inflammatory mediator (Bennett, 2001), has 
been shown to regulate of NCX expression and activity PC12 cells (Sirabella et al., 2012), 
increase NCX activity in forward mode via p38 activation. NCX activity may also be increased 
via activation of PKC (Iwamoto et al., 1996) or PI3K/AkT signaling (Sisalli 2014), all activated 
by an array of inflammatory mediators. Because NCX is not only present but also functional in 
the cell body (Verdru et al., 1997, Lu et al., 2006, Scheff et al., 2014), peripheral (Scheff et al., 
2014) and central (Shutov et al., 2013) axons of primary afferent C fibers, these data suggest that 
there is potential for acute differential modulation of NCX activity by inflammatory mediators 
on top of the persistent inflammation-induced changes occurring at all levels of the afferent. The 
functional implications of acute modulation of NCX activity would depend on where it was 
manifest. With evidence of inflammation-induced changes second messenger signaling cascades 
(Hucho and Levine, 2007) and increase NCX protein in the terminals, it is possible that NCX 
may be dynamically regulated by the actions of inflammatory mediators, thereby implying a 
more complex role for NCX in the inflammatory response than originally hypothesized. 
Hypersensitivity resulting from subcutaneous CFA appears to last roughly two weeks and 
the time course of NCX trafficking within putative nonpeptidergic fibers mostly mirrors this 
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trajectory. This begs the question of what is the underlying mechanism in the presence of chronic 
inflammation lasting months to years. There is a substantial amount of literature implicating 
increased glutamate release as an underlying cause for pain associated with a chronic arthritis-
like inflammatory conditions in both rodent models and in humans (Leem et al., 2001, Walker et 
al., 2001, Du et al., 2003). Inflammatory animal models demonstrate increased levels of 
glutamate in peripheral tissues and that peripheral glutamate, interacting with numerous 
excitatory amino acid receptors (EAARs), produces nociceptive behavior (Miller et al., 2011). 
Administration of glutaminase inhibitors blocking the synthesis of glutamate in arthritis-like 
inflammatory animal models produces long lasting analgesia (Miller et al., 2011). Inflammation-
induced glutamate elevation has also been confirmed in humans with chronic arthritis as well, 
such that synovial glutamate concentrations are over fifty times the concentration from non-
arthritic controls (McNearney et al., 2000, McNearney et al., 2004). Lidocaine injection in the 
knee joint prevented the glutamate elevation implicating joint nerve terminals as the source of 
the inflammation-induced increase (Lawand et al., 2000). With evidence that peptidegeric fibers 
do not contain adequent machinery for glutametergic signaling, these data implicated 
hyperactivity of the putative nonpeptidergic fiber population as playing a major role in 
hyperaglesia associated with arthritis-like inflammatory. Based on the hypothesis that NCX plays 
a pivotal role in primary afferent signaling in the presence of inflammation, it is possible that in 
these more chronic inflammatory states, a failure to continually transport NCX to the terminals 
might result in the failure of acute inflammation to fully resolve. A potential therapeutic 
approach to increase NCX activity at the peripheral terminal in the presence of persistent 
inflammation might aid in the reduction in nonpeptidergic fiber activity specifically and reduce 
primary afferent activity devoid of any major side effects. 
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5.4 LIMITATIONS OF EXPERIMENTAL APPROACH: LOOKING BEYOND THE 
CELL BODY 
The heterogeneity in the underlying mechanisms of Ca
2+
 regulation during inflammatory 
pain in the peripheral neuron truly underscores the importance of recognizing the complexity of 
these two systems. While not without its limitations, the work described here highlights four 
major components of experimental design critical for interpretation of results. The first is the 
identification of the tissue of innervation. There is a tremendous amount of evidence 
demonstrating the differences between primary afferents innervating the visceral system versus 
somatic and muscle tissues (Raja et al., 1988, Sessle and Hu, 1991, Robinson and Gebhart, 
2008). Therefore, when assessing changes in the putative nociceptor cell body, the use of 
retrograde dyes injected into the target tissue for identification of the subpopulation of interest 
among all others in the ganglia is a crucial component.  
The second is the uses of additional histological and functional markers to further 
identify the groups within the subpopulation of interest. As described in the Introduction, a 
substantial amount of work has been done to classify types of nociceptors in the naïve animal. 
Because evidence suggests that the heterogeneity in pain phenotypes is reflected, at least in part, 
by the heterogeneity of primary afferents, a better understanding of the qualifications of afferents 
involved has the potential to yield a more specific the therapeutic approach. However, it is 
important to note that while nociceptors differentially express a variety of anatomical and 
biochemical markers, there are important species differences (Price and Flores, 2007). 
Furthermore, injury-induced changes afferent function (e.g. “silent” nociceptors) and marker 
expression (Woodbury et al., 2008, Jankowski et al., 2012) makes post hoc identification of the 
population responsible for the pain signaling more challenging. 
 157 
Third, while one of the advantages to the use of whole cell patch electrophysiology 
recordings are the ability to control both intracellular and extracellular milieu, however, this 
technique has its limitations, especially in regard to intracellular Ca
2+
 regulation. During whole-
cell recordings, irreversible ‘washout’ of diffusible intracellular constituents, such as ATP, 
phosphorylating molecules, and most importantly intracellular Ca
2+
, through dialysis can 
significantly impair the properties and functions of ion channels and complicating data analysis. 
However, the perforated patch clamp technique avoids this problem by accessing the 
intracellular space with pore-forming fungicides in the electrode solution allowing the entire cell 
to be voltage-clamped without disrupting its contents and the integrated activity of all the Ca
2+
 
channels, pumps, and exchangers in the membrane can be measured (Inayat et al., 2010). 
Because of its electrogenic properties, whole cell patch clamp recording of NCX current relies 
on manipulation of the artificial ionic environment for activation. However, the perforated patch 
technique allows for the assessment of NCX in a more natural state. Furthermore, using the 
perforated patch clamp technique combine with fura-2AM imaging allows for the ability to 
simultaneously study the [Ca
2+
]i and the electrophysiological properties of the cell such that the 
relative contribution of voltage dependent and -independent processes can be assessed that 
govern intracellular Ca
2+
 homeostasis. 
Lastly, the cell body has served as an extremely useful model to study molecules and 
modulatory mechanisms mediating nociceptor transduction and sensitization, as many of these 
mechanisms are manifest in the cell body. Furthermore, the soma expresses many molecular 
entities that are expressed in free nerve endings both at the central and peripheral terminals 
(Malin et al., 2007). However, as a model, it has limitations. The spatial distribution of cytosolic 
components is not the same throughout the neuron suggesting different protein-protein 
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interaction. Furthermore, there appear to be differences in transduction and spike adaptation 
processes. The underlying differences may be due the lack of non-neuronal peripheral 
components required in vivo or differential distribution and modulation of transduction 
molecules. Interpreting injury-induced changes may be most misleading if the cell body is 
studied in isolation as demonstrated in the work described here, a loss of NCX activity in the cell 
body, while still important for pain signaling in the presence of inflammation, is not 
representative of what is happening at either the central or the peripheral terminals. This 
underscores the importance of corroborating results from cultured neurons with additional 
approaches attempting to retain an intact terminal field as well as behavior. 
5.5 CONCLUSIONS AND FUTURE DIRECTIONS 
All together this work emphasizes the importance of the regulation of intracellular Ca
2+
 in the 
initiation, maintenance and potentially resolution of hyperalgesia in the presence of 
inflammation. In the future, it will be necessary to figure out what NCX3 is doing on a functional 
level in the peripheral terminals. Furthermore, upon the discovery of the underlying mechanisms 
of the inflammation-induced increase in the magnitude of the evoked transient, it will be 
important to explore the interactions of these two mechanisms both at the cell body and in the 
terminals. As new technologies come available, it will be essential to look at multiple levels of 
this heterogeneous nociceptive system simultaneously to decode how changes in the intracellular 
Ca
2+
 signaling at different levels of the neuron results in functional aspects, such as excitability 
and neurotransmission at both the central and peripheral terminals for a better understanding of 
how to target this system effectively in the presence of chronic pain. 
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